
<html lang="en"     class="pb-page"  data-request-id="470e4732-b2dd-4547-9739-da69a7577a8f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b01213;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-20;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer" /></meta><meta name="dc.Creator" content="Mitsuyasu  Kawaguchi" /></meta><meta name="dc.Creator" content="Xiang  Han" /></meta><meta name="dc.Creator" content="Tomoka  Hisada" /></meta><meta name="dc.Creator" content="Sayaka  Nishikawa" /></meta><meta name="dc.Creator" content="Kuniyuki  Kano" /></meta><meta name="dc.Creator" content="Naoya  Ieda" /></meta><meta name="dc.Creator" content="Junken  Aoki" /></meta><meta name="dc.Creator" content="Tatsuya  Toyama" /></meta><meta name="dc.Creator" content="Hidehiko  Nakagawa" /></meta><meta name="dc.Description" content="Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein that is involved in bone metabolism and insulin resistance, hydrolyzes 2′,3′-cGAMP (a STING ligand..." /></meta><meta name="Description" content="Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein that is involved in bone metabolism and insulin resistance, hydrolyzes 2′,3′-cGAMP (a STING ligand..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 19, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01213" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01213" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01213" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01213" /></link>
        
    
    

<title>Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01213" /></meta><meta property="og:title" content="Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0012.jpeg" /></meta><meta property="og:description" content="Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein that is involved in bone metabolism and insulin resistance, hydrolyzes 2′,3′-cGAMP (a STING ligand that promotes innate immunity), and is associated with cancer stemness in breast cancers and glioblastoma. Therefore, ENPP1 is considered a candidate therapeutic target and/or biomarker for early diagnosis of malignant tumors. In this study, we designed and synthesized a sensitive ENPP1 fluorescence probe, Tokyo Green (TG) mAMP. We used it to screen a chemical library for non-phosphate ENPP1 inhibitors. Structural optimization of a selected hit afforded a potent and specific ENPP1 inhibitor. We further found that ENPP1 mRNA expression in tissue samples from patients with triple-negative breast cancer was significantly inversely related to recurrence-free survival (RFS) and overall survival (OS), and TG-mAMP assay revealed a significant difference in ENPP1 activity between ENPP1 high-expressing and ENPP1 low-expressing samples. Our results suggest that TG-mAMP assay might be a rapid and inexpensive tool for predicting the prognosis of patients with malignant breast cancers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01213"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01213">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01213&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01213&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01213&amp;href=/doi/10.1021/acs.jmedchem.9b01213" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9254-9269</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01187" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01247" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Mitsuyasu Kawaguchi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mitsuyasu Kawaguchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>M.K.: e-mail, <a href="/cdn-cgi/l/email-protection#6f02040e180e081a0c07062f1f070e1d41010e0800160e420c1a410e0c41051f"><span class="__cf_email__" data-cfemail="422f292335232537212a2b02322a23306c2c23252d3b236f21376c23216c2832">[email protected]</span></a>; phone, +81-52-836-3408.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mitsuyasu++Kawaguchi">Mitsuyasu Kawaguchi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiang Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiang Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiang++Han">Xiang Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomoka Hisada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomoka Hisada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Medical Sciences, Department of Breast Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomoka++Hisada">Tomoka Hisada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sayaka Nishikawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sayaka Nishikawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Medical Sciences, Department of Breast Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sayaka++Nishikawa">Sayaka Nishikawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kuniyuki Kano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kuniyuki Kano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kuniyuki++Kano">Kuniyuki Kano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naoya Ieda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoya Ieda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoya++Ieda">Naoya Ieda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Junken Aoki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Junken Aoki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Junken++Aoki">Junken Aoki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tatsuya Toyama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tatsuya Toyama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Medical Sciences, Department of Breast Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tatsuya++Toyama">Tatsuya Toyama</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hidehiko Nakagawa</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hidehiko Nakagawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>H.N.: e-mail, <a href="/cdn-cgi/l/email-protection#214544424e61514940530f4f40464e58400c42540f40420f4b51"><span class="__cf_email__" data-cfemail="5b3f3e38341b2b333a29">[email protected]</span>.nagoya-cu.ac.jp</a>; phone, +81-52-836-3407.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hidehiko++Nakagawa">Hidehiko Nakagawa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8435-4401" title="Orcid link">http://orcid.org/0000-0001-8435-4401</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01213&amp;href=/doi/10.1021%2Facs.jmedchem.9b01213" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9254–9269</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 19, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 July 2019</li><li><span class="item_label"><b>Published</b> online</span>19 September 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01213" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01213</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9254%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMitsuyasu%2BKawaguchi%252C%2BXiang%2BHan%252C%2BTomoka%2BHisada%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D20%26contentID%3Dacs.jmedchem.9b01213%26title%3DDevelopment%2Bof%2Ban%2BENPP1%2BFluorescence%2BProbe%2Bfor%2BInhibitor%2BScreening%252C%2BCellular%2BImaging%252C%2Band%2BPrognostic%2BAssessment%2Bof%2BMalignant%2BBreast%2BCancer%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9269%26publicationDate%3DOctober%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01213"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2424</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01213" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mitsuyasu&quot;,&quot;last_name&quot;:&quot;Kawaguchi&quot;},{&quot;first_name&quot;:&quot;Xiang&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Tomoka&quot;,&quot;last_name&quot;:&quot;Hisada&quot;},{&quot;first_name&quot;:&quot;Sayaka&quot;,&quot;last_name&quot;:&quot;Nishikawa&quot;},{&quot;first_name&quot;:&quot;Kuniyuki&quot;,&quot;last_name&quot;:&quot;Kano&quot;},{&quot;first_name&quot;:&quot;Naoya&quot;,&quot;last_name&quot;:&quot;Ieda&quot;},{&quot;first_name&quot;:&quot;Junken&quot;,&quot;last_name&quot;:&quot;Aoki&quot;},{&quot;first_name&quot;:&quot;Tatsuya&quot;,&quot;last_name&quot;:&quot;Toyama&quot;},{&quot;first_name&quot;:&quot;Hidehiko&quot;,&quot;last_name&quot;:&quot;Nakagawa&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9254-9269&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01213&quot;},&quot;abstract&quot;:&quot;Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein that is involved in bone metabolism and insulin resistance, hydrolyzes 2′,3′-cGAMP (a STING ligand that promotes innate immunity), and is associated with cancer stemness in breast cancers and glioblastoma. Therefore, ENPP1 is considered a candidate therapeutic target and/or biomarker for early diagnosis of malignant tumors. In this study, we designed and synthesized a sensitive ENPP1 fluorescence probe, Tokyo Green (TG) mAMP. We used it to screen a chemical library for non-phosphate ENPP1 inhibitors. Structural optimization of a selected hit afforded a potent and specific ENPP1 inhibitor. We further found that ENPP1 mRNA expression in tissue samples from patients with triple-negative breast cancer was significantly inversely related to recurrence-free survival (RFS) and overall survival (OS), and TG-mAMP assay revealed a significant difference in ENPP1 activity between ENPP1 high-expressing and ENPP1 low-express&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01213&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01213" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01213&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01213" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01213&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01213" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01213&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01213&amp;href=/doi/10.1021/acs.jmedchem.9b01213" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01213" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01213" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01213%26sid%3Dliteratum%253Aachs%26pmid%3D31536342%26genre%3Darticle%26aulast%3DKawaguchi%26date%3D2019%26atitle%3DDevelopment%2Bof%2Ban%2BENPP1%2BFluorescence%2BProbe%2Bfor%2BInhibitor%2BScreening%252C%2BCellular%2BImaging%252C%2Band%2BPrognostic%2BAssessment%2Bof%2BMalignant%2BBreast%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D20%26spage%3D9254%26epage%3D9269%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=292601" title="Probes">Probes</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/jmcmar.2019.62.issue-20/20191024/jmcmar.2019.62.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein that is involved in bone metabolism and insulin resistance, hydrolyzes 2′,3′-cGAMP (a STING ligand that promotes innate immunity), and is associated with cancer stemness in breast cancers and glioblastoma. Therefore, ENPP1 is considered a candidate therapeutic target and/or biomarker for early diagnosis of malignant tumors. In this study, we designed and synthesized a sensitive ENPP1 fluorescence probe, Tokyo Green (TG) mAMP. We used it to screen a chemical library for non-phosphate ENPP1 inhibitors. Structural optimization of a selected hit afforded a potent and specific ENPP1 inhibitor. We further found that <i>ENPP1</i> mRNA expression in tissue samples from patients with triple-negative breast cancer was significantly inversely related to recurrence-free survival (RFS) and overall survival (OS), and TG-mAMP assay revealed a significant difference in ENPP1 activity between <i>ENPP1</i> high-expressing and <i>ENPP1</i> low-expressing samples. Our results suggest that TG-mAMP assay might be a rapid and inexpensive tool for predicting the prognosis of patients with malignant breast cancers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein that converts extracellular nucleotide triphosphates, such as ATP and GTP, into nucleotide monophosphates, such as AMP and GMP, and inorganic pyrophosphate (PPi).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> It is an ectoenzyme whose catalytic domain is located in the extracellular space of mineralizing cells, such as osteoblasts and chondrocytes, contributing to the regulation of bone metabolism.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The generation of PPi in the extracellular space inhibits mineralization by binding to hydroxyapatite, while the hydrolysis of PPi by tissue nonspecific alkaline phosphatase (TNAP) affords phosphate (Pi), which crystallizes with calcium to form hydroxyapatite.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> Therefore, ENPP1, in concert with TNAP, is a key regulator of bone metabolism. Indeed, mutation of ENPP1 is associated with generalized arterial calcification of infancy (GACI), while upregulation of ENPP1 is associated with cardiac calcification after heart injury.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> ENPP1 also inhibits insulin signaling through direct binding with insulin receptor on the plasma membrane,<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> and the K173Q polymorph of ENPP1 is associated with insulin resistance, type II diabetes, and obesity, which in turn may lead to stroke and various kidney diseases.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a></div><div class="NLM_p">Recently, it was reported that ENPP1 is a major player in the hydrolysis of cyclic dinucleotides (CDNs), such as 2′,3′-cGAMP, which is the second messenger produced by a DNA sensor enzyme, cyclic GMP-AMP synthase (cGAS).<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> 2′,3′-cGAMP can stimulate the STING (stimulator of interferon genes) pathway through binding with STING protein, which is localized in endoplasmic reticulum and promotes innate immune responses by inducing the production of cytokines, including type I interferons.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Because the STING pathway is a potential target for cancer immunotherapy, a number of STING agonists have developed and some have shown efficacy in in vivo cancer models.<a onclick="showRef(event, 'ref15 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref20 ref21 ref22 ref23">(15,20−23)</a> However, since hyperactivation of the STING pathway by STING agonists may lead to excess accumulation of proinflammatory cytokines, it is important to develop immunotherapeutics that only mildly activate this pathway. In this context, immunotherapy with ENPP1 inhibitors as indirect activators of the STING pathway through the suppression of 2′,3′-cGAMP degradation, in combination with PD-1 immune checkpoint blockade with PD-1 antibody, has attracted much attention.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Furthermore, in 2015, Ochiya and co-workers reported that ENPP1 is upregulated in breast cancers via downregulation of microRNA-27b, and plays a role in cancer stem cell properties, including drug resistance and tumor seeding ability.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Other groups have reported similar pathological roles of ENPP1 in glioblastoma and lung cancers.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a> Therefore, ENPP1 is considered to be a promising candidate as an antitumor target, especially for targeting cancer stem cells, as well as a novel biomarker for aggressive tumors, including triple-negative breast cancer (TNBC) and glioblastoma.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p last">For the development of drug-like ENPP1 inhibitors and diagnostic agents for ENPP1-overexpressing tumors, we require a fluorescence probe with high sensitivity and selectivity. However, the only probe so far reported is the chromogen <i>p</i>-nitrophenyl thymidine 5′-monophosphate (<i>p</i>NP-TMP), which is an artificial substrate of not only ENPP1 but also other ENPP family members, including ENPP2, -3, -4, and -5, and enables detection of their activity in terms of absorbance change at 405 nm.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> In addition, most reported ENPP1 inhibitors are not promising as drug candidates because they are phosphate-containing ATP analogues, which may be hydrolyzed under physiological conditions to generate purine receptor agonists/antagonists.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref36 ref37 ref38">(32−38)</a> Although a few non-ATP-like ENPP1 inhibitors have been reported, their inhibitory activities are weak in ATP-based assay, notwithstanding reasonable potency in <i>p</i>NP-TMP assay.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> Therefore, our aims in this study were first to develop a practically useful ENPP1 fluorescence probe and second to apply the developed probe, Tokyo Green methyleneoxy-AMP (TG-mAMP), for chemical screening to identify potent and specific drug-like ENPP1 inhibitors. We also show that TG-mAMP is suitable for fluorescence imaging of ENPP1 activity in living cells. In addition, TG-mAMP assay revealed a significant difference in ENPP1 activity between <i>ENPP1</i> high-expressing and <i>ENPP1</i> low-expressing patients with triple-negative breast cancer, in whom <i>ENPP1</i> mRNA expression is inversely correlated with poor prognosis. This result indicates that TG-mAMP could be a useful tool for rapid and inexpensive prediction of the prognosis of patients with malignant tumors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> shows the synthesis of TG-mAMP and TG-mGMP. Phenol group of 2-Me-4-OMe TG was chloromethylated with chloromethyl chlorosulfate to afford TG-mCl. Alkylation of AMP and GMP with TG-mCl gave TG-mAMP and TG-mGMP, respectively. <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> illustrates the synthesis of TG-AMP and TG-GMP. Esterification of phosphate group of AMP and GMP with phenol group of 2-Me-4-OMe TG in the presence of EDCI and DMAP gave TG-AMP and TG-GMP, respectively. All fluorescence probes were purified by HPLC, and the purity of them was ≥95%.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of TG-mAMP and TG-mGMP<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloromethyl chlorosulfate, <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C to rt, 46%; (b) AMP, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 4.8%; (c) GMP·2Na salt, <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, rt, 2.7%.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of TG-AMP and TG-GMP<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AMP, EDCI, DMAP, NEt<sub>3</sub>, <i>t</i>BuOH/H<sub>2</sub>O, reflux, 15%; (b) GMP·2Na salt, EDCI, DMAP, NEt<sub>3</sub>, <i>t</i>BuOH/H<sub>2</sub>O, reflux, 18%.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> shows the preparation of compounds <b>A</b>, <b>B</b>, <b>C</b>, and <b>E</b>. Alkylation of ethyl acetoacetate (compound <b>1</b>) with benzyl bromide or its derivatives afforded the desired compounds <b>2</b>, <b>4</b>, and <b>8</b>. Cyclization of compounds <b>2</b>, <b>4</b>, and <b>8</b> with 3-amino-1,2,4-triazole gave 1,2,4-triazolo[1,5-<i>a</i>]pyrimidin scaffold, compound <b>E</b>, compounds <b>5</b> and <b>9</b>, respectively. Chlorination of compound <b>E</b>, compounds <b>5</b> and <b>9</b> in POCl<sub>3</sub> gave compounds <b>3</b>, <b>6</b>, and <b>10</b>, respectively. Substitution of the chlorine atom of compounds <b>3</b>, <b>6</b>, and <b>10</b> with dimethylamine yielded compounds <b>A</b>, <b>7</b>, and <b>11</b>, respectively. Catalytic reduction of the nitro group in compounds <b>7</b> and <b>11</b> afforded compounds <b>B</b> and <b>C</b>, respectively.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>A</b>, <b>B</b>, <b>C</b>, and <b>E</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>t</i>BuOK, benzyl bromide (for compound <b>2</b>), 4-nitrobenzyl bromide (for compound <b>4</b>), 3-nitrobenzyl bromide (for compound <b>8</b>), THF, 0 °C, then reflux, 72% for compound <b>2</b>, 38% for compound <b>4</b>, 48% for compound <b>8</b>; (b) 3-amino-1,2,4-triazole, AcOH, reflux, 73% for compound <b>E</b>, 71% for compound <b>5</b>, 77% for compound <b>9</b>; (c) POCl<sub>3</sub>, reflux, 57% for compound <b>3</b>, 44% for compound <b>6</b>, 38% for compound <b>10</b>; (d) 50% NHMe<sub>2</sub>, EtOH, rt, 78% for compound <b>A</b>, 97% for <b>7</b>, 97% for compound <b>11</b>; (e) Pd/C, H<sub>2</sub>, MeOH/CH<sub>2</sub>Cl<sub>2</sub>, rt, 56% for compound <b>B</b>, 38% for compound <b>C</b>.</p></p></figure><div class="NLM_p">The preparation of compound <b>D</b> is illustrated in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Cyclization of acetoacetate (compound <b>1</b>) with 3-amino-1,2,4-triazole gave compound <b>12</b>. Chlorination and substitution reaction with dimethylamine of compound <b>12</b> afforded desired compound <b>D</b>.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>D</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-amino-1,2,4-triazole, AcOH, reflux, 53%; (b) POCl<sub>3</sub>, reflux, 46%; (c) 50% NHMe<sub>2</sub>, EtOH, rt, 73%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Development of ENPP1 Fluorescence Probe TG-mAMP</h3><div class="NLM_p">Because ENPP1 efficiently hydrolyzes ATP to AMP and PPi, and 2′,3′-cGAMP to AMP and GMP (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A),<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> we speculated that ENPP1 recognizes the AMP moiety and that the β- and γ-phosphate groups of ATP are not necessary for substrate recognition. On the basis of our previously reported fluorescence probes for ENPP2 (also known as autotaxin) and ENPP6 and widely used ENPP substrate, <i>p</i>NP-TMP,<a onclick="showRef(event, 'ref31 ref39'); return false;" href="javascript:void(0);" class="ref ref31 ref39">(31,39)</a> we designed and synthesized TG-mAMP and TG-mGMP, which consist of the Tokyo Green (TG) fluorophore, a methyleneoxy linker, and nucleotide monophosphate (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> We also synthesized TG-AMP and TG-GMP, which lack the methyleneoxy linker of TG-mAMP and TG-mGMP, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reaction of ENPP1 with (A) native substrates ATP and 2′,3′-cGAMP and with (B) an artificial substrate, <i>p</i>NP-TMP, and the fluorescence probes TG-mAMP and TG-AMP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The photochemical properties of the probes and 2-Me-4-OMe TG are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The fluorescence quantum yields of the four fluorescence probes were sufficiently low compared to that of 2-Me-4-OMe TG, and this is considered to be due to acceptor-excited photoinduced electron transfer (a-PeT) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S1</a>).<a onclick="showRef(event, 'ref31 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref31 ref39 ref40">(31,39,40)</a> We measured the reactivities of the four fluorescence probes with ENPP family members (ENPP1–7) and found that all four probes were good substrates of ENPP1 and ENPP3, resulting in large fluorescence increments (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S2</a>), probably because ENPP1 and ENPP3 are phylogenetically similar and the native substrate is ATP in both cases.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Next, we calculated the kinetic parameters from Michaelis–Menten plots and found that TG-mAMP is a better substrate of ENPP1 than TG-mGMP (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S3</a>). Further, hydrolysis of TG-mAMP by ENPP1 resulted in a fluorescence increase of about 375-fold (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S4</a>). We next performed a docking study of TG-mAMP with ENPP1 and compared the binding mode with AMP (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S5</a>). In the result, we found that the AMP moiety of TG-mAMP binds to a nucleotide binding pocket in the same binding manner as AMP itself; in addition, that TG moiety exists on the surface of ENPP1 without interfering with a binding of AMP moiety into the catalytic pocket. These results strongly support the finding that TG-mAMP is a good substrate of ENPP1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Product analysis of the enzymatic reaction of TG-mAMP with ENPP1 showed clean generation of the fluorescent product 2-Me-4-OMe TG without side reactions. Since the expression of ENPP3 is limited to specific tissues, especially basophils and mast cells,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> these results suggest that TG-mAMP would be practically useful to detect ENPP1 activity with high sensitivity and good selectivity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Photochemical Properties of ENPP1 Fluorescence Probes and 2-Me-4-OMe TG<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">λ<sub>max</sub> (nm)</th><th class="colsep0 rowsep0" align="center" char=".">ε (×10<sup>4</sup> M<sup>–1</sup> cm<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">λ<sub>max</sub> (nm)</th><th class="colsep0 rowsep0" align="center" char=".">Φ<sub>FL</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TG-mAMP</td><td class="colsep0 rowsep0" align="char" char=".">455</td><td class="colsep0 rowsep0" align="char" char=".">1.80</td><td class="colsep0 rowsep0" align="char" char=".">517</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TG-mGMP</td><td class="colsep0 rowsep0" align="char" char=".">457</td><td class="colsep0 rowsep0" align="char" char=".">1.85</td><td class="colsep0 rowsep0" align="char" char=".">514</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TG-AMP</td><td class="colsep0 rowsep0" align="char" char=".">454</td><td class="colsep0 rowsep0" align="char" char=".">1.51</td><td class="colsep0 rowsep0" align="char" char=".">510</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TG-GMP</td><td class="colsep0 rowsep0" align="char" char=".">454</td><td class="colsep0 rowsep0" align="char" char=".">2.01</td><td class="colsep0 rowsep0" align="char" char=".">517</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2-Me-4-OMe TG</td><td class="colsep0 rowsep0" align="char" char=".">492</td><td class="colsep0 rowsep0" align="char" char=".">7.59</td><td class="colsep0 rowsep0" align="char" char=".">511</td><td class="colsep0 rowsep0" align="char" char=".">0.84</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data were measured in sodium phosphate buffer (pH 7.4). For determination of Φ<sub>FL</sub>, fluorescein in 0.1 N NaOH (Φ<sub>FL</sub> = 0.85) was used as a fluorescence standard.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinetic Parameters of TG-mAMP, TG-mGMP, <i>p</i>NP-TMP, and ATP with ENPP1<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>Κ</i><sub>Μ</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>cat</sub> (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> (s<sup>–1</sup> M<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TG-mAMP</td><td class="colsep0 rowsep0" align="left">130 ± 10</td><td class="colsep0 rowsep0" align="left">7.3 ± 0.28</td><td class="colsep0 rowsep0" align="char" char=".">58000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TG-mGMP</td><td class="colsep0 rowsep0" align="left">85 ± 4.5</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.067</td><td class="colsep0 rowsep0" align="char" char=".">37000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>p</i>NP-TMP</td><td class="colsep0 rowsep0" align="left">230 ± 5.7</td><td class="colsep0 rowsep0" align="left">16 ± 0.17</td><td class="colsep0 rowsep0" align="char" char=".">68000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="char" char=".">348000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The initial velocity, <i>v</i>, was evaluated from the change of fluorescence intensity at 535 nm for Tokyo Green (TG) and the change of absorbance at 405 nm for <i>p</i>-nitrophenol. The results are shown as the mean ± SD (<i>n</i> = 3).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Data from ref <a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a>.</p></div></div></div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Fluorescence enhancement of TG-mAMP upon hydrolysis by ENPP1. Fluorescence enhancement (FI<sub>30min</sub>/FI<sub>0min</sub>) due to enzymatic reactions of (A) TG-mAMP and (B) TG-mGMP with various ENPPs at 30 min. Reactions were performed with 1 μM TG-mAMP or TG-mGMP and 1 μg/mL ENPPs in ENPP assay buffer (100 mM Tris-HCl (pH 9.0), 150 mM NaCl, 5 mM MgCl<sub>2</sub>, and 0.05% Triton X-100) at 37 °C. Excitation and emission wavelengths were 485 and 535 nm, respectively. The results are shown as the mean ± SD (<i>n</i> = 3). (C) HPLC analyses of the enzymatic reaction of 5 μM TG-mAMP and 1 μg/mL ENPP1. Absorbance at 490 nm was monitored.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemical Screening of ENPP1 Inhibitors Using TG-mAMP, and Lead Optimization Study</h3><div class="NLM_p">We next used TG-mAMP to screen part of a large chemical library of 9600 compounds for drug-like ENPP1 inhibitors without a phosphate group. First, we established the screening system by optimizing the concentrations of enzyme and DMSO and the incubation time and confirmed that the developed system can screen ENPP1 inhibitors with high sensitivity and reliability (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S6</a>). The <i>Z</i>′ factor of the optimized screening system was calculated to be 0.91, indicating excellent reliability (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S7</a>). Since ENPP1 activity is inhibited by its product AMP,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> we searched for a suitable positive control compound among 11 kinds of nucleotides, including AMP, GMP, CMP, TMP, UMP, IMP, 2′-dCMP, 3′-CMP, ATP, AP<sub>3</sub>A, and AP<sub>4</sub>A, and found that AMP most efficiently inhibited the activities of ENPP1 and ENPP3 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S8A,B</a>). The IC<sub>50</sub> values of AMP toward ENPP1 and ENPP3 were calculated to be 5.3 and 270 μM, respectively, which is consistent with the preference of ENPP1 and ENPP3 for ATP as a natural substrate (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S8C</a>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus, we selected AMP as a positive control for the chemical screening.</div><div class="NLM_p">The screening was performed in a 384-well format, and all compounds were tested at 10 μM, in the presence of 1% DMSO. After a second screening to confirm dose-dependency and to eliminate false-positives, 13 compounds showed >90% inhibition at 10 μM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). These 13 compounds were further tested to determine their specificity for ENPP1 over ENPP3 (≥10-fold) because ENPP3 has the highest homology with ENPP1 among ENPPs, and we finally obtained six compounds as ENPP1 inhibitor candidates. Among these six compounds, we focused on compound <b>A</b> because compound <b>A</b> showed a good potency and high selectivity for ENPP1 over other ENPP family enzymes, including ENPP3 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Results of chemical screening of ENPP1 inhibitors and structural optimization. (A) Scheme of chemical screening and hit compounds in the three screens. (B) Structure of compound <b>A</b> and inhibitory activity and selectivity (10 μM) toward ENPP1 over other ENPP family members. The results are shown as the mean ± SD (<i>n</i> = 3). (C) Structures of compounds <b>B</b>–<b>E</b>. (D) IC<sub>50</sub> values of compounds <b>A</b>–<b>E</b> toward ENPP1 and ENPP3 evaluated by means of TG-mAMP, <i>p</i>NP-TMP, and ATP assays (at least two experiments). N.D. = not determined. For details, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S9</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We then set out to synthesize compound <b>A</b> and its analogues in order to study the structure–activity relationship (SAR) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). We found that the benzyl group and dimethylamino group of compound <b>A</b> are essential for potent ENPP1 inhibition because compounds <b>D</b> and <b>E</b> showed quite weak inhibitory activities. In contrast, the introduction of an amino group at the 4- or 3-position of the benzyl group, compounds <b>B</b> and <b>C</b>, respectively, increased the inhibitory activity about 2- to 3-fold while retaining high selectivity over other ENPP family members, including ENPP3 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">S9</a>). We evaluated the inhibitory activities of compounds <b>A</b>–<b>E</b> with other substrates, including <i>p</i>NP-TMP and ATP, and found that compounds <b>A</b>–<b>C</b> showed potent ENPP1-inhibitory activity and good selectivity in both <i>p</i>NP-TMP and ATP assays (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">S9</a>). It is noteworthy that compound <b>C</b> exhibited potent inhibitory activity in ATP assay because many reported ENPP1 inhibitors show weak inhibitory activity in ATP assay despite potent activity in <i>p</i>NP-TMP assay.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> We finally set out to elucidate the inhibition mechanism of compounds <b>A</b>–<b>C</b>. Lineweaver–Burk plots indicated that all three compounds show mixed-type inhibition of ENPP1-mediated hydrolysis of TG-mAMP (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S10</a>).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Detection of ENPP1 Activity in Various Kinds of Cultured Cells</h3><div class="NLM_p">ENPP1 is overexpressed in some cancers, including breast cancers, glioblastoma, and lung cancers<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26−29)</a> and is a potential facilitator of breast cancer bone metastasis,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> so we speculated that ENPP1 activity could be a useful diagnostic biomarker.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Therefore, we first examined whether TG-mAMP can measure ENPP1 activity in living cells. We prepared a panel of 10 cell lines, including 7 breast cancer cell lines (MDA-MB-231, MDA-MB-436, Hs578T, MCF7, ZR-75-1, SK-BR-3, and HCC1954 cells, among which MDA-MB-231, MDA-MB-468, and Hs578T cells are classed as TNBC), two gliomas (rat C6 and SK-N-SH cells) and HEK293 cells, of which MDA-MB-231 and C6 cells strongly express ENPP1.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> We measured the expression levels of ENPP1 in MDA-MB-231, MCF7, rat C6, and HEK293 cells and confirmed that MDA-MB-231 and rat C6 cells highly express ENPP1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,C). We next incubated these cells with TG-mAMP for 2 h and measured the fluorescence intensity. MDA-MB-231 and rat C6 cells showed strong fluorescence enhancements, which were completely suppressed to the background level by pretreatment with 50 μM compound <b>C</b>, suggesting that TG-mAMP can specifically detect ENPP1 activity in living cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In cellulo detection of ENPP1 activity using TG-mAMP. (A) Fluorescence enhancements of TG-mAMP upon incubation with 10 cell lines (TNBC lines are shown in bold). Reactions were performed with 2 μM TG-mAMP in the presence or absence of 50 μM compound <b>C</b> in DPBS at 37 °C for 2 h in 96-well microplates. The results are shown as the mean ± SD (<i>n</i> = 3). (B, C) Expression levels of ENPP1 in MDA-MB-231, MCF7, rat C6, and HEK293 cells. The molecular weights of human ENPP1 (red arrows) and rat ENPP1 (red arrowhead) are 140 and 110 kDa, respectively. β-Actin and α-tubulin were used as loading controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next examined the reactivity and selectivity of TG-mAMP for ENPP1 in comparison with other fluorescence probes, TG-mGMP, TG-AMP, TG-GMP. In the assay with MDA-MB-231 cells, TG-AMP and TG-GMP showed larger fluorescence enhancements than did TG-mAMP, but pretreatment of compound <b>C</b> did not suppress the fluorescence increments, suggesting that TG-AMP and TG-GMP react not only with ENPP1 but also with other enzymes (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). On the other hand, the fluorescence increments detected by TG-mAMP and TG-mGMP were completely suppressed by compound <b>C</b>, in agreement with the above results (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Thus, we considered that TG-mAMP and TG-mGMP can be used for the detection of cellular ENPP1 activity, and the methyleneoxy linkers appear to be very important for the selectivity for ENPP1 over other extracellular enzymes (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). This is in accordance with our previous finding that linker structures of the phosphoester bond affect the substrate specificity toward several phosphatases, including alkaline phosphatase, tyrosine phosphatase, and serine/threonine phosphatase, probably due to the effect on the p<i>K</i><sub>a</sub> value of the leaving hydroxyl group.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Thus, it appears that a high p<i>K</i><sub>a</sub> value of the methyleneoxy linker is important for the selectivity for ENPP1.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of methyleneoxy linker on reactivity and selectivity in MDA-MB-231 cells. (A) Fluorescence enhancements of TG-AMP, TG-GMP, TG-mAMP, and TG-mGMP upon incubation with MDA-MB-231 cells. Reactions were performed with 2 μM fluorescence probes in the presence or absence of 50 μM compound <b>C</b> in DPBS at 37 °C for 2 h in 96-well microplates. The results are shown as the mean ± SD (<i>n</i> = 3). (B) Differences in the linker structures of the four ENPP fluorescence probes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Live Cell Imaging Using TG-mAMP</h3><div class="NLM_p">We further examined whether TG-mAMP is suitable for live cell fluorescence imaging. In both MDA-MB-231 and rat C6 cells, potent fluorescence enhancement was observed upon addition of TG-mAMP (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The reason why fluorescence enhancement was observed in the medium, as well as inside the cells, is that TG-mAMP is hydrolyzed by ENPP1 in extracellular space due to its hydrophilicity and the product, 2-Me-4-OMe TG, generated in the extracellular space by ENPP1 can penetrate the plasma membrane and easily leaks out of the cells. Pretreatment with compounds <b>A</b>–<b>C</b> suppressed the fluorescence enhancement, whereas pretreatment with compound <b>E</b> did not. The rank order of suppression of the fluorescence enhancement in living cells was similar to that of the in vitro IC<sub>50</sub> values of the ENPP1 inhibitors. We also confirmed that compound <b>C</b> suppressed the fluorescence signal in a dose-dependent manner (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S11</a>), suggesting that compound <b>C</b> serves as a potent ENPP1 inhibitor even in living cells. These results indicate that TG-mAMP is available for live cell imaging and that compounds <b>A</b>–<b>C</b> are potent inhibitors of ENPP1 activity in cellulo.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Fluorescence microscopic imaging of ENPP1 activity in living cells with TG-mAMP. (A) MDA-MB-231 and (C) rat C6 cells were incubated with 2 μM TG-mAMP in DPBS in the presence or absence of 10 μM compounds <b>A</b>–<b>C</b> and <b>E</b> at 37 °C. Confocal fluorescence and DIC images were acquired at 1 h after addition of TG-mAMP. Comparison of the fluorescence intensities of (B) MDA-MB-231 and (D) rat C6 cells treated with DMSO and compounds <b>A</b>–<b>C</b> and <b>E</b>. Fluorescence intensities of regions of interest (inside cells) under each condition were calculated with ImageJ. The results are shown as the mean ± SD (<i>n</i> = 10): ***<i>P</i> < 0.001, NS = not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Evaluation of ENPP1 mRNA Expression and Measurement of ENPP1 Activity in Specimens from Breast Cancer Patients</h3><div class="NLM_p">We next evaluated <i>ENPP1</i> mRNA expression in 437 breast cancer tissue samples collected at Nagoya City University Hospital and examined the relationship between <i>ENPP1</i> expression and prognosis. Although no correlation was seen between <i>ENPP1</i> mRNA expression and prognosis in all of these breast cancer patients, we found inverse correlations of <i>ENPP1</i> mRNA expression with recurrence-free survival (RFS) and overall survival (OS) in the subset of triple-negative breast cancer patients, who lack expression of estrogen receptor (ER), progesterone receptor (PR), and HER2 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B). Ochiya and co-workers have reported that coexpression of <i>ENPP1</i> and <i>ABCG2</i> was moderately associated with poor prognosis in luminal A and B-type cancers.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Taken together, these results suggest that high expression of <i>ENPP1</i> in breast cancers may be associated with a poor prognosis and may be a useful biomarker of the malignant potential of breast cancers.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. High expression of <i>ENPP1</i> mRNA is significantly correlated with poor prognosis in triple-negative breast cancers. Kaplan–Meier representations of (A) recurrence-free survival and (B) overall survival in 53 TNBC patients classified according to the expression level of <i>ENPP1</i>. (C) Fluorescence intensities of breast cancer specimens obtained with 2 μM TG-mAMP in the presence or absence of 50 μM compound <b>C</b>. Patients 1, 2, 3, 4, and 13 are TNBC. (D) Comparison of normalized fluorescence intensities in TG-mAMP assay (a.u./g tumor tissue) between ENPP1 low- and high-expressing specimens. (E) Correlation between mRNA expression (<i>ENPP1</i>/<i>GAPDH</i>) and ENPP1 activity measured with TG-mAMP, normalized by the activity of patient 2. Red circles: low <i>ENPP1</i> expression and low ENPP1 activity. Blue open triangles: high <i>ENPP1</i> expression but low ENPP1 activity, which might be false-negative. Blue squares: high <i>ENPP1</i> expression and high ENPP1 activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We therefore examined whether TG-mAMP can measure ENPP1 activity in breast cancer specimens. We divided the specimens into two classes, with high and low expression of <i>ENPP1</i> mRNA; the threshold value of <i>ENPP1</i>/<i>GAPDH</i> ratio was 16.945. To evaluate ENPP1 activity in specimens by using TG-mAMP, we cut a specimen roughly into two halves and measured the fluorescence increment in the presence or absence of compound <b>C</b> to confirm specific detection of ENPP1. Some specimens, whose <i>ENPP1</i> mRNA expression level was high, showed potent fluorescence enhancement in the absence of compound <b>C</b>, while the enhancement was mostly suppressed in the presence of compound <b>C</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). As for the apparently anomalous result of patient 13, we speculate that inhibition by compound <b>C</b> was unsuccessful because of an extremely high expression level of <i>ENPP1</i>. Because the weights of specimens were not the same, we standardize fluorescence intensity by the weight of each specimen. We found that there was a significant difference in ENPP1 activity detected with TG-mAMP between the <i>ENPP1</i> high-expressing group and the <i>ENPP1</i> low-expressing group (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">S12</a>). It should be noted that we could not detect ENPP1 activity in all <i>ENPP1</i> high-expressing specimens, and we consider there are two possible explanations for this: (i) inconsistency between protein expression levels and mRNA expression levels of <i>ENPP1</i> and (ii) differences in subcellular localization of ENPP1. Although ENPP1 is generally thought to be localized in plasma membrane, a recent report suggests that it is also expressed intracellularly, especially in Golgi apparatus.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> If this is the case, we would not be able to detect the activity because TG-mAMP cannot penetrate the plasma membrane to reach Golgi bodies.</div><div class="NLM_p last">Although TG-mAMP did not give a positive result for all <i>ENPP1</i> high-expressing specimens, it is important that those specimens whose fluorescence enhancement was sufficiently high in TG-mAMP assay clearly showed a poor prognosis, and all low <i>ENPP1</i>-expressing specimens exhibited low fluorescence, meaning that the TG-mAMP assay did not generate false-positives (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>E). Therefore, TG-mAMP might be a useful diagnostic tool for evaluating the prognosis of breast cancer patients because TG-mAMP fluorescence assay of clinical specimens obtained at surgery or biopsy could be promptly performed and is much simpler than <i>ENPP1</i> mRNA analysis. TG-mAMP might also be useful as a tool for early diagnosis of malignant tumors, including glioblastoma and lung cancers.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> However, further work will be required to confirm this.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">There is increasing evidence that ENPP1 could be a therapeutic target and an early biomarker of malignant tumors, and it is considered that ENPP1 inhibitors are candidates for cancer immunotherapy via activation of the STING pathway. In this study, we designed and synthesized a novel ENPP1 fluorescence probe, TG-mAMP, which can detect ENPP1 activity with high sensitivity. We further used this probe to screen a chemical library for ENPP1 inhibitors and carried out structural optimization of a selected hit compound, obtaining a potent and selective ENPP1 inhibitor. We believe this represents a novel scaffold for ENPP1 inhibitors. Using our probe TG-mAMP and ENPP1 inhibitors, we demonstrated specific imaging of ENPP1-overexpressing MDA-MB-231 and rat C6 cells. Analysis of tissue samples from a series of breast cancer patients at Nagoya City University Hospital showed significant inverse correlations of <i>ENPP1</i> mRNA expression with recurrence-free survival (RFS) and overall survival (OS) in the subset of triple-negative breast cancer patients, and measurements of ENPP1 activity with TG-mAMP revealed a significant difference in ENPP1 activity between the <i>ENPP1</i> high-expressing and <i>ENPP1</i> low-expressing groups. These results suggest that TG-mAMP assay might be a rapid and inexpensive tool for predicting the prognosis of patients with malignant breast cancers.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">1.  General Information</h3><div class="NLM_p last">Proton nuclear magnetic resonance spectra (<sup>1</sup>H NMR) and carbon nuclear magnetic resonance spectra (<sup>13</sup>C NMR) were recorded on a JEOL JNM-ECZ500R, JEOL JNM-LA500 or Varian VNMRS 500 spectrometer in the indicated solvent. Chemical shifts (δ) are reported in parts per million relative to the internal standard, tetramethylsilane (TMS). Electrospray ionization (ESI) mass spectra were recorded on a JEOL JMS-T100LC mass spectrometer equipped with a nanospray ion source. Ultraviolet–visible-light absorption spectra were recorded on an UV-1800 spectrophotometer (Shimadzu, Japan). Fluorescence spectra were recorded on an RF-5300PC fluorometer (Hitachi, Japan). Analytical HPLC was performed with a Shimadzu pump system equipped with a reversed-phase ODS column (Inertsil ODS-3 4.6 mm × 150 mm, GL Science) at a flow rate of 1.0 mL/min. Semipreparative HPLC purification was performed with a JASCO PU-2086 pump system equipped with a reversed-phase ODS column (Inertsil ODS-3 20 mm × 250 mm, GL Science) at a flow rate of 10 mL/min. Microplate fluorescence assay was performed on an ARVO X5 plate reader (PerkinElmer). For chemical screening, reagents were dispensed with a Multidrop Combi (Thermo Scientific, USA) into 384-well plates and fluorescence assay performed on a PHERAstar (BMG LABTECH, Germany). For Western blot analysis, the immunoblots were visualized by an LAS3000 (FUJIFILM, Japan). Confocal fluorescence images were taken with an IX-71 (Olympus) equipped with a disk scanning unit. Half-area 96-well microplates (no. 3694) were purchased from Corning. 384-well microplates (no. 784900) were purchased from Greiner Bio-One. Glass-bottomed dishes (D11130H) were purchased from Matsunami. PLL-coated 96-well microplates (4860-040) were purchased from IWAKI. TaKaRa BCA protein assay kit was purchased from Takara Bio Inc. Anti-ENPP1, anti-β-actin, goat anti-rabbit IgG-HRP conjugates and anti-mouse IgG-HRP conjugates antibodies were purchased from Cell Signaling Technology. All other reagents and solvents were purchased from Sigma-Aldrich, Tokyo Chemical Industry Co., Ltd. (TCI), Wako Pure Chemical Industries, Kanto Kagaku, Junsei Kagaku, or Nacalai Tesque and used without further purification. Flash column chromatography was performed using silica gel 60 (particle size 0.032–0.075) supplied by Taikoh-shoji. The purity of all synthesized compounds was assessed by HPLC and was ≥95% (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S13</a>).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">2.  Chemistry</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Synthesis of TG-mCl</h4><div class="NLM_p last">To a solution of 2-Me-4-OMe TG (100 mg, 0.31 mmol), NaHCO<sub>3</sub> (104 mg, 1.2 mmol), and <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub> (11 mg, 0.031 mmol) in distilled water (2 mL) was added CH<sub>2</sub>Cl<sub>2</sub> (2 mL) at 0 °C. The reaction mixture was stirred for 10 min, then chloromethyl chlorosulfate (40 μL, 0.403 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added dropwise. The solution was vigorously stirred at 0 °C for 30 min, then at room temperature for 12 h. The organic phase was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, CHCl<sub>3</sub>) to give TG-mCl (55 mg, 0.14 mmol), yield 46% as an orange solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 Hz, ppm): δ 2.06 (s, 3H), 3.90 (s, 3H), 5.94 (s, 2H), 6.45 (d, 1H, <i>J</i> = 1.9 Hz), 6.58 (dd, 1H, <i>J</i> = 1.9, 9.7 Hz), 6.89–6.95 (m, 3H), 7.01 (d, 1H, <i>J</i> = 9.7 Hz), 7.06–7.12 (m, 2H), 7.19 (d, 1H, <i>J</i> = 2.5 Hz). MS (ESI<sup>+</sup>): 381 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Synthesis of TG-mAMP</h4><div class="NLM_p last">To a solution of TG-mCl (30 mg, 0.079 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (26 mg, 0.079 mmol) in dry DMF (3 mL) was added AMP (137 mg, 0.40 mmol). The reaction mixture was stirred for 48 h at room temperature, then evaporated. The residue was purified by reversed-phase preparative HPLC (A:B = 80:20 to 0:100 (20 min). A: triethylamine acetate (TEAA) buffer (pH 6.5). B: CH<sub>3</sub>CN). The eluate was desalted on a reversed-phase column and evaporated to obtain TG-mAMP (2.6 mg, 0.0038 mmol), yield 4.8% as an orange solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 Hz, ppm): δ 1.95 (s, 3H), 3.77–3.90 (m, 2H), 3.84 (s, 3H), 3.97–4.02 (m, 1H), 4.11–4.16 (m, 1H), 4.55–4.62 (m, 1H), 5.30–5.33 (d, 1H, <i>J</i> = 4.0 Hz), 5.44 (t, 1H, <i>J</i> = 5.6 Hz), 5.57 (d, 2H, <i>J</i> = 11.0 Hz), 5.88 (d, 1H, <i>J</i> = 5.7 Hz), 6.23 (s, 1H), 6.42 (d, 1H, <i>J</i> = 9.6 Hz), 6.88 (d, 1H, <i>J</i> = 9.8 Hz), 6.92–7.00 (m, 3H), 7.01–7.05 (m, 1H), 7.14–7.24 (m, 3H), 7.30 (s, 1H), 8.09 (s, 1H), 8.38 (s, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 Hz, ppm): δ 19.4, 55.2, 64.7, 69.8, 70.9, 73.6, 83.8, 86.8, 87.6, 102.6, 104.7, 111.7, 114.3, 114.7, 115.8, 118.0, 118.9, 124.0, 129.3, 129.6, 130.4, 130.6, 137.4, 139.4, 149.0, 149.6, 152.6, 153.6, 155.9, 158.4, 159.9, 161.5, 184.0. MS (ESI<sup>+</sup>): 692 [M + H]<sup>+</sup>. HPLC purity (at 254 nm): 98.2%, <i>t</i><sub>R</sub> = 11.8 min. HPLC condition: A:B = 80:20 to 0:100 (20 min). A: 100 mM TEAA buffer. B: 80% acetonitrile, 20% Milli-Q.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Synthesis of TG-mGMP</h4><div class="NLM_p last">To a solution of TG-mCl (20 mg, 0.053 mmol), GMP disodium salt (43 mg, 0.11 mmol), NaHCO<sub>3</sub> (43 mg, 0.11 mmol), and <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub> (2.0 mg, 0.0031 mmol) in distilled water (2 mL) was added CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The reaction mixture was vigorously stirred at room temperature for 48 h, then evaporated. The residue was purified by reversed-phase preparative HPLC (A:B = 80:20 to 0:100 (20 min). A: triethylamine acetate (TEAA) buffer (pH 6.5). B: CH<sub>3</sub>CN). The eluate was desalted on a reversed-phase column and evaporated to obtain TG-mGMP (1.0 mg, 0.0014 mmol), yield 2.7% as an orange solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 Hz, ppm): δ 1.98 (s, 3H), 3.90 (s, 3H), 4.04–4.10 (m, 2H), 4.26–4.30 (m, 1H), 4.50–4.60 (m, 1H), 4.62–4.69 (m, 1H), 5.67–5.78 (m, 3H), 6.45 (dd, 1H, <i>J</i> = 2.0, 10.0 Hz), 6.60 (dd, 1H, <i>J</i> = 2.0, 9.8 Hz), 6.97–7.07 (m, 3H), 7.09–7.16 (m, 2H), 7.18–7.28 (m, 2H), 7.82–7.92 (m, 1H). MS (ESI<sup>+</sup>): 708 [M + H]<sup>+</sup>. HPLC purity (at 254 nm): 99.2%, <i>t</i><sub>R</sub> = 12.3 min. HPLC conditions: A:B = 80:20 to 0:100 (20 min). A: 100 mM TEAA buffer. B: 80% acetonitrile, 20% Milli-Q.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Synthesis of TG-AMP</h4><div class="NLM_p last">To a solution of AMP (12.5 mg, 0.036 mmol), EDCI (19 mg, 0.10 mmol), DMAP (2.2 mg, 0.018 mmol), and NEt<sub>3</sub> (1 drop) in <i>t</i>BuOH/H<sub>2</sub>O (3 mL/2 mL) was added 2-Me-4-OMe TG (30 mg, 0.090 mmol). The reaction mixture was refluxed for 7 h, then evaporated. The residue was purified by reversed-phase preparative HPLC (A:B = 80:20 to 0:100 (20 min). A: triethylamine acetate (TEAA) buffer (pH 6.5). B: CH<sub>3</sub>CN). The eluate was desalted on a reversed-phase column and evaporated to obtain TG-AMP·NEt<sub><b>3</b></sub> (3.5 mg, 0.0053 mmol), yield 15% as an orange solid. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ 1.24 (t, 9H, <i>J</i> = 7.3 Hz), 1.94 and 1.99 (s, 3H), 3.00–3.09 (m, 6H), 3.89 and 3.90 (s, 3H), 4.23–4.29 (m, 3H), 4.33–4.36 (m, 1H), 4.61–4.65 (m, 1H), 6.04–6.08 (m, 1H), 6.36 and 6.42 (d, 1H, <i>J</i> = 2.0 Hz), 6.57–6.63 (m, 1H), 6.95–7.03 (m, 2H), 7.05–7.23 (m, 4H), 7.49 (d, 1H, <i>J</i> = 2.2 Hz), 8.11 and 8.15 (s, 1H), 8.28 and 8.33 (s, 1H). HRMS (ESI<sup>+</sup>): calcd, 684.1472; found, 684.1476 [M + Na]<sup>+</sup> (+0.72 ppm). HPLC purity (at 254 nm): 99.3%, <i>t</i><sub>R</sub> = 9.5, 9.6 min. HPLC condition: A:B = 80:20 to 0:100 (20 min). A: 0.1% FA Milli-Q. B: 0.1% FA CH<sub>3</sub>CN.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Synthesis of TG-GMP</h4><div class="NLM_p">To a solution of GMP·2Na (96 mg, 0.23 mmol), EDCI (86 mg, 0.23 mmol), DMAP (2.2 mg, 0.018 mmol), and NEt<sub>3</sub> (1 drop) in <i>t</i>BuOH/H<sub>2</sub>O (3 mL/2 mL) was added 2-Me-4-OMe TG (30 mg, 0.090 mmol). The reaction mixture was refluxed for 2 h, then GMP·2Na (96 mg, 0.23 mmol) and EDCI (86 mg, 0.23 mmol) were added. The reaction mixture was further refluxed for 2 h, then evaporated. The residue was purified by reversed-phase preparative HPLC (A:B = 80:20 to 0:100 (20 min). A: triethylamine acetate (TEAA) buffer (pH 6.5). B: CH<sub>3</sub>CN). The eluate was desalted on a reversed-phase column and evaporated to obtain TG-GMP·NEt<sub>3</sub> (11 mg, 0.016 mmol), yield 18% as an orange solid. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD): δ 1.29 (t, 9H, <i>J</i> = 7.4 Hz), 1.97 and 2.02 (s, 3H), 3.17 (q, 6H, <i>J</i> = 7.4 Hz), 3.90 (s, 3H), 4.20–4.32 (m, 4H), 4.74–4.84 (m, 1H), 5.80–5.85 (m, 1H), 6.37 and 6.42 (d, 1H, <i>J</i> = 2.0 Hz), 6.58–6.62 (m, 1H), 6.98–7.42 (m, 6H), 7.48 (dd, 1H, <i>J</i> = 2.1, 8.1 Hz), 7.69 and 7.80 (s, 1H). HRMS (ESI<sup>+</sup>): calcd, 700.1421; found, 700.1445 [M + Na]<sup>+</sup> (+3.43 ppm). HPLC purity (at 254 nm): 99.2%, <i>t</i><sub>R</sub> = 11.3, 11.9 min (mixture of diastereomers). HPLC condition: A:B = 80:20 to 0:100 (20 min). A: 0.1% FA Milli-Q. B: 0.1% FA CH<sub>3</sub>CN.</div><div class="NLM_p last">The purity of the following compounds was confirmed by HPLC (A:B = 80:20 → 0:100 (20 min). A: 0.1% TFA Milli-Q. B: 0.1% TFA CH<sub>3</sub>CN).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Synthesis of Ethyl 2-benzyl-3-oxobutanoate (Compound <b>2</b>)</h4><div class="NLM_p last">To a solution of <i>t</i>BuOK (561 mg, 5.0 mmol, 1.0 equiv) in dry THF (10 mL) was added ethyl acetoacetate (compound <b>1</b>) (638 μL, 5.0 mmol, 1.0 equiv) at 0 °C, and the mixture was stirred for 30 min. Benzyl bromide (5.0 mmol, 1.0 equiv) was added to it at 0 °C, and the whole was refluxed for 4 h, then cooled down. AcOEt was added, and the organic layer was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, <i>n</i>-hexane/AcOEt = 7/1 → 6/1) to obtain compound <b>2</b> (790 mg, 3.6 mmol), yield 72% as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 1.20 (t, 3H, <i>J</i> = 7.1 Hz), 2.19 (s, 3H), 3.16 (d, 2H, <i>J</i> = 7.2 Hz), 3.77 (t, 1H, <i>J</i> = 7.2 Hz), 4.10–4.18 (m, 2H), 7.14–7.29 (m, 5H).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Synthesis of 6-Benzyl-5-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-ol (Compound <b>E</b>)</h4><div class="NLM_p last">A mixture of compound <b>2</b> (441 mg, 2.0 mmol) and 3-amino-1,2,4-triazole (168 mg, 2.0 mmol) in AcOH (2 mL) was refluxed for 6 h, then cooled down. The resulting precipitate was collected and washed with cold AcOEt to obtain compound <b>E</b> (350 mg, 1.5 mmol), yield 73% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.34 (s, 3H), 3.86 (s, 2H), 7.15–7.28 (m, 5H), 8.20 (s, 1H), 13.16 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): 17.2, 30.0, 108.0, 126.0, 127.9, 128.3, 139.7, 148.3, 149.7, 152.2, 156.7. HRMS (ESI<sup>+</sup>): calcd, 263.0909; found, 263.0909 [M + Na]<sup>+</sup> (+0.16 ppm); purity 98.2%, <i>t</i><sub>R</sub> = 8.8 min.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Synthesis of 6-Benzyl-7-chloro-5-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidine (Compound <b>3</b>)</h4><div class="NLM_p last">A solution of compound <b>E</b> (240 mg, 1.0 mmol) in POCl<sub>3</sub> (1.5 mL) was refluxed for 2.5 h, then evaporated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>. This solution washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, <i>n</i>-hexane/AcOEt = 1/1 → AcOEt) to obtain compound <b>3</b> (148 mg, 0.57 mmol), yield 57% as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 2.64 (s, 3H), 4.30 (s, 2H), 7.11 (d, 2H, <i>J</i> = 6.6 Hz), 7.25–7.29 (m, 1H), 7.29–7.34 (m, 2H), 8.50 (s, 1H).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Synthesis of 6-Benzyl-<i>N</i>,<i>N</i>,5-trimethyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-amine (Compound <b>A</b>)</h4><div class="NLM_p last">To a solution of compound <b>3</b> (148 mg, 0.57 mmol) in EtOH (5 mL) was added 50% dimethylamine solution (155 μL, 1.72 mmol). The reaction mixture was stirred at rt for 10 h, then evaporated. The residue was purified by column chromatography on silica gel (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 95/5 → 93/7) to obtain compound <b>A</b> (120 mg, 0.45 mmol), yield 78% as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 2.50 (s, 3H), 3.10 (s, 6H), 4.18 (s, 2H), 7.08 (d, 2H, <i>J</i> = 7.3 Hz), 7.25 (dd, 1H, <i>J</i> = 7.3, 7.4 Hz), 7.31 (dd, 2H, <i>J</i> = 7.3, 7.4 Hz), 8.35 (s, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): 23.8, 32.3, 41.9, 111.0, 126.2, 127.6, 128.6, 139.3, 150.4, 154.0, 155.0, 166.0. HRMS (ESI<sup>+</sup>): calcd, 268.1562; found, 268.1560 [M + H]<sup>+</sup> (- 0.69 ppm); purity 98.0%, <i>t</i><sub>R</sub> = 10.7 min.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Synthesis of Ethyl 2-(4-Nitrobenzyl)-3-oxobutanoate (Compound <b>4</b>)</h4><div class="NLM_p last">To a solution of <i>t</i>BuOK (561 mg, 5.0 mmol, 1.0 equiv) in dry THF (10 mL) was added ethyl acetoacetate (compound <b>1</b>) (638 μL, 5.0 mmol, 1.0 equiv) at 0 °C. The mixture was stirred for 30 min, then 4-nitrobenzyl bromide (5.0 mmol, 1.0 equiv) was added to it at 0 °C. The whole was refluxed for 4 h, then cooled down. AcOEt was added, and the organic layer was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, <i>n</i>-hexane/AcOEt = 7/1 → 6/1) to obtain compound <b>4</b> (506 mg, 1.9 mmol), yield 38% as a yellow oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 1.22 (t, 3H, <i>J</i> = 7.0 Hz), 2.24 (s, 3H), 3.20–3.31 (m, 2H), 3.78 (t, 1H, <i>J</i> = 7.3 Hz), 4.12–4.20 (m, 2H), 7.36 (d, 2H, <i>J</i> = 8.9 Hz), 8.14 (d, 2H, <i>J</i> = 8.9 Hz).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Synthesis of 5-Methyl-6-(4-nitrobenzyl)[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-ol (Compound <b>5</b>)</h4><div class="NLM_p last">A mixture of compound <b>4</b> (506 mg, 1.9 mmol) and 3-amino-1,2,4-triazole (160 mg, 1.9 mmol) in AcOH (4 mL) was refluxed for 6 h, then cooled down. The resulting precipitate was collected and washed with cold AcOEt to obtain compound <b>5</b> (383 mg, 1.3 mmol), yield 71% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.35 (s, 3H), 4.00 (s, 2H), 7.52 (d, 2H, <i>J</i> = 8.9 Hz), 8.12 (d, 2H, <i>J</i> = 8.9 Hz), 8.21 (s, 1H), 13.24 (brs, 1H).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Synthesis of 7-Chloro-5-methyl-6-(4-nitrobenzyl)[1,2,4]triazolo[1,5-<i>a</i>]pyrimidine (Compound <b>6</b>)</h4><div class="NLM_p last">A solution of compound <b>5</b> (383 mg, 1.3 mmol) in POCl<sub>3</sub> (3 mL) was refluxed for 2 h, then evaporated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>. The resulting solution was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, <i>n</i>-hexane/AcOEt = 1/1 → AcOEt) to obtain compound <b>6</b> (180 mg, 0.59 mmol), yield 44% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.52 (s, 3H), 4.46 (s, 2H), 7.52 (d, 2H, <i>J</i> = 8.9 Hz), 8.16 (d, 2H, <i>J</i> = 8.9 Hz), 8.69 (s, 1H).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Synthesis of 6-(4-Nitrobenzyl)-<i>N</i>,<i>N</i>,5-trimethyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-amine (Compound <b>7</b>)</h4><div class="NLM_p last">To a solution of compound <b>6</b> (180 mg, 0.59 mmol) in EtOH (5 mL) was added 50% dimethylamine solution (160 μL, 1.8 mmol). The reaction mixture was stirred at rt for 10 h, then evaporated. The residue was purified by column chromatography on silica gel (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 98/2 → 95/5) to obtain compound <b>7</b> (179 mg, 0.57 mmol), yield 97% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.37 (s, 3H), 3.02 (s, 6H), 4.32 (s, 2H), 7.46 (d, 2H, <i>J</i> = 8.9 Hz), 8.16 (d, 2H, <i>J</i> = 8.9 Hz), 8.46 (s, 1H). HRMS (ESI<sup>+</sup>): calcd, 313.1413; found, 313.1417 [M + H]<sup>+</sup> (+1.27 ppm); purity 99.8%, <i>t</i><sub>R</sub> = 10.7 min.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Synthesis of 6-(4-Aminobenzyl)-<i>N</i>,<i>N</i>,5-trimethyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-amine (Compound <b>B</b>)</h4><div class="NLM_p last">To a solution of compound <b>7</b> (140 mg, 0.45 mmol) in CH<sub>2</sub>Cl<sub>2</sub>/MeOH (12 mL) was added Pd/C. The reaction mixture was stirred at rt for 2.5 h under H<sub>2</sub>, then filtered, and the filtrate was evaporated. The residue was purified by column chromatography on silica gel (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 97/3 → 95/5) to obtain compound <b>B</b> (71 mg, 0.25 mmol), yield 56% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.38 (s, 3H), 3.05 (s, 6H), 3.97 (s, 2H), 4.91 (s, 2H), 6.49 (d, 2H, <i>J</i> = 8.5 Hz), 6.76 (d, 2H, <i>J</i> = 8.5 Hz), 8.43 (s, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): 23.7, 31.4, 41.9, 111.8, 114.2, 125.6, 128.0, 146.9, 150.1, 153.9, 155.0, 166.1. HRMS (ESI<sup>+</sup>): calcd, 283.1671; found, 283.1674 [M + H]<sup>+</sup> (+1.13 ppm); purity 96.0%, <i>t</i><sub>R</sub> = 2.6 min.</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Synthesis of 2-(3-Nitrobenzyl)-3-oxobutanoate (Compound <b>8</b>)</h4><div class="NLM_p last">To a solution of <i>t</i>BuOK (561 mg, 5.0 mmol, 1.0 equiv) in dry THF (10 mL) was added ethyl acetoacetate (compound <b>1</b>) (638 μL, 5.0 mmol, 1.0 equiv) at 0 °C, and the mixture was stirred for 30 min. 3-Nitrobenzyl bromide (5.0 mmol, 1.0 equiv) was added to it at 0 °C, and the whole was refluxed for 4 h, then cooled down. AcOEt was added, and the organic layer was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, <i>n</i>-hexane/AcOEt = 7/1 → 6/1) to obtain compound <b>8</b> (632 mg, 2.4 mmol), yield 48% as a yellow oil. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.09 (t, 3H, <i>J</i> = 7.0 Hz), 2.22 (s, 3H), 3.08–3.25 (m, 2H), 4.02–4.09 (m, 2H), 4.13–4.18 (m, 1H), 7.59 (dd, 1H, <i>J</i> = 7.6, 8.3 Hz), 7.70 (d, 1H, <i>J</i> = 7.6 Hz), 8.08 (d, 1H, <i>J</i> = 8.3 Hz), 8.13 (s, 1H).</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Synthesis of 5-Methyl-6-(3-nitrobenzyl)[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-ol (Compound <b>9</b>)</h4><div class="NLM_p last">A mixture of compound <b>8</b> (632 mg, 2.4 mmol) and 3-amino-1,2,4-triazole (200 mg, 2.4 mmol) in AcOH (4 mL) was refluxed for 10 h, then cooled down. The resulting precipitate was collected and washed with cold AcOEt to obtain compound <b>9</b> (524 mg, 1.8 mmol), yield 77% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.38 (s, 3H), 4.00 (s, 2H), 7.56 (dd, 1H, <i>J</i> = 7.6, 8.3 Hz), 7.71 (d, 1H, <i>J</i> = 7.6 Hz), 8.05 (d, 1H, <i>J</i> = 8.3 Hz), 8.21 (s, 1H), 13.22 (brs, 1H).</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Synthesis of 7-Chloro-5-methyl-6-(3-nitrobenzyl)[1,2,4]triazolo[1,5-<i>a</i>]pyrimidine (Compound <b>10</b>)</h4><div class="NLM_p last">A solution of compound <b>9</b> (500 mg, 1.8 mmol) in POCl<sub>3</sub> (3 mL) was refluxed for 2 h, then evaporated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>. This solution was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, <i>n</i>-hexane/AcOEt = 1/1 → AcOEt) to obtain compound <b>10</b> (203 mg, 0.67 mmol), yield 38% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.54 (s, 3H), 4.46 (s, 2H), 7.59 (dd, 1H, <i>J</i> = 7.9, 8.3 Hz), 7.66 (d, 1H, <i>J</i> = 7.9 Hz), 8.11 (d, 1H, <i>J</i> = 8.3 Hz), 8.69 (s, 1H).</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Synthesis of 6-(3-Nitrobenzyl)-<i>N</i>,<i>N</i>,5-trimethyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-amine (Compound <b>11</b>)</h4><div class="NLM_p last">To a solution of compound <b>10</b> (203 mg, 0.67 mmol) in EtOH (6 mL) was added 50% dimethylamine solution (181 μL, 2.0 mmol). The reaction mixture was stirred at rt for 10 h, then evaporated. The residue was purified by column chromatography on silica gel (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 98/2 → 95/5) to obtain compound <b>11</b> (203 mg, 0.65 mmol), yield 97% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.39 (s, 3H), 3.03 (s, 6H), 4.32 (s, 2H), 7.57–7.63 (m, 2H), 8.07 (s, 1H), 8.09 (d, 1H, <i>J</i> = 7.6 Hz),, 8.46 (s, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): 23.9, 32.0, 41.9, 110.1, 121.4, 122.5, 130.1, 134.3, 141.9, 148.0, 150.7, 154.1, 155.2, 165.8. HRMS (ESI<sup>+</sup>): calcd, 313.1413; found, 313.1415 [M + H]<sup>+</sup> (+0.78 ppm); purity 99.0%, <i>t</i><sub>R</sub> = 10.5 min.</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Synthesis of 6-(3-Aminobenzyl)-<i>N</i>,<i>N</i>,5-trimethyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-amine (Compound <b>C</b>)</h4><div class="NLM_p last">To a solution of compound <b>11</b> (184 mg, 0.59 mmol) in CH<sub>2</sub>Cl<sub>2</sub>/MeOH (16 mL) was added Pd/C. The reaction mixture was stirred at rt for 1.5 h under H<sub>2</sub>, then filtered and evaporated. The residue was purified by column chromatography on silica gel (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 97/3 → 95/5) to obtain compound <b>C</b> (64 mg, 0.23 mmol), yield 38% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.39 (s, 3H), 3.07 (s, 6H), 4.02 (s, 2H), 5.00 (s, 2H), 6.26 (s, 1H), 6.31 (d, 1H, <i>J</i> = 7.6 Hz), 6.38 (d, 1H, <i>J</i> = 8.3 Hz), 6.94 (dd, 1H, <i>J</i> = 7.6, 8.3 Hz), 8.44 (s, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): 23.7, 32.3, 41.9, 111.1, 111.8, 112.7, 115.3, 129.1, 139.7, 149.0, 150.2, 154.0, 155.0, 166.2. HRMS (ESI<sup>+</sup>): calcd, 283.1671; found, 283.1673 [M + H]<sup>+</sup> (+0.64 ppm); purity 98.2%, <i>t</i><sub>R</sub> = 3.0 min.</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Synthesis of 5-Methyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-ol (Compound <b>12</b>)</h4><div class="NLM_p last">A mixture of ethyl acetoacetate (compound <b>1</b>) (255 μL, 2.0 mmol) and 3-amino-1,2,4-triazole (168 mg, 2.0 mmol) in AcOH (2 mL) was refluxed for 6 h, then cooled down. The resulting precipitate was collected and washed with cold AcOEt to obtain compound <b>12</b> (160 mg, 1.1 mmol), yield 53% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.32 (s, 3H), 5.84 (s, 1H), 8.19 (s, 1H), 13.19 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): 18.6, 98.2, 150.6, 151.6, 151.9, 155.9. HRMS (ESI<sup>+</sup>): calcd, 173.0439; found, 173.0435 [M + Na]<sup>+</sup> (−2.79 ppm); purity 99.5%, <i>t</i><sub>R</sub> = 2.1 min.</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Synthesis of 7-Chloro-5-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin (Compound <b>13</b>)</h4><div class="NLM_p last">A solution of compound <b>12</b> (100 mg, 0.67 mmol) in POCl<sub>3</sub> (1 mL) was refluxed for 2.5 h, then evaporated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and this solution was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by column chromatography on silica gel (eluent, <i>n</i>-hexane/AcOEt = 1/1 → AcOEt) to obtain compound <b>13</b> (52 mg, 0.31 mmol), yield 46% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.63 (s, 3H), 7.66 (s, 1H), 8.68 (s, 1H).</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Synthesis of <i>N</i>,<i>N</i>,5-Trimethyl[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-7-amine (Compound <b>D</b>)</h4><div class="NLM_p last">To a solution of compound <b>13</b> (13 mg, 0.077 mmol) in EtOH (0.5 mL) was added 50% dimethylamine solution (17 μL, 0.19 mmol). The reaction mixture was stirred at rt for 10 h, then evaporated. The residue was purified by column chromatography on silica gel (eluent, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 95/5 → 93/7) to obtain compound <b>D</b> (10 mg, 0.056 mmol), yield 73% as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.43 (s, 3H), 3.35 (s, 6H), 6.31 (s, 1H), 8.34 (s, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): 24.5, 40.9, 92.9, 150.0, 153.6, 156.9, 163.5. HRMS (ESI<sup>+</sup>): calcd, 178.1093; found, 178.1087 [M + H]<sup>+</sup> (- 3.32 ppm); purity 99.2%, <i>t</i><sub>R</sub> = 2.5 min.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42">3.  In Vitro Assay</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">3.1.  Preparation of ENPP Assay Buffer</h4><div class="NLM_p last">The buffer (100 mM Tris-HCl (pH 9.0), 150 mM NaCl, and 5 mM MgCl<sub>2</sub>) was prepared and autoclaved, and ENPP assay buffer was prepared at the time of use by adding 10% Triton X-100 (final concentration: 0.05%).</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">3.2.  Absorption and Fluorescence Measurements</h4><div class="NLM_p last">Absorption and fluorescence spectra were measured in a quartz cuvette (4 mm × 4 mm × 40 mm) on a UV-1800 spectrometer (Shimadzu, Japan) and RF-5300PC fluorometer, respectively. Spectra of TG-mAMP, TG-mGMP, TG-AMP, and TG-GMP were measured in sodium phosphate buffer at the final concentration of 1 μM. The fluorometer slit width was 5.0 nm for both excitation and emission, the sensitivity was set to low, and the excitation wavelength was 490 nm. Relative fluorescence quantum yield was obtained by comparing the area under the emission spectrum of the sample in sodium phosphate buffer (pH 7.4) with that of fluorescein in 0.1 N NaOH, whose quantum yield is 0.85.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">3.3.  Preparation of Recombinant ENPP Proteins</h4><div class="NLM_p last">Recombinant ENPPs (ENPP1–7) were prepared as previously described.<a onclick="showRef(event, 'ref31 ref39'); return false;" href="javascript:void(0);" class="ref ref31 ref39">(31,39)</a></div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">3.4.  Enzymatic Reaction of ENPP1 Probes and ENPPs on 96-Well Microplate</h4><div class="NLM_p last">Enzymatic assay was performed in Corning 96-well half-area plates (no. 3694). Enzymatic reactions were performed in ENPP1 assay buffer containing ENPP1 probes (TG-mAMP, TG-mGMP, TG-AMP, and TG-GMP, 2 μM, 20 μL, final 1 μM) with ENPPs (4 μg/mL, 10 μL, final 1 μg/mL). Total assay volume was 40 μL. Fluorescence intensity was measured for 60 min every 5 min with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). Experiments were done at least in triplicate, and the results are shown as the mean ± SD.</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">3.5.  HPLC Analysis of ENPP1 Enzymatic Reaction</h4><div class="NLM_p last">Enzymatic reaction was performed in ENPP1 assay buffer containing 5 μM TG-mAMP with 1 μg/mL ENPP1 at 37 °C. Aliquots (20 μL) were taken at 10, 30, 60, 90, and 120 min and analyzed by HPLC. TG-mAMP and 2-Me-4-OMe TG (5 μM in ENPP1 assay buffer) were analyzed under the same conditions. HPLC conditions: A:B = 80:20 (initial) to 0:100 (20 min) with a linear gradient. A: 100 mM TEAA buffer. B: 80% acetonitrile, 20% Milli-Q. Absorbance was monitored at 490 nm.</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">3.6.  Determination of Kinetic Parameters</h4><div class="NLM_p last">ENPP1 probes (TG-mAMP, TG-mGMP, and <i>p</i>NP-TMP) were dissolved at various concentrations in ENPP assay buffer, and 0.18 μg/mL ENPP1 or 0.63 μg/mL ENPP3 was finally added to the solution. For fluorescence probes, the fluorescence intensity at 535 nm was recorded at 37 °C for 20 min every 1 min with an ARVO X5 plate reader. The initial velocity (μM/s) of enzymatic reaction between 10 and 20 min after addition of ENPP1 or ENPP3 was calculated and plotted against ENPP1 probe concentration (<i>n</i> = 3). For <i>p</i>NP-TMP, absorbance at 405 nm was recorded at 37 °C for 20 min every 1 min. The initial velocity (μM/s) of enzymatic reaction was calculated similarly. The points were fitted to a Michaelis–Menten curve by using GraphPad Prism6, and <i>K</i><sub>d</sub> and <i>k</i><sub>cat</sub> values were calculated.</div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">3.7.  Absorbance and Fluorescence Spectral Changes upon Enzymatic Reaction of TG-mAMP with ENPP1</h4><div class="NLM_p last">Enzymatic reaction was performed in ENPP1 assay buffer containing TG-mAMP (500 μM, 1 μL, final 1 μM) with ENPP1 (70 μg/mL, 7.1 μL, final 1 μg/mL) at 37 °C. Total assay volume was 500 μL. Absorption and fluorescence spectra were measured every 5 min for 100 min. Excitation wavelength was 490 nm.</div></div><div id="sec5_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">3.8.  Optimization of ENPP1 Concentration</h4><div class="NLM_p last">Enzymatic reactions were performed in ENPP1 assay buffer containing TG-mAMP (2 μM, 20 μL, final 1 μM) with ENPP1 (0.72, 1.4, or 2.8 μg/mL, 10 μL, final 0.18, 0.35, or 0.70 μg/mL). Total assay volume was 40 μL. Fluorescence intensity was measured every 30 min for 120 min with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). Experiments were done at least in triplicate, and the results are shown as the mean ± SD.</div></div><div id="sec5_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">3.9.  Optimization of DMSO Concentration</h4><div class="NLM_p last">Enzymatic reactions were performed in ENPP1 assay buffer containing TG-mAMP (2 μM, 20 μL, final 1 μM) with ENPP1 (1.4 μg/mL, 10 μL, final 0.35 μg/mL) in the presence (0.5, 1, 2, 5%) or absence of DMSO. Total assay volume was 40 μL. Fluorescence intensity was measured every 30 min for 240 min with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). Experiments were done at least in triplicate, and the results are shown as the mean ± SD.</div></div><div id="sec5_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">3.10.  Calculation of Screening Validation Factors</h4><div class="NLM_p last">Screening validation was performed under our optimized conditions using 48 wells of a 96-well plate. Enzymatic reactions were performed in ENPP1 assay buffer containing TG-mAMP (2 μM, 20 μL, final 1 μM) in the presence (40 wells) or absence (8 wells) of ENPP1 (0.72 μg/mL, 10 μL, final 0.18 μg/mL), containing 1% DMSO. Total assay volume was 40 μL. The plates were incubated at 37 °C for 2 h, and fluorescence intensity was measured with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). From the results, we calculated the following values:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_m001.gif" alt="" id="_i53" /></img></span><span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_m002.gif" alt="" id="_i54" /></img></span><span class="NLM_disp-formula" id="ueq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_m003.gif" alt="" id="_i55" /></img></span><span class="NLM_disp-formula" id="ueq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_m004.gif" alt="" id="_i56" /></img></span>where AV<sub>100%</sub> is the average fluorescence intensity of forty 100% activity samples (i.e., with ENPP1). Av<sub>0%</sub> is the average fluorescence intensity of eight 0% activity samples (i.e., without ENPP1).</div></div><div id="sec5_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">3.11.  Evaluation of Nucleotides as ENPP1 Inhibitors on Plate Reader</h4><div class="NLM_p">Eleven nucleotides (AMP, GMP, CMP, TMP, UMP, IMP, 2′-dCMP, 3′-CMP, ATP, AP<sub>3</sub>A, and AP<sub>4</sub>A) were dissolved in Milli-Q and diluted as required with ENPP assay buffer (final 40, 400, 4000 μM). Enzymatic reactions were performed in ENPP1 assay buffer containing TG-mAMP (2 μM, 20 μL, final 1 μM) and nucleotides (40, 400, 4000 μM, 10 μL, final 10, 100, 1000 μM) with ENPP1 (0.72 μg/mL, 10 μL, final 0.18 μg/mL) or ENPP3 (2.5 μg/mL, 10 μL, final 0.63 μg/mL). Total assay volume was 40 μL. The plates were incubated at 37 °C for 2 h, and fluorescence intensity was measured with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). Experiments were done at least in triplicate, and the results are shown as the mean ± SD.</div><div class="NLM_p last">For determination of IC<sub>50</sub> of AMP toward ENPP1 and ENPP3, 0.01, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100, 300, 1000 μM (final) AMP was used. The IC<sub>50</sub> values of AMP toward ENPP1 and ENPP3 were calculated by using GraphPad Prism6.</div></div><div id="sec5_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">3.12.  ENPP1 Inhibitor Screening</h4><div class="NLM_p">For primary screening, high-throughput screening (HTS) of a part of the chemical library (9600 compounds) of the University of Tokyo was performed. First, a prepared solution (1 mM in DMSO, 100 nL, final 10 μM (1% DMSO)) of screening compounds was dispensed into 384-well microplate (320 compounds/well, total 30 plates). Next, TG-mAMP (2 μM, 5 μL, final 1 μM) was dispensed into the individual wells of the assay plates. Finally, ENPP1 solution (0.35 μg/mL, 5 μL) was dispensed (total volume was 10 μL), and the plates were incubated at room temperature for 2 h. The fluorescence of 2-Me-4-OMe TG was measured (λ<sub>ex</sub> = 485 nm, λ<sub>em</sub> = 535 nm) for all plates with a microplate reader (PHERAStar). Control wells, i.e., no enzyme wells, no compound wells, and 100 μM AMP wells as positive controls (<i>n</i> = 16 each) were also prepared for all plates.</div><div class="NLM_p">The second screening of 72 hit compounds was performed similarly to the primary screening except for the concentrations of hit compounds (1, 0.3, 0.1, 0.03, 0.01 mM in DMSO, 100 nL, final 10, 3, 1, 0.3, 0.1 μM (1% DMSO) (<i>n</i> = 3)).</div><div class="NLM_p last">For counterassay, we used 0.63 μg/mL ENPP3. The procedure for 69 hit compounds was the same as that used for the second screening. The IC<sub>50</sub> values were calculated by using GraphPad Prism6.</div></div><div id="sec5_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">3.13.  Selectivity Test of Compounds <b>A</b>–<b>C</b> in <i>p</i>NP-TMP and <i>p</i>NPPC Assays</h4><div class="NLM_p last">Inhibitory activities of compounds <b>A</b>–<b>C</b> toward ENPP1–7 were calculated using <i>p</i>NP-TMP (for ENPP1–4) and <i>p</i>NPPC (for ENPP5–7). Enzymatic reaction was performed in ENPP1 assay buffer containing <i>p</i>NP-TMP and <i>p</i>NPPC (1 mM, 10 μL, final 100 μM) and compounds <b>A</b>–<b>C</b> (100 μM in DMSO, 10 μL, final 10 μM (1% DMSO)) with ENPP1–7 (4 μg/mL, 25 μL). Total volume of each well was 100 μL. The plate was incubated at 37 °C for 2 h, and absorbance at 405 nm was measured with an ARVO X5 plate reader.</div></div><div id="sec5_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">3.14.  Evaluation of Compounds <b>A</b>–<b>E</b> Using TG-mAMP on Plate Reader</h4><div class="NLM_p last">Compounds <b>A</b>–<b>E</b> were dissolved in DMSO, and the solutions were diluted as required with ENPP assay buffer (10 μL, final 0.01, 0.03, 0.1, 0.3, 1, 3, 10, 30 μM (0.5% DMSO)). Enzymatic reactions were performed in ENPP1 assay buffer containing TG-mAMP (2 μM, 20 μL, final 1 μM) with ENPP1 (0.75 μg/mL, 10 μL, final 0.18 μg/mL) or ENPP3 (2.5 μg/mL, 10 μL, final 0.63 μg/mL). Total assay volume was 40 μL. The plates were incubated at 37 °C for 2 h, and fluorescence intensity was measured with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). Experiments were done at least in triplicate, and the results are shown as mean ± SD. The IC<sub>50</sub> values were calculated by using GraphPad Prism6.</div></div><div id="sec5_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">3.15.  Evaluation of Compounds <b>A</b>–<b>C</b> Using <i>p</i>NP-TMP with a Plate Reader</h4><div class="NLM_p last">Compounds <b>A</b>–<b>C</b> were dissolved in DMSO and diluted as required with ENPP assay buffer (10 μL, final 0.01, 0.03, 0.1, 0.3, 1, 3, 10, 30 μM (0.5% DMSO)). Enzymatic reactions were performed in ENPP1 assay buffer containing <i>p</i>NP-TMP (1 mM, 10 μL, final 100 μM) with ENPP1 (0.75 μg/mL, 10 μL, final 0.18 μg/mL) or ENPP3 (1.7 μg/mL, 10 μL, final 0.43 μg/mL). Total assay volume was 100 μL. The plate was incubated at 37 °C for 2 h, and absorbance at 405 nm was measured with an ARVO X5 plate reader. Experiments were done at least in triplicate, and the results are shown as the mean ± SD. The IC<sub>50</sub> values were calculated by using GraphPad Prism6.</div></div><div id="sec5_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">3.16.  Evaluation of Compounds <b>A</b>–<b>E</b> Using ATP with a Plate Reader</h4><div class="NLM_p last">Compounds <b>A</b>–<b>E</b> were dissolved in DMSO and diluted as required with ENPP assay buffer (10 μL, final 0.1, 0.3, 1, 3, 10, 30 μM (0.5% DMSO)). Enzymatic reactions were performed in ENPP1 assay buffer containing ATP (900 μM, 10 μL, final 300 μM) with ENPP1 (7.5 μg/mL, 10 μL, final 2.5 μg/mL) or ENPP3 (4.3 μg/mL, 10 μL, final 1.4 μg/mL). Total assay volume was 30 μL. The plate was incubated at 37 °C for 1 h, then molybdenum reagent (30 μL; 20 mM ammonium molybdate tetrahydrate in 2.5 M H<sub>2</sub>SO<sub>4</sub>) and 5-amino-6-hydroxy-2-naphthalenesulfonic acid sodium salt reagent (42 μL; 1.4 mM 5-amino-6-hydroxy-2-naphthalenesulfonic acid sodium salt, 2.8 mM sodium sulfite, 20 mM sodium hydrogen sulfite, and 360 mM 2-mercaptoethanol in Milli-Q) were added. The plate was incubated at room temperature for 30 min, and the absorbance at 570 nm was measured with an ARVO X5 plate reader. Experiments were done at least in triplicate, and the results are shown as the mean ± SD. The IC<sub>50</sub> values were calculated by using GraphPad Prism6.</div></div><div id="sec5_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">3.17.  Competition Assay with TG-mAMP (Lineweaver–Burk Plots)</h4><div class="NLM_p last">ENPP1 (0.75 μg/mL, 10 μL, final 0.18 μg/mL) was added to a solution of TG-mAMP (2, 4, 8 μM, 20 μL, final 1, 2, and 4 μM) in ENPP assay buffer. The fluorescence intensity was measured with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm) at 1 min intervals for 30 min at 37 °C. The rate of fluorescence increase (<i>v</i>; RFU/sec) from 10 to 30 min was calculated, and a double-reciprocal plot of initial velocity as a function of substrate concentration, 1/<i>v</i> against 1/[TG-mAMP], was drawn. The results are shown as the mean ± SD (<i>n</i> = 3).</div></div><div id="sec5_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">3.18.  Cell Culture and Media</h4><div class="NLM_p">MDA-MB-231 cells were cultured in Leibovitz’s L15 medium containing 10% FBS and 1% P/S. MDA-MB-436 cells were cultured in Leibovitz’s L15 medium containing 10% FBS, 10 μg/mL insulin, and 1% P/S. Both cell lines were incubated in a humidified incubator without CO<sub>2</sub> gas at 37 °C.</div><div class="NLM_p last">Hs578T, MCF7, SK-N-SH cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% FBS and 1% P/S. ZR-75-1, SK-BR-3, HCC1954 cells were cultured in RPMI1640 medium containing 10% FBS and 1% P/S. Rat C6 glioma cells were cultured in Ham’s F-10 medium containing 2.5% FBS, 15% HBS, and 1% P/S. HEK293 cells were cultured in DMEM containing 5% FBS and 1% P/S. These cells were incubated in a humidified incubator containing 5% CO<sub>2</sub> gas at 37 °C.</div></div><div id="sec5_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">3.19.  Cell-Based ENPP1 Enzymatic Assay</h4><div class="NLM_p last">MDA-MB-231 and MDA-MB-436 cells (1.0 × 10<sup>4</sup> cells/well) were grown on PLL-coated 96-well microplates (IWAKI) overnight in the appropriate culture medium (100 μL/well) in a humidified incubator without CO<sub>2</sub> at 37 °C for 24 h. Eight other cancer cell lines (1.0 × 10<sup>4</sup> cells/well) were grown on PLL-coated 96-well microplates (IWAKI) overnight in the appropriate culture medium (100 μL/well) in a humidified incubator containing 5% CO<sub>2</sub> in air at 37 °C for 24 h. The plates were washed with Dulbecco’s phosphate-buffered saline (DPBS, 100 μL) twice, and fresh DPBS (70 μL) was added. 5% DMSO or compound <b>C</b> (500 μM, 10 μL, final 50 μM (0.5% DMSO)) was added to each well, and then TG-mAMP (10 μM, 20 μL, final 2 μM) was finally added. After 2 h incubation at 37 °C, the fluorescence intensity was measured with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). The results are shown as the mean ± SD (<i>n</i> = 3).</div></div><div id="sec5_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">3.20.  Western Blotting</h4><div class="NLM_p last">Rat C6, HEK293, MDA-MB-231, and MCF7 cells were plated on 60 mm culture plates at the initial density of 1.0 × 10<sup>6</sup> cells/well with the appropriate culture medium and allowed to attach overnight. The cells were washed with DPBS containing CaCl<sub>2</sub> and MgCl<sub>2</sub>, and 1 mL CelLytic M (Sigma) was added. After incubation at 0 °C for 15 min, the cells were collected and centrifuged at 15 000<i>g</i> for 15 min at 4 °C. The supernatant was used as whole cell lysate. Protein concentrations were determined using a TaKaRa BCA protein assay kit (Takara Bio Inc.). The lysates were boiled with 2-ME at 95 °C for 5 min and centrifuged. Protein (10 μg) from each lysate was separated in 7.5% SDS–polyacrylamide gel and transferred onto nitrocellulose membranes (Bio-Rad Laboratories). The membranes were blocked for 30 min with Tris-buffered saline containing 0.05% Tween 20 (TBS-T) with 3% skimmed milk (MLK-TBS-T), and then the transblotted membranes were incubated overnight at 4 °C with anti-ENPP1 antibody (1/1000, CST) and anti-α-tubulin antibody (1/1000, Sigma) or anti-β-actin antibody (1/1000, CST) in MLK-TBS-T. Each membrane was washed (5 min × 6 times) with TBS-T, then incubated with goat anti-rabbit (for ENPP1 and β-actin, 1/1000) or anti-mouse (for α-tubulin, 1/1000) IgG-horseradish peroxidase conjugates in MLK-TBS-T for 2 h at room temperature, and again washed (5 min ×6 times) with TBS-T. The immunoblots were visualized by enhanced chemiluminescence (LAS3000, FUJIFILM).</div></div><div id="sec5_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">3.21.  ENPP1 Enzymatic Assay Using TG-mAMP, TG-mGMP, TG-AMP, and TG-GMP in MDA-MB-231 Cells</h4><div class="NLM_p last">MDA-MB-231 (1.0 × 10<sup>4</sup> cells/well) were grown on a PLL-coated 96-well microplate (IWAKI) overnight in culture medium (100 μL/well) in a humidified incubator without CO<sub>2</sub> at 37 °C for 24 h. The cells were washed with DPBS (100 μL) twice, then fresh DPBS (70 μL) was added. 5% DMSO or compound <b>C</b> (500 μM, 10 μL, final 50 μM (0.5% DMSO)) was added to each well, then TG-mAMP, TG-mGMP, TG-AMP, or TG-GMP (10 μM, 20 μL, final 2 μM) was finally added. After 2 h incubation at 37 °C, the fluorescence intensity was measured with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). The results are shown as the mean ± SD (<i>n</i> = 3).</div></div><div id="sec5_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">3.22.  Fluorescence Imaging of ENPP1 Activity in Living Cells</h4><div class="NLM_p last">MDA-MB-231 and rat C6 cells (2.0 × 10<sup>5</sup> cells) were grown on a PLL-coated 35 mm glass-bottomed dish (Matsunami) overnight in the appropriate culture medium (2 mL). The cells were washed with DPBS (1 mL) twice, then fresh DPBS (1 mL) was added, and the cells were incubated with 5 μL of DMSO, compound <b>A</b>, <b>B</b>, <b>C</b>, or <b>E</b> (2 mM, 5 μL, final 10 μM (0.5% DMSO)) at 37 °C for 5 min. Finally, TG-mAMP (1 mM, 2 μL, final 2 μM) was added, and incubation was continued at 37 °C for 1 h. Then, without washing, confocal fluorescence images were taken with an IX-71 (Olympus) equipped with a disc scanning unit.</div></div><div id="sec5_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">3.23.  Quantitative Analysis of Fluorescence Imaging</h4><div class="NLM_p last">Fluorescence intensities of region of interest (inside cells) for each condition (at least four pictures) were calculated with ImageJ. The results are shown as the mean ± SD (<i>n</i> = 10).</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70">4.  Clinical Sample Assay</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">4.1.  Patients and Samples</h4><div class="NLM_p last">A total of 437 invasive breast cancer samples collected between 2000 and 2007 from the archive of the Department of Breast Surgery, Nagoya City University Hospital, Japan, were included in this study to measure <i>ENPP1</i> mRNA expression. Tissues were fixed in 10% buffered formalin and embedded in paraffin or snap-frozen in liquid nitrogen immediately after resection and stored at −80 °C until RNA extraction. Disease-free survival (DFS) was defined as the interval from the date of primary surgery to the earliest occurrence of one of the following: locoregional recurrence, distant metastasis, or death from any cause. Overall survival (OS) was defined as the interval from the date of primary surgery to death from any cause. The median follow-up period was 10.8 years (range 0.4–545.2 months) for <i>ENPP1</i> mRNA expression analysis. Written informed consent forms for comprehensive research use of samples had been obtained from all patients before surgery. This protocol was approved by the Institutional Review Board of Nagoya City University Graduate School of Medical Sciences and conformed to the guidelines of the Declaration of Helsinki.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">4.2.  RNA Extraction and Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR)</h4><div class="NLM_p last">Total RNA was isolated using the miRNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s protocol. Reverse transcription was performed using a high capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s protocol. TaqMan gene expression assays (Applied Biosystems) were used to measure the mRNA expression of <i>ENPP1</i> and the housekeeping gene <i>GAPGH</i>. Quantitative RT-PCR assays were performed using a StepOnePlus real-time PCR system (Applied Biosystems). Results were converted into relative concentrations, and the relative concentrations were normalized against the <i>GAPDH</i> gene as an internal control.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73">4.3.  Immunohistochemistry of ERα, Progesterone Receptor (PgR), and Human Epidermal Growth Factor Receptor 2 (HER2)</h4><div class="NLM_p last">One 4-μm section from each paraffin block specimen was stained with hematoxylin and eosin to verify that an adequate number of invasive cancer cells were present and that the fixation quality was suitable for immunohistochemical analysis. Serial sections (4 μm) were then prepared from suitable blocks and float-mounted on adhesive-coated glass slides for ERα, PgR, and HER2 staining. The primary antibodies were mouse monoclonal anti-human ERα antibody (1D5; DAKO, Glostrup, Denmark) and PgR (636; DAKO), both at 1:100 dilution. Expression levels of ERα and PgR were scored by assigning a proportion and an intensity score according to Allred’s procedure.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> HER2 immunostaining was evaluated using the HercepTest (DAKO) scoring method. The membrane staining pattern was estimated and scored on a scale of 0 to 3+. Tumors with scores of 0 and 1 were considered negative for HER2 overexpression, and tumors with a score of 3 were considered positive for HER2 overexpression. Tumors with a score of 2+ were tested for gene amplification by fluorescence in situ hybridization using the PathVysion assay (Vysis, Abbott Laboratories, Abbott Park, IL, USA) according to the manufacturer’s protocol. A ratio of ≥2.0 for HER2 gene/chromosome 17 was considered positive. Tumors were considered HER2-positive if immunohistochemical staining was 3+ or positive by fluorescence in situ hybridization.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">4.4.  Fluorescence Measurement of Breast Cancer Specimens and Standardization by Weight of Each Specimen</h4><div class="NLM_p last">Frozen breast cancer specimens were roughly cut in half (about equal weights) and weighed in Eppendorf tubes (about 0.02–0.04 g/specimen). The specimens were washed with specimen buffer (50 mM HEPES (pH 8.5), 150 mM NaCl, and 5 mM MgCl<sub>2</sub>) twice (500 μL) and then placed in specimen buffer containing DMSO (0.5%) or compound <b>C</b> (50 μM (0.5% DMSO), 499 μL). TG-mAMP (1 mM, 1 μL, final 2 μM) was finally added and the specimens were incubated at 37 °C for 30 min. Aliquots (40 μL) of specimen under each condition were taken (<i>n</i> = 3), and fluorescence intensity was measured with an ARVO X5 plate reader (filters: Ex = 485/14 nm, Em = 535/25 nm). For standardization of the fluorescence intensity of each specimen, the fluorescence intensity measured with a plate reader was divided by the weight of each specimen.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75">5.  Statistical Analysis</h3><div class="NLM_p last">Data are presented as the mean ± SD (shown as error bars). Statistical significance was examined by means of Student’s <i>t</i>-test or Bonferroni-type multiple <i>t</i>-test by using GraphPad Prism6: *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, NS = not significant. Survival curves were analyzed using the Kaplan–Meier method and verified by log-rank test. RFS was censored at the date of last follow-up if patients were still relapse-free and alive, and OS was censored at the time when patients were alive. Statistical calculations were performed with JMP13.0.0 software (SAS Institute, Inc., Cary, NC, USA).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01213" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01213" class="ext-link">10.1021/acs.jmedchem.9b01213</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Reactivity of TG-AMP and TG-GMP with ENPPs, Michaelis–Menten plots of TG-mAMP, TG-mGMP, and <i>p</i>NP-TMP, optimization of screening condition, ENPP1 and ENPP3 inhibition curves of compounds <b>A</b>–<b>E</b>, competition analyses of compounds <b>A</b>–<b>C</b>, dose-dependent inhibition of compound <b>C</b> in MDA-MB-231 cells, normalized fluorescence intensity of each specimen by each weight, and purity data of four fluorescence probes (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and enzyme inhibition data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf">jm9b01213_si_001.pdf (1.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_002.csv">jm9b01213_si_002.csv (0.65 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01213" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mitsuyasu Kawaguchi</span> - <span class="hlFld-Affiliation affiliation">Graduate School
of Pharmaceutical Sciences, Nagoya City
University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#610c0a001600061402090821110900134f0f00060e18004c02144f00024f0b11"><span class="__cf_email__" data-cfemail="fa97919b8d9b9d8f999293ba8a929b88d4949b9d95839bd7998fd49b99d4908a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hidehiko Nakagawa</span> - <span class="hlFld-Affiliation affiliation">Graduate School
of Pharmaceutical Sciences, Nagoya City
University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8435-4401" title="Orcid link">http://orcid.org/0000-0001-8435-4401</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3b5f5e58547b4b535a4915555a5c54425a16584e155a5815514b"><span class="__cf_email__" data-cfemail="c3a7a6a0ac83b3aba2b1edada2a4acbaa2eea0b6eda2a0eda9b3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiang Han</span> - <span class="hlFld-Affiliation affiliation">Graduate School
of Pharmaceutical Sciences, Nagoya City
University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomoka Hisada</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Medical Sciences, Department of Breast Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sayaka Nishikawa</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Medical Sciences, Department of Breast Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuniyuki Kano</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoya Ieda</span> - <span class="hlFld-Affiliation affiliation">Graduate School
of Pharmaceutical Sciences, Nagoya City
University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junken Aoki</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatsuya Toyama</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Medical Sciences, Department of Breast Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank all the members of H.N.’s laboratory for fruitful discussions and also thank Dr. Hirotatsu Kojima, Dr. Takayoshi Okabe, and Dr. Riyo Imamura at the Drug Discovery Initiative, The University of Tokyo, for the assistance of chemical screening. This work was supported in part by JSPS KAKENHI Grant 26893223, 15K18899 (M.K.) and Grant 16H05103 (H.N.), as well as by the Hori Sciences and Arts Foundation and Mochida Memorial Foundation for Medical and Pharmaceutical Research (M.K.), a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (Grant 26111012, H.N.), and a grant from Daiichi Sankyo Foundation of Life Science (H.N.). This research was partially supported by the Platform Project for Supporting Drug Discovery and Life Science Research from AMED under Grant JP19am0101086.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ENPP</td><td class="NLM_def"><p class="first last">ectonucleotide pyrophosphatase/phosphodiesterase</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">GTP</td><td class="NLM_def"><p class="first last">guanosine triphosphate</p></td></tr><tr><td class="NLM_term">AMP</td><td class="NLM_def"><p class="first last">adenosine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">GMP</td><td class="NLM_def"><p class="first last">guanosine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">CMP</td><td class="NLM_def"><p class="first last">cytidine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">TMP</td><td class="NLM_def"><p class="first last">thymidine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">UMP</td><td class="NLM_def"><p class="first last">uridine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">MP</td><td class="NLM_def"><p class="first last">inosine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">2′-dCMP</td><td class="NLM_def"><p class="first last">2′-deoxycytidine 5′-monophosphate;</p></td></tr><tr><td class="NLM_term">3′-CMP</td><td class="NLM_def"><p class="first last">cytidine 3′-monophosphate</p></td></tr><tr><td class="NLM_term">AP<sub>3</sub>A</td><td class="NLM_def"><p class="first last">diadenosine triphosphate</p></td></tr><tr><td class="NLM_term">AP<sub>4</sub>A</td><td class="NLM_def"><p class="first last">diadenosine tetraphosphate</p></td></tr><tr><td class="NLM_term">TG</td><td class="NLM_def"><p class="first last">Tokyo Green</p></td></tr><tr><td class="NLM_term">TNAP</td><td class="NLM_def"><p class="first last">tissue nonspecific alkaline phosphatase</p></td></tr><tr><td class="NLM_term">Pi</td><td class="NLM_def"><p class="first last">inorganic phosphate</p></td></tr><tr><td class="NLM_term">PPi</td><td class="NLM_def"><p class="first last">pyrophosphate</p></td></tr><tr><td class="NLM_term">GACI</td><td class="NLM_def"><p class="first last">generalized arterial calcification of infancy</p></td></tr><tr><td class="NLM_term">CDN</td><td class="NLM_def"><p class="first last">cyclic dinucleotide</p></td></tr><tr><td class="NLM_term">cGAS</td><td class="NLM_def"><p class="first last">cyclic GMP-AMP synthase</p></td></tr><tr><td class="NLM_term">STING</td><td class="NLM_def"><p class="first last">stimulator of interferon genes</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term"><i>p</i>NP-TMP</td><td class="NLM_def"><p class="first last"><i>p</i>-nitrophenyl thymidine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethyl-4-aminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">RFS</td><td class="NLM_def"><p class="first last">recurrence-free survival</p></td></tr><tr><td class="NLM_term">OS</td><td class="NLM_def"><p class="first last">overall survival</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">ABCG2</td><td class="NLM_def"><p class="first last">ATP-binding cassette transporter G2</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritzker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span> <span> </span><span class="NLM_article-title">Matrix Vesicle Plasma Cell Membrane Glycoprotein-1 Regulates Mineralization by Murine Osteoblastic MC3T3 Cells</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1359/jbmr.1999.14.6.883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1359%2Fjbmr.1999.14.6.883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10352096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=883-892&author=K.+Johnsonauthor=A.+Moffaauthor=Y.+Chenauthor=K.+Pritzkerauthor=J.+Godingauthor=R.+Terkeltaub&title=Matrix+Vesicle+Plasma+Cell+Membrane+Glycoprotein-1+Regulates+Mineralization+by+Murine+Osteoblastic+MC3T3+Cells&doi=10.1359%2Fjbmr.1999.14.6.883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells</span></div><div class="casAuthors">Johnson, Kristen; Moffa, Allison; Chen, Ying; Pritzker, Kenneth; Goding, James; Terkeltaub, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-892</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">A naturally occurring nonsense truncation mutation of the inorg. pyrophosphate (PPi)-generating nucleoside triphosphate pyrophosphohydrolase (NTPPPH) PC-1 is assocd. with spinal and periarticular ligament hyperostosis and cartilage calcification in "tiptoe walking" (ttw) mice.  Thus, we tested the hypothesis that PC-1 acts directly in the extracellular matrix to restrain mineralization.  Cultured osteoblastic MC3T3 cells expressed PC-1 mRNA and produced hydroxyapatite deposits at 12-14 days.  NTPPPH activity increased steadily over 14 days.  Transforming growth factor-β and 1,25-dihydroxyvitamin D3 increased PC-1 and NTPPPH in matrix vesicles (MVs).  Because PC-1/NTPPPH was regulated in mineralizing MC3T3 cells, we stably transfected or infected cells with recombinant adenovirus, in order to express 2- to 6-fold more PC-1.  PC-1/NTPPPH and PPi content increased severalfold in MVs derived from cells transfected with PC-1.  Furthermore, MC3T3 cells transfected with PC-1 deposited ∼80-90% less hydroxyapatite (by wt.) than cells transfected with empty plasmid or enzymically inactive PC-1.  ATP-dependent 45Ca pptn. by MVs from cells overexpressing active PC-1 was comparably diminished.  Thus, regulation of PC-1 controls the PPi content and function of osteoblast-derived MVs and matrix hydroxyapatite deposition.  PC-1 may provide a novel therapeutic target in certain disorders of bone mineralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol0dQhA3qcyLVg90H21EOLACvtfcHk0lgjzEsUFAH6Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFKqtbw%253D&md5=cd5a14bda9ada2ab63e13069b1ee987c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.1999.14.6.883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.1999.14.6.883%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DMoffa%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPritzker%26aufirst%3DK.%26aulast%3DGoding%26aufirst%3DJ.%26aulast%3DTerkeltaub%26aufirst%3DR.%26atitle%3DMatrix%2520Vesicle%2520Plasma%2520Cell%2520Membrane%2520Glycoprotein-1%2520Regulates%2520Mineralization%2520by%2520Murine%2520Osteoblastic%2520MC3T3%2520Cells%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1999%26volume%3D14%26spage%3D883%26epage%3D892%26doi%3D10.1359%2Fjbmr.1999.14.6.883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Etten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span> <span> </span><span class="NLM_article-title">Linked Deficiencies in Extracellular PP<sub>i</sub> and Osteopontin Mediate Pathologic Calcification Associated with Defective PC-1 and ANK Expression</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1359/jbmr.2003.18.6.994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1359%2Fjbmr.2003.18.6.994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12817751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslOhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=994-1004&author=K.+Johnsonauthor=J.+Godingauthor=D.+Van+Ettenauthor=A.+Saliauthor=S.+I.+Huauthor=D.+Farleyauthor=H.+Krugauthor=L.+Hessleauthor=J.+L.+Mill%C3%A1nauthor=R.+Terkeltaub&title=Linked+Deficiencies+in+Extracellular+PPi+and+Osteopontin+Mediate+Pathologic+Calcification+Associated+with+Defective+PC-1+and+ANK+Expression&doi=10.1359%2Fjbmr.2003.18.6.994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression</span></div><div class="casAuthors">Johnson, Kristen; Goding, James; Van Etten, Deborah; Sali, Adnan; Hu, Shou-Ih; Farley, David; Krug, Hollis; Hessle, Lovisa; Millan, Jose Luis; Terkeltaub, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">994-1004</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Osteopontin and pyrophosphate (PPi) both suppress hydroxyapatite deposition.  Extracellular PPi deficiency causes spontaneous hypercalcification, yet unchallenged osteopontin knockout mice have only subtle mineralization abnormalities.  We report that extracellular PPi deficiency promotes osteopontin deficiency and correction of osteopontin deficiency prevents hypercalcification, suggesting synergistic inhibition of hydroxyapatite deposition.  Nucleotide pyrophosphatase phosphodiesterase (NPP) isoenzymes including PC-1 (NPP1) function partly to generate PPi, a physiol. calcification inhibitor.  PPi transport is modulated by the membrane channel protein ANK.  Spontaneous articular cartilage calcification, increased vertebral cortical bone formation, and peripheral joint and intervertebral ossific ankylosis are assocd. with both PC-1 deficiency and expression of truncated ANK in ank/ank mice.  To assess how PC-1, ANK, and PPi regulate both calcification and cell differentiation, we studied cultured PC-1-/- and ank/ank mouse calvarial osteoblasts.  PC-1-/- osteoblasts demonstrated ∼50% depressed NPP activity and markedly lowered extracellular PPi assocd. with hypercalcification.  These abnormalities were rescued by transfection of PC-1 but not of the NPP isoenzyme B10/NPP3.  PC-1-/- and ank/ank cultured osteoblasts demonstrated not only comparable extracellular PPi depression and hypercalcification but also marked redn. in expression of osteopontin (OPN), another direct calcification inhibitor.  Sol. PC-1 (which cor. extracellular PPi and OPN), and OPN itself (≥15 pg/mL), cor. hypercalcification by PC-1-/- and ank/ank osteoblasts.  Thus, linked regulatory effects on extracellular PPi and OPN expression mediate the ability of PC-1 and ANK to regulate calcification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtSEw6YYGtN7Vg90H21EOLACvtfcHk0lgjzEsUFAH6Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslOhsLY%253D&md5=d9d41489d04f15c80e2126da63c7a82d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.6.994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.6.994%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DGoding%26aufirst%3DJ.%26aulast%3DVan%2BEtten%26aufirst%3DD.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DS.%2BI.%26aulast%3DFarley%26aufirst%3DD.%26aulast%3DKrug%26aufirst%3DH.%26aulast%3DHessle%26aufirst%3DL.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26aulast%3DTerkeltaub%26aufirst%3DR.%26atitle%3DLinked%2520Deficiencies%2520in%2520Extracellular%2520PPi%2520and%2520Osteopontin%2520Mediate%2520Pathologic%2520Calcification%2520Associated%2520with%2520Defective%2520PC-1%2520and%2520ANK%2520Expression%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D994%26epage%3D1004%26doi%3D10.1359%2Fjbmr.2003.18.6.994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Cellular Function and Molecular Structure of Ecto-Nucleotidases</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9309-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1007%2Fs11302-012-9309-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=22555564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=437-502&author=H.+Zimmermannauthor=M.+Zebischauthor=N.+Str%C3%A4ter&title=Cellular+Function+and+Molecular+Structure+of+Ecto-Nucleotidases&doi=10.1007%2Fs11302-012-9309-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular function and molecular structure of ecto-nucleotidases</span></div><div class="casAuthors">Zimmermann, Herbert; Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-502</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotidases play a pivotal role in purinergic signal transmission.  They hydrolyze extracellular nucleotides and thus can control their availability at purinergic P2 receptors.  They generate extracellular nucleosides for cellular reuptake and salvage via nucleoside transporters of the plasma membrane.  The extracellular adenosine formed acts as an agonist of purinergic P1 receptors.  They also can produce and hydrolyze extracellular inorg. pyrophosphate that is of major relevance in the control of bone mineralization.  This review discusses and compares four major groups of ecto-nucleotidases: the ecto-nucleoside triphosphate diphosphohydrolases, ecto-5'-nucleotidase, ecto-nucleotide pyrophosphatase/phosphodiesterases, and alk. phosphatases.  Only recently and based on crystal structures, detailed information regarding the spatial structures and catalytic mechanisms has become available for members of these four ecto-nucleotidase families.  This permits detailed predictions of their catalytic mechanisms and a comparison between the individual enzyme groups.  The review focuses on the principal biochem., cell biol., catalytic, and structural properties of the enzymes and provides brief ref. to tissue distribution, and physiol. and pathophysiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwf4PFcTEl0LVg90H21EOLACvtfcHk0ljd-FddaEvWdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D&md5=d36e58f25676e47b9749e43896ac4cb2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9309-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9309-4%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCellular%2520Function%2520and%2520Molecular%2520Structure%2520of%2520Ecto-Nucleotidases%26jtitle%3DPurinergic%2520Signalling%26date%3D2012%26volume%3D8%26spage%3D437%26epage%3D502%26doi%3D10.1007%2Fs11302-012-9309-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addison, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaartinen, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, M. D.</span></span> <span> </span><span class="NLM_article-title">Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15872</span>– <span class="NLM_lpage">15883</span>, <span class="refDoi"> DOI: 10.1074/jbc.M701116200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1074%2Fjbc.M701116200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=17383965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2nsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15872-15883&author=W.+N.+Addisonauthor=F.+Azariauthor=E.+S.+Sorensenauthor=M.+T.+Kaartinenauthor=M.+D.+McKee&title=Pyrophosphate+Inhibits+Mineralization+of+Osteoblast+Cultures+by+Binding+to+Mineral%2C+Up-regulating+Osteopontin%2C+and+Inhibiting+Alkaline+Phosphatase+Activity&doi=10.1074%2Fjbc.M701116200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity</span></div><div class="casAuthors">Addison, William N.; Azari, Fereshteh; Sorensen, Esben S.; Kaartinen, Mari T.; McKee, Marc D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15872-15883</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inorg. pyrophosphate (PPi) produced by cells inhibits mineralization by binding to crystals.  Its ubiquitous presence is thought to prevent "soft" tissues from mineralizing, whereas its degrdn. to Pi in bones and teeth by tissue-nonspecific alk. phosphatase (Tnap, Tnsalp, Alpl, Akp2) may facilitate crystal growth.  Whereas the crystal binding properties of PPi are largely understood, less is known about its effects on osteoblast activity.  We have used MC3T3-E1 osteoblast cultures to investigate the effect of PPi on osteoblast function and matrix mineralization.  Mineralization in the cultures was dose-dependently inhibited by PPi.  This inhibition could be reversed by Tnap, but not if PPi was bound to mineral.  PPi also led to increased levels of osteopontin (Opn) induced via the Erk1/2 and p38 MAPK signaling pathways.  Opn regulation by PPi was also insensitive to foscarnet (an inhibitor of phosphate uptake) and levamisole (an inhibitor of Tnap enzymic activity), suggesting that increased Opn levels did not result from changes in phosphate.  Exogenous OPN inhibited mineralization, but dephosphorylation by Tnap reversed this effect, suggesting that OPN inhibits mineralization via its neg. charged phosphate residues and that like PPi, hydrolysis by Tnap reduces its mineral inhibiting potency.  Using enzyme kinetic studies, we have shown that PPi inhibits Tnap-mediated Pi release from β-glycerophosphate (a commonly used source of org. phosphate for culture mineralization studies) through a mixed type of inhibition.  In summary, PPi prevents mineralization in MC3T3-E1 osteoblast cultures by at least three different mechanisms that include direct binding to growing crystals, induction of Opn expression, and inhibition of Tnap activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzGXuSBMwdgbVg90H21EOLACvtfcHk0ljd-FddaEvWdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2nsL0%253D&md5=17e136605a85bae22502720f5d6a9a9d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M701116200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M701116200%26sid%3Dliteratum%253Aachs%26aulast%3DAddison%26aufirst%3DW.%2BN.%26aulast%3DAzari%26aufirst%3DF.%26aulast%3DSorensen%26aufirst%3DE.%2BS.%26aulast%3DKaartinen%26aufirst%3DM.%2BT.%26aulast%3DMcKee%26aufirst%3DM.%2BD.%26atitle%3DPyrophosphate%2520Inhibits%2520Mineralization%2520of%2520Osteoblast%2520Cultures%2520by%2520Binding%2520to%2520Mineral%252C%2520Up-regulating%2520Osteopontin%252C%2520and%2520Inhibiting%2520Alkaline%2520Phosphatase%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15872%26epage%3D15883%26doi%3D10.1074%2Fjbc.M701116200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harmey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narisawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span> <span> </span><span class="NLM_article-title">Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by akp2, enpp1, and ank: An Integrated Model of the Pathogenesis of Mineralization Disorders</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1209</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63208-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2FS0002-9440%2810%2963208-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=15039209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFemur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2004&pages=1199-1209&author=D.+Harmeyauthor=L.+Hessleauthor=S.+Narisawaauthor=K.+A.+Johnsonauthor=R.+Terkeltaubauthor=J.+L.+Mill%C3%A1n&title=Concerted+Regulation+of+Inorganic+Pyrophosphate+and+Osteopontin+by+akp2%2C+enpp1%2C+and+ank%3A+An+Integrated+Model+of+the+Pathogenesis+of+Mineralization+Disorders&doi=10.1016%2FS0002-9440%2810%2963208-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank: An integrated model of the pathogenesis of mineralization disorders</span></div><div class="casAuthors">Harmey, Dympna; Hessle, Lovisa; Narisawa, Sonoko; Johnson, Kristen A.; Terkeltaub, Robert; Millan, Jose Luis</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1199-1209</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Tissue-nonspecific alk. phosphatase (TNAP) hydrolyzes the mineralization inhibitor inorg. pyrophosphate (PPi).  Deletion of the TNAP gene (Akp2) in mice results in hypophosphatasia characterized by elevated levels of PPi and poorly mineralized bones, which are rescued by deletion of nucleotide pyrophosphatase phosphodiesterase 1 (NPP1) that generates PPi.  Mice deficient in NPP1 (Enpp1-/-), or defective in the PPi channeling function of ANK (ank/ank), have decreased levels of extracellular PPi and are hypermineralized.  Given the similarity in function between ANK and NPP1 we crossbred Akp2-/- mice to ank/ank mice and found a partial normalization of the mineralization phenotypes and PPi levels.  Examn. of Enpp1-/- and ank/ank mice revealed that Enpp1-/- mice have a more severe hypermineralized phenotype than ank/ank mice and that NPP1 but not ANK localizes to matrix vesicles, suggesting that failure of ANK deficiency to correct hypomineralization in Akp2-/- mice reflects the lack of ANK activity in the matrix vesicle compartment.  We also found that the mineralization inhibitor osteopontin (OPN) was increased in Akp2-/-, and decreased in ank/ank mice.  PPi and OPN levels were normalized in [Akp2-/-; Enpp1-/-] and [Akp2-/-; ank/ank] mice, at both the mRNA level and in serum.  Wild-type osteoblasts treated with PPi showed an increase in OPN, and a decrease in Enpp1 and Ank expression.  Thus TNAP, NPP1, and ANK coordinately regulate PPi and OPN levels.  The hypomineralization obsd. in Akp2-/- mice arises from the combined inhibitory effects of PPi and OPN.  In contrast, NPP1 or ANK deficiencies cause a decrease in the PPi and OPN pools that leads to hypermineralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrke3ClmgGYOLVg90H21EOLACvtfcHk0ljd-FddaEvWdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFemur0%253D&md5=a2949f01d80e3723bb80d3b508e91329</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963208-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963208-7%26sid%3Dliteratum%253Aachs%26aulast%3DHarmey%26aufirst%3DD.%26aulast%3DHessle%26aufirst%3DL.%26aulast%3DNarisawa%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26atitle%3DConcerted%2520Regulation%2520of%2520Inorganic%2520Pyrophosphate%2520and%2520Osteopontin%2520by%2520akp2%252C%2520enpp1%252C%2520and%2520ank%253A%2520An%2520Integrated%2520Model%2520of%2520the%2520Pathogenesis%2520of%2520Mineralization%2520Disorders%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D164%26spage%3D1199%26epage%3D1209%26doi%3D10.1016%2FS0002-9440%2810%2963208-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hessle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narisawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goding, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span> <span> </span><span class="NLM_article-title">Tissue-Nonspecific Alkaline Phosphatase and Pasma Cell Membrane Glycoprotein-1 are Central Antagonistic Regulators of Bone Mineralization</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">9445</span>– <span class="NLM_lpage">9449</span>, <span class="refDoi"> DOI: 10.1073/pnas.142063399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1073%2Fpnas.142063399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12082181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVGgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=9445-9449&author=L.+Hessleauthor=K.+A.+Johnsonauthor=H.+C.+Andersonauthor=S.+Narisawaauthor=A.+Saliauthor=J.+W.+Godingauthor=R.+Terkeltaubauthor=J.+L.+Mill%C3%A1n&title=Tissue-Nonspecific+Alkaline+Phosphatase+and+Pasma+Cell+Membrane+Glycoprotein-1+are+Central+Antagonistic+Regulators+of+Bone+Mineralization&doi=10.1073%2Fpnas.142063399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization</span></div><div class="casAuthors">Hessle, Lovisa; Johnson, Kristen A.; Anderson, H. Clarke; Narisawa, Sonoko; Sali, Adnan; Goding, James W.; Terkeltaub, Robert; Millan, Jose Luis</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9445-9449</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Osteoblasts mineralize bone matrix by promoting hydroxyapatite crystal formation and growth in the interior of membrane-limited matrix vesicles (MVs) and by propagating the crystals onto the collagenous extracellular matrix.  Two osteoblast proteins, tissue-nonspecific alk. phosphatase (TNAP) and plasma cell membrane glycoprotein-1 (PC-1) are involved in this process.  Mutations in the TNAP gene result in the inborn error of metab. known as hypophosphatasia, characterized by poorly mineralized bones, spontaneous fractures, and elevated extracellular concns. of inorg. pyrophosphate (PPi).  PPi suppresses the formation and growth of hydroxyapatite crystals.  PPi is produced by the nucleoside triphosphate pyrophosphohydrolase activity of a family of isoenzymes, with PC-1 being the only member present in MVs.  Mice with spontaneous mutations in the PC-1 gene have hypermineralization abnormalities that include osteoarthritis and ossification of the posterior longitudinal ligament of the spine.  Here, we show the resp. correction of bone mineralization abnormalities in knockout mice null for both the TNAP (Akp2) and PC-1 (Enpp1) genes.  Each allele of Akp2 and Enpp1 has a measurable influence on mineralization status in vivo.  Ex vivo expts. using cultured double-knockout osteoblasts and their MVs demonstrate normalization of PPi content and mineral deposition.  Our data provide evidence that TNAP and PC-1 are key regulators of the extracellular PPi concns. required for controlled bone mineralization.  Our results suggest that inhibiting PC-1 function may be a viable therapeutic strategy for hypophosphatasia.  Conversely, interfering with TNAP activity may correct pathol. hyperossification because of PPi insufficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa0UKJ_EUwN7Vg90H21EOLACvtfcHk0lh7vZhEJTylFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVGgt70%253D&md5=a7b4d685857661f31505e39ba3985e5a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.142063399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.142063399%26sid%3Dliteratum%253Aachs%26aulast%3DHessle%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DAnderson%26aufirst%3DH.%2BC.%26aulast%3DNarisawa%26aufirst%3DS.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DGoding%26aufirst%3DJ.%2BW.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26atitle%3DTissue-Nonspecific%2520Alkaline%2520Phosphatase%2520and%2520Pasma%2520Cell%2520Membrane%2520Glycoprotein-1%2520are%2520Central%2520Antagonistic%2520Regulators%2520of%2520Bone%2520Mineralization%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D9445%26epage%3D9449%26doi%3D10.1073%2Fpnas.142063399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutsch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaingankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toliat, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höhne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roscioli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnabel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epplen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knisely, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinaiko, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallance, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nürnberg, P.</span></span> <span> </span><span class="NLM_article-title">Mutations in ENPP1 are Associated with 'Idiopathic' Infantile Arterial Calcification</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1038/ng1221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fng1221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12881724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Skurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=379-381&author=F.+Rutschauthor=N.+Rufauthor=S.+Vaingankarauthor=M.+R.+Toliatauthor=A.+Sukauthor=W.+H%C3%B6hneauthor=G.+Schauerauthor=M.+Lehmannauthor=T.+Roscioliauthor=D.+Schnabelauthor=J.+T.+Epplenauthor=A.+Kniselyauthor=A.+Superti-Furgaauthor=J.+McGillauthor=M.+Filipponeauthor=A.+R.+Sinaikoauthor=H.+Vallanceauthor=B.+Hinrichsauthor=W.+Smithauthor=M.+Ferreauthor=R.+Terkeltaubauthor=P.+N%C3%BCrnberg&title=Mutations+in+ENPP1+are+Associated+with+%27Idiopathic%27+Infantile+Arterial+Calcification&doi=10.1038%2Fng1221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in ENPP1 are associated with "idiopathic" infantile arterial calcification</span></div><div class="casAuthors">Rutsch, Frank; Ruf, Nico; Vaingankar, Sucheta; Toliat, Mohammad R.; Suk, Anita; Hoehne, Wolfgang; Schauer, Galen; Lehmann, Mandy; Roscioli, Tony; Schnabel, Dirk; Epplen, Joerg T.; Knisely, Alex; Superti-Furga, Andrea; McGill, James; Filippone, Marco; Sinaiko, Alan R.; Vallance, Hillary; Hinrichs, Bernd; Smith, Wendy; Ferre, Merry; Terkeltaub, Robert; Nuernberg, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-381</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with an emphasis on the authors' research.  Idiopathic infantile arterial calcification (IIAC; OMIM 208000) is characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation.  We analyzed affected individuals from 11 unrelated kindreds and found that IIAC was assocd. with mutations that inactivated ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1).  This cell surface enzyme generates inorg. pyrophosphate (PPi), a solute that regulates cell differentiation and serves as an essential physiol. inhibitor of calcification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEzkAL5KKqTbVg90H21EOLACvtfcHk0lh7vZhEJTylFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Skurg%253D&md5=79a84beb933ce5274445cf6b5ec70d22</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng1221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1221%26sid%3Dliteratum%253Aachs%26aulast%3DRutsch%26aufirst%3DF.%26aulast%3DRuf%26aufirst%3DN.%26aulast%3DVaingankar%26aufirst%3DS.%26aulast%3DToliat%26aufirst%3DM.%2BR.%26aulast%3DSuk%26aufirst%3DA.%26aulast%3DH%25C3%25B6hne%26aufirst%3DW.%26aulast%3DSchauer%26aufirst%3DG.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DRoscioli%26aufirst%3DT.%26aulast%3DSchnabel%26aufirst%3DD.%26aulast%3DEpplen%26aufirst%3DJ.%2BT.%26aulast%3DKnisely%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DA.%26aulast%3DMcGill%26aufirst%3DJ.%26aulast%3DFilippone%26aufirst%3DM.%26aulast%3DSinaiko%26aufirst%3DA.%2BR.%26aulast%3DVallance%26aufirst%3DH.%26aulast%3DHinrichs%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DW.%26aulast%3DFerre%26aufirst%3DM.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DN%25C3%25BCrnberg%26aufirst%3DP.%26atitle%3DMutations%2520in%2520ENPP1%2520are%2520Associated%2520with%2520%2527Idiopathic%2527%2520Infantile%2520Arterial%2520Calcification%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D379%26epage%3D381%26doi%3D10.1038%2Fng1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nürnberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutsch, F.</span></span> <span> </span><span class="NLM_article-title">The Mutational Spectrum of ENPP1 as Arising after the Analysis of 23 Unrelated Patients with Generalized Arterial Calcification of Infancy (GACI)</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">98</span>, <span class="refDoi"> DOI: 10.1002/humu.9297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1002%2Fhumu.9297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=15605415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BD2cnjslGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=98&author=N.+Rufauthor=B.+Uhlenbergauthor=R.+Terkeltaubauthor=P.+N%C3%BCrnbergauthor=F.+Rutsch&title=The+Mutational+Spectrum+of+ENPP1+as+Arising+after+the+Analysis+of+23+Unrelated+Patients+with+Generalized+Arterial+Calcification+of+Infancy+%28GACI%29&doi=10.1002%2Fhumu.9297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI)</span></div><div class="casAuthors">Ruf Nico; Uhlenberg Birgit; Terkeltaub Robert; Nurnberg Peter; Rutsch Frank</div><div class="citationInfo"><span class="NLM_cas:title">Human mutation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Generalized arterial calcification of infancy (GACI), is characterized by calcification of the internal elastic lamina of large and medium-sized arteries and stenosis due to myointimal proliferation.  Although survival to adulthood has been reported, most patients die within the first six months of life.  Recently, we found mutations of ENPP1 coding for ecto-nucleotide pyrophosphatase/phosphodiesterase 1 to be associated with GACI in 8 of 11 families.  In this study, we analyzed ENPP1 in affected individuals of another 12 unrelated families.  We identified 11 novel homozygous or compound heterozygous mutations in 10 of the 12 new families.  The mutations (1 nonsense, 7 missense, 1 single amino acid deletion, and 2 frame shift mutations) were scattered over the whole coding region with a slightly more condensed distribution within the catalytic and nuclease-like domain as compared to the first survey.  In this study, three mutations were found repeatedly in apparently unrelated patients, 7 x c.913C>A (p.Pro305Thr) and c.2662C [corrected]>T (p.Arg888Trp) as well as c.2320C>T (p.Arg774Cys) each twice.  However, haplotype analysis suggested a founder effect of British extraction for mutation c.913C>A (p.Pro305Thr).  The fact that the two other mutations c.2662C [corrected]>T (p.Arg888Trp) and c.2320C>T (p.Arg774Cys) occurred twice within a single allele also suggests a single founder.  This study confirms the role of ENPP1 mutations as the main cause of GACI and adds considerably to the mutational spectrum of ENPP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyydZBW41YW0h5eUSa2oe_fW6udTcc2eYRzu5DPVvxdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnjslGnsw%253D%253D&md5=b8df93e6e89c72f67556c3f96a0908d6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fhumu.9297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.9297%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DN.%26aulast%3DUhlenberg%26aufirst%3DB.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DN%25C3%25BCrnberg%26aufirst%3DP.%26aulast%3DRutsch%26aufirst%3DF.%26atitle%3DThe%2520Mutational%2520Spectrum%2520of%2520ENPP1%2520as%2520Arising%2520after%2520the%2520Analysis%2520of%252023%2520Unrelated%2520Patients%2520with%2520Generalized%2520Arterial%2520Calcification%2520of%2520Infancy%2520%2528GACI%2529%26jtitle%3DHum.%2520Mutat.%26date%3D2005%26volume%3D25%26spage%3D98%26doi%3D10.1002%2Fhumu.9297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, I. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusis, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deb, A.</span></span> <span> </span><span class="NLM_article-title">Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification</span>. <i>Cell Stem Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/j.stem.2016.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.stem.2016.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=27867037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWgurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=218-232&author=I.+C.+L.+Pillaiauthor=S.+Liauthor=M.+Romayauthor=L.+Lamauthor=Y.+Luauthor=J.+Huangauthor=N.+Dillardauthor=M.+Zemanovaauthor=L.+Rubbiauthor=Y.+Wangauthor=J.+Leeauthor=M.+Xiaauthor=O.+Liangauthor=Y.+H.+Xieauthor=M.+Pellegriniauthor=A.+J.+Lusisauthor=A.+Deb&title=Cardiac+Fibroblasts+Adopt+Osteogenic+Fates+and+Can+Be+Targeted+to+Attenuate+Pathological+Heart+Calcification&doi=10.1016%2Fj.stem.2016.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification</span></div><div class="casAuthors">Pillai, Indulekha C. L.; Li, Shen; Romay, Milagros; Lam, Larry; Lu, Yan; Huang, Jie; Dillard, Nathaniel; Zemanova, Marketa; Rubbi, Liudmilla; Wang, Yibin; Lee, Jason; Xia, Ming; Liang, Owen; Xie, Ya-Hong; Pellegrini, Matteo; Lusis, Aldons J.; Deb, Arjun</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-232.e5</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1875-9777</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mammalian tissues calcify with age and injury.  Analogous to bone formation, osteogenic cells are thought to be recruited to the affected tissue and induce mineralization.  In the heart, calcification of cardiac muscle leads to conduction system disturbances and is one of the most common pathologies underlying heart blocks.  However the cell identity and mechanisms contributing to pathol. heart muscle calcification remain unknown.  Using lineage tracing, murine models of heart calcification and in vivo transplantation assays, we show that cardiac fibroblasts (CFs) adopt an osteoblast cell-like fate and contribute directly to heart muscle calcification.  Small-mol. inhibition of ENPP1, an enzyme that is induced upon injury and regulates bone mineralization, significantly attenuated cardiac calcification.  Inhibitors of bone mineralization completely prevented ectopic cardiac calcification and improved post injury heart function.  Taken together, these findings highlight the plasticity of fibroblasts in contributing to ectopic calcification and identify pharmacol. targets for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiuSkDz5INS7Vg90H21EOLACvtfcHk0lhZIPxf3Kpkpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWgurvK&md5=eebbf2c530effe407be3145e97394284</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2016.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2016.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DI.%2BC.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRomay%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDillard%26aufirst%3DN.%26aulast%3DZemanova%26aufirst%3DM.%26aulast%3DRubbi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DO.%26aulast%3DXie%26aufirst%3DY.%2BH.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26aulast%3DDeb%26aufirst%3DA.%26atitle%3DCardiac%2520Fibroblasts%2520Adopt%2520Osteogenic%2520Fates%2520and%2520Can%2520Be%2520Targeted%2520to%2520Attenuate%2520Pathological%2520Heart%2520Calcification%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2017%26volume%3D20%26spage%3D218%26epage%3D232%26doi%3D10.1016%2Fj.stem.2016.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maddux, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grupe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henzel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reaven, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, I. D.</span></span> <span> </span><span class="NLM_article-title">Membrane Glycoprotein PC-1 and Insulin Resistance in Non-Insulin-Dependent Diabetes Mellitus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1038/373448a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2F373448a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=7830796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADyaK2MXjsFCjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=1995&pages=448-451&author=B.+A.+Madduxauthor=P.+Sbracciaauthor=S.+Kumakuraauthor=S.+Sassonauthor=J.+Youngrenauthor=A.+Fisherauthor=S.+Spencerauthor=A.+Grupeauthor=W.+Henzelauthor=T.+A.+Stewartauthor=G.+M.+Reavenauthor=I.+D.+Goldfine&title=Membrane+Glycoprotein+PC-1+and+Insulin+Resistance+in+Non-Insulin-Dependent+Diabetes+Mellitus&doi=10.1038%2F373448a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus</span></div><div class="casAuthors">Maddux, Betty A.; Sbraccia, Paolo; Kumakura, Shinobu; Sasson, Shiomo; Youngren, Jack; Fisher, Alexander; Spencer, Steven; Grupe, Andrew; Henzel, William; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">6513</span>),
    <span class="NLM_cas:pages">448-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Most patients with non-insulin-dependent diabetes mellitus are resistant to both endogenous and exogenous insulin.  Insulin resistance precedes the onset of this disease, suggesting that it may be an initial abnormality.  Insulin-receptor kinase activity is impaired in muscle, fibroblasts and other tissues of many patients with non-insulin-dependent diabetes mellitus, but abnormalities in the insulin-receptor gene do not appear to be the cause of this decreased kinase activity.  Skin fibroblasts from certain insulin-resistant patients contain an inhibitor of insulin-receptor tyrosine kinase.  Here we show that this inhibitor is a membrane glycoprotein, termed PC-1.  We find that PC-1 activity is increased in fibroblasts from seven of nine patients with typical non-insulin-dependent diabetes mellitus.  In addn. overexpression of PC-1 in transfected cultured cells reduces insulin-stimulated tyrosine kinase activity.  These studies raise the possibility that PC-1 has a role in the insulin resistance of non-insulin-dependent diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVPl5dEjSWSbVg90H21EOLACvtfcHk0lhZIPxf3Kpkpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsFCjsL0%253D&md5=3e266cc35cf6013d9f325629b0ed57f8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F373448a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F373448a0%26sid%3Dliteratum%253Aachs%26aulast%3DMaddux%26aufirst%3DB.%2BA.%26aulast%3DSbraccia%26aufirst%3DP.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DSasson%26aufirst%3DS.%26aulast%3DYoungren%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DSpencer%26aufirst%3DS.%26aulast%3DGrupe%26aufirst%3DA.%26aulast%3DHenzel%26aufirst%3DW.%26aulast%3DStewart%26aufirst%3DT.%2BA.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26atitle%3DMembrane%2520Glycoprotein%2520PC-1%2520and%2520Insulin%2520Resistance%2520in%2520Non-Insulin-Dependent%2520Diabetes%2520Mellitus%26jtitle%3DNature%26date%3D1995%26volume%3D373%26spage%3D448%26epage%3D451%26doi%3D10.1038%2F373448a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grupe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alleman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, T. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Insulin Receptor Phosphorylation by PC-1 is not Mediated by the Hydrolysis of Adenosine Triphosphate or the Generation of Adenosine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">22085</span>– <span class="NLM_lpage">22088</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.38.22085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1074%2Fjbc.270.38.22085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=7673181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADyaK2MXot1Giu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=22085-22088&author=A.+Grupeauthor=J.+Allemanauthor=I.+D.+Goldfineauthor=M.+Sadickauthor=T.+A.+Stewart&title=Inhibition+of+Insulin+Receptor+Phosphorylation+by+PC-1+is+not+Mediated+by+the+Hydrolysis+of+Adenosine+Triphosphate+or+the+Generation+of+Adenosine&doi=10.1074%2Fjbc.270.38.22085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine</span></div><div class="casAuthors">Grupe, Andrew; Alleman, Jennifer; Goldfine, Ira D.; Sadick, Mike; Stewart, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">22085-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Individuals with insulin resistance show increased levels of PC-1 expression in skeletal muscle and fibroblasts, and in transfected cell lines that overexpress PC-1 there is a redn. in the insulin-stimulated insulin receptor tyrosine phosphorylation.  As PC-1 is a type II transmembrane protein with extracellular phosphodiesterase and pyrophosphatase activity, increased expression of PC-1 at the cell surface will decrease extracellular ATP levels and increase extracellular adenosine levels.  Consequently it is possible that PC-1-mediated insulin resistance could be caused either by a decrease in ATP or an indirect increase in adenosine levels.  The authors have tested this hypothesis and find that the PC-1-mediated inhibition of insulin-stimulated insulin receptor autophosphorylation is not altered by agents that alter the level or action of adenosine.  Further, a mutated PC-1 with a single amino acid change that abolishes the phosphodiesterase and pyrophosphatase activities is still able to inhibit insulin-stimulated insulin receptor phosphorylation.  The results of these expts. indicate that the phosphodiesterase activity of PC-1 is not involved in the inhibition of insulin receptor autophosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAijMXH0BearVg90H21EOLACvtfcHk0lhZIPxf3Kpkpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXot1Giu7Y%253D&md5=e01547283cc0bb10acdf11028e1089fe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.38.22085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.38.22085%26sid%3Dliteratum%253Aachs%26aulast%3DGrupe%26aufirst%3DA.%26aulast%3DAlleman%26aufirst%3DJ.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DSadick%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DT.%2BA.%26atitle%3DInhibition%2520of%2520Insulin%2520Receptor%2520Phosphorylation%2520by%2520PC-1%2520is%2520not%2520Mediated%2520by%2520the%2520Hydrolysis%2520of%2520Adenosine%2520Triphosphate%2520or%2520the%2520Generation%2520of%2520Adenosine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D22085%26epage%3D22088%26doi%3D10.1074%2Fjbc.270.38.22085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abate, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandalia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundy, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trischitta, V.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Disease: Ectonucleotide Pyrophosphatase Phosphodiesterase 1 as a 'Gatekeeper' of Insulin Receptors</span>. <i>Nat. Clin. Pract. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1038/ncpendmet0367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fncpendmet0367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=17143316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=694-701&author=N.+Abateauthor=M.+Chandaliaauthor=R.+Di+Paolaauthor=D.+W.+Fosterauthor=S.+M.+Grundyauthor=V.+Trischitta&title=Mechanisms+of+Disease%3A+Ectonucleotide+Pyrophosphatase+Phosphodiesterase+1+as+a+%27Gatekeeper%27+of+Insulin+Receptors&doi=10.1038%2Fncpendmet0367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors</span></div><div class="casAuthors">Abate, Nicola; Chandalia, Manisha; Di Paola, Rosa; Foster, Daniel W.; Grundy, Scott M.; Trischitta, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">694-701</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Insulin resistance is pathogenic for type 2 diabetes and cardiovascular disease.  Several inhibitors of insulin signaling have a role in human insulin resistance.  The transmembrane glycoprotein ectonucleotide pyrophosphatase phosphodiesterase 1 (E-NPP1; also known as plasma cell membrane glycoprotein PC-1) interacts with the insulin receptor and inhibits subsequent signaling by decreasing its β-subunit autophosphorylation.  E-NPP1 is overexpressed in skeletal muscle, adipose tissue and cultured skin fibroblasts of insulin-resistant individuals who are not yet obese or diabetic, which indicates that excessive E-NPP1 expression is an early, intrinsic defect in human insulin resistance.  Genetic studies also support a primary role of E-NPP1 in insulin resistance.  Among other variants, a missense polymorphism, Lys121Gln, has been described.  The Gln121 variant is a stronger inhibitor than Lys121 of insulin receptor function, and is assocd. with insulin resistance, type 2 diabetes and both cardiovascular and nephrovascular complications in diabetic patients.  E-NPP1 is measurable in human serum, where it might represent a valuable biomarker of insulin resistance, but its relationship to tissue and systemic insulin resistance remains to be thoroughly elucidated.  Understanding the mechanisms that regulate E-NPP1 expression and/or function might render this protein a new target for strategies to treat and prevent type 2 diabetes and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_8d1m1gbqPbVg90H21EOLACvtfcHk0ljAAohog7BZ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntA%253D%253D&md5=2a8cf7f987081c122f5567e4fee940e5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fncpendmet0367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpendmet0367%26sid%3Dliteratum%253Aachs%26aulast%3DAbate%26aufirst%3DN.%26aulast%3DChandalia%26aufirst%3DM.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DD.%2BW.%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26aulast%3DTrischitta%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520Disease%253A%2520Ectonucleotide%2520Pyrophosphatase%2520Phosphodiesterase%25201%2520as%2520a%2520%2527Gatekeeper%2527%2520of%2520Insulin%2520Receptors%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Endocrinol.%2520Metab.%26date%3D2006%26volume%3D2%26spage%3D694%26epage%3D701%26doi%3D10.1038%2Fncpendmet0367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frittitta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercolino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozzali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiolas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santagati, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spampinato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigneri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trischitta, V.</span></span> <span> </span><span class="NLM_article-title">A Cluster of Three Single Nucleotide Polymorphisms in the 3′-Untranslated Region of Human Glycoprotein PC-1 Gene Stabilizes PC-1 mRNA and is Associated with Increased PC-1 Protein Content and Insulin Resistance-Related Abnormalities</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1952</span>– <span class="NLM_lpage">1955</span>, <span class="refDoi"> DOI: 10.2337/diabetes.50.8.1952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.2337%2Fdiabetes.50.8.1952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=11473061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslKms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=1952-1955&author=L.+Frittittaauthor=T.+Ercolinoauthor=M.+Bozzaliauthor=A.+Argiolasauthor=S.+Graciauthor=M.+G.+Santagatiauthor=D.+Spampinatoauthor=R.+Di+Paolaauthor=C.+Cisterninoauthor=V.+Tassiauthor=R.+Vigneriauthor=A.+Pizzutiauthor=V.+Trischitta&title=A+Cluster+of+Three+Single+Nucleotide+Polymorphisms+in+the+3%E2%80%B2-Untranslated+Region+of+Human+Glycoprotein+PC-1+Gene+Stabilizes+PC-1+mRNA+and+is+Associated+with+Increased+PC-1+Protein+Content+and+Insulin+Resistance-Related+Abnormalities&doi=10.2337%2Fdiabetes.50.8.1952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A cluster of three single nucleotide polymorphisms in the 3'-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities</span></div><div class="casAuthors">Frittitta, Lucia; Ercolino, Tonino; Bozzali, Maura; Argiolas, Alessandra; Graci, Salvo; Santagati, Maria G.; Spampinato, Daniela; Di Paola, Rosa; Cisternino, Carmela; Tassi, Vittorio; Vigneri, Riccardo; Pizzuti, Antonio; Trischitta, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1952-1955</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Glycoprotein PC-1 inhibits insulin signaling and, when overexpressed, plays a role in human insulin resistance.  Mechanisms of PC-1 overexpression are unknown.  The authors have identified a haplotype in the 3'-untranslated region of the PC-1 gene that may modulate PC-1 expression and confer an increased risk for insulin resistance.  Individuals from Sicily, Italy, carrying the "P" haplotype (i.e., a cluster of three single nucleotide polymorphisms: G2897A, G2906C, and C2948T) were at higher risk for insulin resistance and had higher levels of plasma glucose and insulin during an oral glucose tolerance test and higher levels of cholesterol, HDL cholesterol, and systolic blood pressure.  They also had higher PC-1 protein content in both skeletal muscle and cultured skin fibroblasts.  In CHO cells transfected with either P or wild-type cDNA, specific PC-1 mRNA half-life was increased for those transfected with P (t/2=3.73 vs. 1.57 h).  In a population of different ethnicity (Gargano, East Coast Italy), patients with type 2 diabetes (the most likely clin. outcome of insulin resistance) had a higher P haplotype frequency than healthy control subjects (7.8 vs. 1.5%), thus replicating the assocn. between the P allele and the insulin resistance-related abnormalities obsd. among Sicilians.  In conclusion, the authors have identified a possible mol. mechanism for PC-1 overexpression that confers an increased risk for insulin resistance-related abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA7LTeCpnkzLVg90H21EOLACvtfcHk0ljAAohog7BZ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslKms7o%253D&md5=73790ec972015d9d8f09768fceb7a5ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.50.8.1952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.50.8.1952%26sid%3Dliteratum%253Aachs%26aulast%3DFrittitta%26aufirst%3DL.%26aulast%3DErcolino%26aufirst%3DT.%26aulast%3DBozzali%26aufirst%3DM.%26aulast%3DArgiolas%26aufirst%3DA.%26aulast%3DGraci%26aufirst%3DS.%26aulast%3DSantagati%26aufirst%3DM.%2BG.%26aulast%3DSpampinato%26aufirst%3DD.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DCisternino%26aufirst%3DC.%26aulast%3DTassi%26aufirst%3DV.%26aulast%3DVigneri%26aufirst%3DR.%26aulast%3DPizzuti%26aufirst%3DA.%26aulast%3DTrischitta%26aufirst%3DV.%26atitle%3DA%2520Cluster%2520of%2520Three%2520Single%2520Nucleotide%2520Polymorphisms%2520in%2520the%25203%25E2%2580%25B2-Untranslated%2520Region%2520of%2520Human%2520Glycoprotein%2520PC-1%2520Gene%2520Stabilizes%2520PC-1%2520mRNA%2520and%2520is%2520Associated%2520with%2520Increased%2520PC-1%2520Protein%2520Content%2520and%2520Insulin%2520Resistance-Related%2520Abnormalities%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D1952%26epage%3D1955%26doi%3D10.2337%2Fdiabetes.50.8.1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belisário, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sales, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velloso-Rodrigues, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, M. B.</span></span> <span> </span><span class="NLM_article-title">Association Between ENPP1 K173Q and Stroke in a Newborn Cohort of 395 Brazilian Children with Sickle Cell Anemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-05-645176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1182%2Fblood-2015-05-645176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=26337355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGisrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1259-1260&author=A.+R.+Belis%C3%A1rioauthor=R.+R.+Salesauthor=N.+E.+Toledoauthor=C.+Velloso-Rodriguesauthor=C.+M.+Silvaauthor=M.+B.+Viana&title=Association+Between+ENPP1+K173Q+and+Stroke+in+a+Newborn+Cohort+of+395+Brazilian+Children+with+Sickle+Cell+Anemia&doi=10.1182%2Fblood-2015-05-645176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Association between ENPP1 K173Q and stroke in a newborn cohort of 395 Brazilian children with sickle cell anemia</span></div><div class="casAuthors">Belisario, Andre Rolim; Sales, Rahyssa Rodrigues; Toledo, Nayara Evelin; Velloso-Rodrigues, Cibele; Silva, Celia Maria; Viana, Marcos Borato</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1259-1260</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The aim of this article is to evaluate the influence of GOLGB1 Y1212C (rs3732410) and ENPP1 K173Q (rs104449) mutations on the risk of developing overt ischemic stroke in a newborn cohort with sickle cell anemia from Minas Gerais, Brazil.  There was no assocn. was obsd. between mutations GOLGB1 Y1212C (rs3732410) and PON1 Q192R with stroke.  While Q genetic variant of ENPP1 K173Q mutation in children with sickle cell anemia was assocd. with an increased risk of stroke and possibly, with the development of high-risk transcranial doppler readings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-M7vw-RpGrVg90H21EOLACvtfcHk0ljAAohog7BZ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGisrjK&md5=91a109108cf69a908a77182f77bc68f0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-05-645176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-05-645176%26sid%3Dliteratum%253Aachs%26aulast%3DBelis%25C3%25A1rio%26aufirst%3DA.%2BR.%26aulast%3DSales%26aufirst%3DR.%2BR.%26aulast%3DToledo%26aufirst%3DN.%2BE.%26aulast%3DVelloso-Rodrigues%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DC.%2BM.%26aulast%3DViana%26aufirst%3DM.%2BB.%26atitle%3DAssociation%2520Between%2520ENPP1%2520K173Q%2520and%2520Stroke%2520in%2520a%2520Newborn%2520Cohort%2520of%2520395%2520Brazilian%2520Children%2520with%2520Sickle%2520Cell%2520Anemia%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D1259%26epage%3D1260%26doi%3D10.1182%2Fblood-2015-05-645176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maliga, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span> <span> </span><span class="NLM_article-title">Hydrolysis of 2’3′-cGAMP by ENPP1 and Design of Nonhydrolyzable Analogs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fnchembio.1661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25344812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1043-1048&author=L.+Liauthor=Q.+Yinauthor=P.+Kussauthor=Z.+Maligaauthor=J.+L.+Mill%C3%A1nauthor=H.+Wuauthor=T.+J.+Mitchison&title=Hydrolysis+of+2%E2%80%993%E2%80%B2-cGAMP+by+ENPP1+and+Design+of+Nonhydrolyzable+Analogs&doi=10.1038%2Fnchembio.1661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs</span></div><div class="casAuthors">Li, Lingyin; Yin, Qian; Kuss, Pia; Maliga, Zoltan; Millan, Jose L.; Wu, Hao; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1043-1048</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Agonists of mouse STING (TMEM173) shrink and even cure solid tumors by activating innate immunity; human STING (hSTING) agonists are needed to test this therapeutic hypothesis in humans.  The endogenous STING agonist is 2'3'-cGAMP, a second messenger that signals the presence of cytosolic double-stranded DNA.  We report activity-guided partial purifn. and identification of ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP1) to be the dominant 2'3'-cGAMP hydrolyzing activity in cultured cells.  The hydrolysis activity of ENPP1 was confirmed using recombinant protein and was depleted in tissue exts. and plasma from Enpp1-/- mice.  We synthesized a hydrolysis-resistant bisphosphothioate analog of 2'3'-cGAMP (2'3'-cGsAsMP) that has similar affinity for hSTINGin vitro and is ten times more potent at inducing IFN-β secretion from human THP1 monocytes.  Studies in mouse Enpp1-/- lung fibroblasts indicate that resistance to hydrolysis contributes substantially to its higher potency.  2'3'-CGsAsMP is therefore improved over natural 2'3'-cGAMP as a model agonist and has potential as a vaccine adjuvant and cancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruGzJ050f3CbVg90H21EOLACvtfcHk0lju19PrTPX5bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbnO&md5=31000472bd11db78afdb00abedae78b1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1661%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DQ.%26aulast%3DKuss%26aufirst%3DP.%26aulast%3DMaliga%26aufirst%3DZ.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DHydrolysis%2520of%25202%25E2%2580%25993%25E2%2580%25B2-cGAMP%2520by%2520ENPP1%2520and%2520Design%2520of%2520Nonhydrolyzable%2520Analogs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D1043%26epage%3D1048%26doi%3D10.1038%2Fnchembio.1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic GMP-AMP Synthase is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1126/science.1232458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscience.1232458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23258413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ygurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=786-791&author=L.+Sunauthor=J.+Wuauthor=F.+Duauthor=X.+Chenauthor=Z.+J.+Chen&title=Cyclic+GMP-AMP+Synthase+is+a+Cytosolic+DNA+Sensor+That+Activates+the+Type+I+Interferon+Pathway&doi=10.1126%2Fscience.1232458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway</span></div><div class="casAuthors">Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6121</span>),
    <span class="NLM_cas:pages">786-791</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The presence of DNA in the cytoplasm of mammalian cells is a danger signal that triggers host immune responses such as the prodn. of type I interferons.  Cytosolic DNA induces interferons through the prodn. of cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP), which binds to and activates the adaptor protein STING.  Through biochem. fractionation and quant. mass spectrometry, we identified a cGAMP synthase (cGAS), which belongs to the nucleotidyltransferase family.  Overexpression of cGAS activated the transcription factor IRF3 and induced interferon-β in a STING-dependent manner.  Knockdown of cGAS inhibited IRF3 activation and interferon-β induction by DNA transfection or DNA virus infection.  CGAS bound to DNA in the cytoplasm and catalyzed cGAMP synthesis.  These results indicate that cGAS is a cytosolic DNA sensor that induces interferons by producing the second messenger cGAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxxUcksTNZRbVg90H21EOLACvtfcHk0lju19PrTPX5bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ygurw%253D&md5=fe9a64a9c0441eb00852900be8d683bf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232458%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26atitle%3DCyclic%2520GMP-AMP%2520Synthase%2520is%2520a%2520Cytosolic%2520DNA%2520Sensor%2520That%2520Activates%2520the%2520Type%2520I%2520Interferon%2520Pathway%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D786%26epage%3D791%26doi%3D10.1126%2Fscience.1232458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic GMP-AMP is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">826</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1126/science.1229963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscience.1229963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23258412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ygtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=826-830&author=J.+Wuauthor=L.+Sunauthor=X.+Chenauthor=F.+Duauthor=H.+Shiauthor=C.+Chenauthor=Z.+J.+Chen&title=Cyclic+GMP-AMP+is+an+Endogenous+Second+Messenger+in+Innate+Immune+Signaling+by+Cytosolic+DNA&doi=10.1126%2Fscience.1229963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA</span></div><div class="casAuthors">Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Shi, Heping; Chen, Chuo; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6121</span>),
    <span class="NLM_cas:pages">826-830</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cytosolic DNA induces type I interferons and other cytokines that are important for antimicrobial defense but can also result in autoimmunity.  This DNA signaling pathway requires the adaptor protein STING and the transcription factor IRF3, but the mechanism of DNA sensing is unclear.  We found that mammalian cytosolic exts. synthesized cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP) in vitro from ATP and guanosine triphosphate in the presence of DNA but not RNA.  DNA transfection or DNA virus infection of mammalian cells also triggered cGAMP prodn.  CGAMP bound to STING, leading to the activation of IRF3 and induction of interferon-β.  Thus, cGAMP functions as an endogenous second messenger in metazoans and triggers interferon prodn. in response to cytosolic DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0CH1aDO6v5bVg90H21EOLACvtfcHk0lju19PrTPX5bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ygtbs%253D&md5=2d59a6c9c71eb7188e3e9fd01b2c7e84</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1229963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1229963%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26atitle%3DCyclic%2520GMP-AMP%2520is%2520an%2520Endogenous%2520Second%2520Messenger%2520in%2520Innate%2520Immune%2520Signaling%2520by%2520Cytosolic%2520DNA%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D826%26epage%3D830%26doi%3D10.1126%2Fscience.1229963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portnoy, D. A.</span></span> <span> </span><span class="NLM_article-title">c-di-AMP Secreted by Intracellular Listeria Monocytogenes Activates a Host Type I Interferon Response</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>328</i></span>,  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1705</span>, <span class="refDoi"> DOI: 10.1126/science.1189801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscience.1189801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=20508090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=1703-1705&author=J.+J.+Woodwardauthor=A.+T.+Iavaroneauthor=D.+A.+Portnoy&title=c-di-AMP+Secreted+by+Intracellular+Listeria+Monocytogenes+Activates+a+Host+Type+I+Interferon+Response&doi=10.1126%2Fscience.1189801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response</span></div><div class="casAuthors">Woodward, Joshua J.; Iavarone, Anthony T.; Portnoy, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">5986</span>),
    <span class="NLM_cas:pages">1703-1705</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Intracellular bacterial pathogens, such as Listeria monocytogenes, are detected in the cytosol of host immune cells.  Induction of this host response is often dependent on microbial secretion systems and, in L. monocytogenes, is dependent on multidrug efflux pumps (MDRs).  Using L. monocytogenes mutants that overexpressed MDRs, the authors identified cyclic diadenosine monophosphate (c-di-AMP) as a secreted mol. able to trigger the cytosolic host response.  Overexpression of the di-adenylate cyclase, dacA (lmo2120), resulted in elevated levels of the host response during infection.  C-di-AMP thus represents a putative bacterial secondary signaling mol. that triggers a cytosolic pathway of innate immunity and is predicted to be present in a wide variety of bacteria and archea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPoYB1SaNJ27Vg90H21EOLACvtfcHk0lhcW1Y7arx9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVektbY%253D&md5=d71cb2a70f01266a46bc9c93c78ab6d8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1189801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1189801%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DJ.%2BJ.%26aulast%3DIavarone%26aufirst%3DA.%2BT.%26aulast%3DPortnoy%26aufirst%3DD.%2BA.%26atitle%3Dc-di-AMP%2520Secreted%2520by%2520Intracellular%2520Listeria%2520Monocytogenes%2520Activates%2520a%2520Host%2520Type%2520I%2520Interferon%2520Response%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D1703%26epage%3D1705%26doi%3D10.1126%2Fscience.1189801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroe, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo-Troha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwig, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyodo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, R. E.</span></span> <span> </span><span class="NLM_article-title">STING is a Direct Innate Immune Sensor of Cyclic di-GMP</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>478</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1038/nature10429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fnature10429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=21947006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WltLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=515-518&author=D.+L.+Burdetteauthor=K.+M.+Monroeauthor=K.+Sotelo-Trohaauthor=J.+S.+Iwigauthor=B.+Eckertauthor=M.+Hyodoauthor=Y.+Hayakawaauthor=R.+E.+Vance&title=STING+is+a+Direct+Innate+Immune+Sensor+of+Cyclic+di-GMP&doi=10.1038%2Fnature10429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">STING is a direct innate immune sensor of cyclic di-GMP</span></div><div class="casAuthors">Burdette, Dara L.; Monroe, Kathryn M.; Sotelo-Troha, Katia; Iwig, Jeff S.; Eckert, Barbara; Hyodo, Mamoru; Hayakawa, Yoshihiro; Vance, Russell E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">515-518</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The innate immune system detects infection by using germline-encoded receptors that are specific for conserved microbial mols.  The recognition of microbial ligands leads to the prodn. of cytokines, such as type I interferons (IFNs), that are essential for successful pathogen elimination.  Cytosolic detection of pathogen-derived DNA is one major mechanism of inducing IFN prodn., and this process requires signaling through TANK binding kinase 1 (TBK1) and its downstream transcription factor, IFN-regulatory factor 3 (IRF3).  In addn., a transmembrane protein called STING (stimulator of IFN genes; also known as MITA, ERIS, MPYS and TMEM173) functions as an essential signaling adaptor, linking the cytosolic detection of DNA to the TBK1-IRF3 signaling axis.  Recently, unique nucleic acids called cyclic dinucleotides, which function as conserved signaling mols. in bacteria, have also been shown to induce a STING-dependent type I IFN response.  However, a mammalian sensor of cyclic dinucleotides has not been identified.  Here the authors report evidence that STING itself is an innate immune sensor of cyclic dinucleotides.  The authors demonstrate that STING binds directly to radiolabeled cyclic diguanylate monophosphate (c-di-GMP), and the authors show that unlabeled cyclic dinucleotides, but not other nucleotides or nucleic acids, compete with c-di-GMP for binding to STING.  Furthermore, the authors identify mutations in STING that selectively affect the response to cyclic dinucleotides without affecting the response to DNA.  Thus, STING seems to function as a direct sensor of cyclic dinucleotides, in addn. to its established role as a signaling adaptor in the IFN response to cytosolic DNA.  Cyclic dinucleotides have shown promise as novel vaccine adjuvants and immunotherapeutics, and the authors' results provide insight into the mechanism by which cyclic dinucleotides are sensed by the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvnzueDcwVnrVg90H21EOLACvtfcHk0lhcW1Y7arx9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WltLbL&md5=179c4ebb96c6e0385de0370ac42c9bbe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature10429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10429%26sid%3Dliteratum%253Aachs%26aulast%3DBurdette%26aufirst%3DD.%2BL.%26aulast%3DMonroe%26aufirst%3DK.%2BM.%26aulast%3DSotelo-Troha%26aufirst%3DK.%26aulast%3DIwig%26aufirst%3DJ.%2BS.%26aulast%3DEckert%26aufirst%3DB.%26aulast%3DHyodo%26aufirst%3DM.%26aulast%3DHayakawa%26aufirst%3DY.%26aulast%3DVance%26aufirst%3DR.%2BE.%26atitle%3DSTING%2520is%2520a%2520Direct%2520Innate%2520Immune%2520Sensor%2520of%2520Cyclic%2520di-GMP%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D515%26epage%3D518%26doi%3D10.1038%2Fnature10429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corrales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhirter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivick, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katibah, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metchette, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubensky, T. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.celrep.2015.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25959818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVCmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=1018-1030&author=L.+Corralesauthor=L.+H.+Glickmanauthor=S.+M.+McWhirterauthor=D.+B.+Kanneauthor=K.+E.+Sivickauthor=G.+E.+Katibahauthor=S.+R.+Wooauthor=E.+Lemmensauthor=T.+Bandaauthor=J.+J.+Leongauthor=K.+Metchetteauthor=T.+W.+Dubenskyauthor=T.+F.+Gajewski&title=Direct+Activation+of+STING+in+the+Tumor+Microenvironment+Leads+to+Potent+and+Systemic+Tumor+Regression+and+Immunity&doi=10.1016%2Fj.celrep.2015.04.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity</span></div><div class="casAuthors">Corrales, Leticia; Glickman, Laura Hix; McWhirter, Sarah M.; Kanne, David B.; Sivick, Kelsey E.; Katibah, George E.; Woo, Seng-Ryong; Lemmens, Edward; Banda, Tamara; Leong, Justin J.; Metchette, Ken; Dubensky, Thomas W., Jr.; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1018-1030</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Spontaneous tumor-initiated T cell priming is dependent on IFN-β prodn. by tumor-resident dendritic cells.  On the basis of recent observations indicating that IFN-β expression was dependent upon activation of the host STING pathway, we hypothesized that direct engagement of STING through intratumoral (IT) administration of specific agonists would result in effective anti-tumor therapy.  After proof-of-principle studies using the mouse STING agonist DMXAA showed a potent therapeutic effect, we generated synthetic cyclic dinucleotide (CDN) derivs. that activated all human STING alleles as well as murine STING.  IT injection of STING agonists induced profound regression of established tumors in mice and generated substantial systemic immune responses capable of rejecting distant metastases and providing long-lived immunol. memory.  Synthetic CDNs have high translational potential as a cancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBJFLJqaY27Vg90H21EOLACvtfcHk0lhcW1Y7arx9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVCmtbc%253D&md5=0c3516ed7a91a9b3e3d90ccdf0555644</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DCorrales%26aufirst%3DL.%26aulast%3DGlickman%26aufirst%3DL.%2BH.%26aulast%3DMcWhirter%26aufirst%3DS.%2BM.%26aulast%3DKanne%26aufirst%3DD.%2BB.%26aulast%3DSivick%26aufirst%3DK.%2BE.%26aulast%3DKatibah%26aufirst%3DG.%2BE.%26aulast%3DWoo%26aufirst%3DS.%2BR.%26aulast%3DLemmens%26aufirst%3DE.%26aulast%3DBanda%26aufirst%3DT.%26aulast%3DLeong%26aufirst%3DJ.%2BJ.%26aulast%3DMetchette%26aufirst%3DK.%26aulast%3DDubensky%26aufirst%3DT.%2BW.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DDirect%2520Activation%2520of%2520STING%2520in%2520the%2520Tumor%2520Microenvironment%2520Leads%2520to%2520Potent%2520and%2520Systemic%2520Tumor%2520Regression%2520and%2520Immunity%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D11%26spage%3D1018%26epage%3D1030%26doi%3D10.1016%2Fj.celrep.2015.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhirter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechette, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivick, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portnoy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubensky, T. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span> <span> </span><span class="NLM_article-title">STING Agonist Formulated Cancer Vaccines Can Cure Established Tumors Resistant to PD-1 Blockade</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">283ra52</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa4306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscitranslmed.aaa4306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25877890" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=283ra52&author=J.+Fuauthor=D.+B.+Kanneauthor=M.+Leongauthor=L.+H.+Glickmanauthor=S.+M.+McWhirterauthor=E.+Lemmensauthor=K.+Mechetteauthor=J.+J.+Leongauthor=P.+Lauerauthor=W.+Liuauthor=K.+E.+Sivickauthor=Q.+Zengauthor=K.+C.+Soaresauthor=L.+Zhengauthor=D.+A.+Portnoyauthor=J.+J.+Woodwardauthor=D.+M.+Pardollauthor=T.+W.+Dubenskyauthor=Y.+Kim&title=STING+Agonist+Formulated+Cancer+Vaccines+Can+Cure+Established+Tumors+Resistant+to+PD-1+Blockade&doi=10.1126%2Fscitranslmed.aaa4306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa4306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa4306%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DKanne%26aufirst%3DD.%2BB.%26aulast%3DLeong%26aufirst%3DM.%26aulast%3DGlickman%26aufirst%3DL.%2BH.%26aulast%3DMcWhirter%26aufirst%3DS.%2BM.%26aulast%3DLemmens%26aufirst%3DE.%26aulast%3DMechette%26aufirst%3DK.%26aulast%3DLeong%26aufirst%3DJ.%2BJ.%26aulast%3DLauer%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSivick%26aufirst%3DK.%2BE.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DSoares%26aufirst%3DK.%2BC.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DPortnoy%26aufirst%3DD.%2BA.%26aulast%3DWoodward%26aufirst%3DJ.%2BJ.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DDubensky%26aufirst%3DT.%2BW.%26aulast%3DKim%26aufirst%3DY.%26atitle%3DSTING%2520Agonist%2520Formulated%2520Cancer%2520Vaccines%2520Can%2520Cure%2520Established%2520Tumors%2520Resistant%2520to%2520PD-1%2520Blockade%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D283ra52%26doi%3D10.1126%2Fscitranslmed.aaa4306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanjulu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesiridis, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muelbaier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graybill, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charnley, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnia, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puhl, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smothers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Design of Amidobenzimidazole STING Receptor Agonists with Systemic Activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>564</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">–443</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0705-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fs41586-018-0705-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30405246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFejsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=564&publication_year=2018&pages=439-%E2%80%93443&author=J.+M.+Ramanjuluauthor=G.+S.+Pesiridisauthor=J.+Yangauthor=N.+Conchaauthor=R.+Singhausauthor=S.+Y.+Zhangauthor=J.+L.+Tranauthor=P.+Mooreauthor=S.+Lehmannauthor=H.+C.+Eberlauthor=M.+Muelbaierauthor=J.+L.+Schneckauthor=J.+Clemensauthor=M.+Adamauthor=J.+Mehlmannauthor=J.+Romanoauthor=A.+Moralesauthor=J.+Kangauthor=L.+Leisterauthor=T.+L.+Graybillauthor=A.+K.+Charnleyauthor=G.+Yeauthor=N.+Nevinsauthor=K.+Behniaauthor=A.+I.+Wolfauthor=V.+Kasparcovaauthor=K.+Nurseauthor=L.+Wangauthor=A.+C.+Puhlauthor=Y.+Liauthor=M.+Kleinauthor=C.+B.+Hopsonauthor=J.+Gussauthor=M.+Bantscheffauthor=G.+Bergaminiauthor=M.+A.+Reillyauthor=Y.+Lianauthor=K.+J.+Duffyauthor=J.+Adamsauthor=K.+P.+Foleyauthor=P.+J.+Goughauthor=R.+W.+Marquisauthor=J.+Smothersauthor=A.+Hoosauthor=J.+Bertin&title=Design+of+Amidobenzimidazole+STING+Receptor+Agonists+with+Systemic+Activity&doi=10.1038%2Fs41586-018-0705-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design of amidobenzimidazole STING receptor agonists with systemic activity</span></div><div class="casAuthors">Ramanjulu, Joshi M.; Pesiridis, G. Scott; Yang, Jingsong; Concha, Nestor; Singhaus, Robert; Zhang, Shu-Yun; Tran, Jean-Luc; Moore, Patrick; Lehmann, Stephanie; Eberl, H. Christian; Muelbaier, Marcel; Schneck, Jessica L.; Clemens, Jim; Adam, Michael; Mehlmann, John; Romano, Joseph; Morales, Angel; Kang, James; Leister, Lara; Graybill, Todd L.; Charnley, Adam K.; Ye, Guosen; Nevins, Neysa; Behnia, Kamelia; Wolf, Amaya I.; Kasparcova, Viera; Nurse, Kelvin; Wang, Liping; Li, Yue; Klein, Michael; Hopson, Christopher B.; Guss, Jeffrey; Bantscheff, Marcus; Bergamini, Giovanna; Reilly, Michael A.; Lian, Yiqian; Duffy, Kevin J.; Adams, Jerry; Foley, Kevin P.; Gough, Peter J.; Marquis, Robert W.; Smothers, James; Hoos, Axel; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">564</span>
        (<span class="NLM_cas:issue">7736</span>),
    <span class="NLM_cas:pages">439-443</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Stimulator of interferon genes (STING) is a receptor in the endoplasmic reticulum that propagates innate immune sensing of cytosolic pathogen-derived and self DNA1.  The development of compds. that modulate STING has recently been the focus of intense research for the treatment of cancer and infectious diseases and as vaccine adjuvants2.  To our knowledge, current efforts are focused on the development of modified cyclic dinucleotides that mimic the endogenous STING ligand cGAMP; these have progressed into clin. trials in patients with solid accessible tumors amenable to intratumoral delivery3.  Here we report the discovery of a small mol. STING agonist that is not a cyclic dinucleotide and is systemically efficacious for treating tumors in mice.  We developed a linking strategy to synergize the effect of two symmetry-related amidobenzimidazole (ABZI)-based compds. to create linked ABZIs (diABZIs) with enhanced binding to STING and cellular function.  I.v. administration of a diABZI STING agonist to immunocompetent mice with established syngeneic colon tumors elicited strong anti-tumor activity, with complete and lasting regression of tumors.  Our findings represent a milestone in the rapidly growing field of immune-modifying cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jb61D9fGkLVg90H21EOLACvtfcHk0lh6VEuxdB3Kag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFejsb7N&md5=bc8d64d74f22300a4bebe718c0e440ce</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0705-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0705-y%26sid%3Dliteratum%253Aachs%26aulast%3DRamanjulu%26aufirst%3DJ.%2BM.%26aulast%3DPesiridis%26aufirst%3DG.%2BS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DSinghaus%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26aulast%3DTran%26aufirst%3DJ.%2BL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DLehmann%26aufirst%3DS.%26aulast%3DEberl%26aufirst%3DH.%2BC.%26aulast%3DMuelbaier%26aufirst%3DM.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DM.%26aulast%3DMehlmann%26aufirst%3DJ.%26aulast%3DRomano%26aufirst%3DJ.%26aulast%3DMorales%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DLeister%26aufirst%3DL.%26aulast%3DGraybill%26aufirst%3DT.%2BL.%26aulast%3DCharnley%26aufirst%3DA.%2BK.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DA.%2BI.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DNurse%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPuhl%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DM.%26aulast%3DHopson%26aufirst%3DC.%2BB.%26aulast%3DGuss%26aufirst%3DJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DLian%26aufirst%3DY.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DSmothers%26aufirst%3DJ.%26aulast%3DHoos%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520Amidobenzimidazole%2520STING%2520Receptor%2520Agonists%2520with%2520Systemic%2520Activity%26jtitle%3DNature%26date%3D2018%26volume%3D564%26spage%3D439%26epage%3D%25E2%2580%2593443%26doi%3D10.1038%2Fs41586-018-0705-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. Y.</span></span> <span> </span><span class="NLM_article-title">Role of the cGAS-STING Pathway in Cancer Development and Oncotherapeutic Approaches</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">e46935</span>, <span class="refDoi"> DOI: 10.15252/embr.201846935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.15252%2Fembr.201846935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30446584" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=e46935&author=L.+T.+Khooauthor=L.+Y.+Chen&title=Role+of+the+cGAS-STING+Pathway+in+Cancer+Development+and+Oncotherapeutic+Approaches&doi=10.15252%2Fembr.201846935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.15252%2Fembr.201846935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembr.201846935%26sid%3Dliteratum%253Aachs%26aulast%3DKhoo%26aufirst%3DL.%2BT.%26aulast%3DChen%26aufirst%3DL.%2BY.%26atitle%3DRole%2520of%2520the%2520cGAS-STING%2520Pathway%2520in%2520Cancer%2520Development%2520and%2520Oncotherapeutic%2520Approaches%26jtitle%3DEMBO%2520Rep.%26date%3D2018%26spage%3De46935%26doi%3D10.15252%2Fembr.201846935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trason, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R. K.</span></span> <span> </span><span class="NLM_article-title">Development of Enpp1 Inhibitors as a Strategy to Activate Stimulator of Interferon Genes (STING) in Cancers and Other Diseases</span>. <i>Int. J. Cell Sci. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">555655</span>, <span class="refDoi"> DOI: 10.19080/IJCSMB.2018.05.555655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.19080%2FIJCSMB.2018.05.555655" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=555655&author=S.+Manasauthor=T.+Trasonauthor=W.+Alexisauthor=R.+K.+Mohan&title=Development+of+Enpp1+Inhibitors+as+a+Strategy+to+Activate+Stimulator+of+Interferon+Genes+%28STING%29+in+Cancers+and+Other+Diseases&doi=10.19080%2FIJCSMB.2018.05.555655"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.19080%2FIJCSMB.2018.05.555655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.19080%252FIJCSMB.2018.05.555655%26sid%3Dliteratum%253Aachs%26aulast%3DManas%26aufirst%3DS.%26aulast%3DTrason%26aufirst%3DT.%26aulast%3DAlexis%26aufirst%3DW.%26aulast%3DMohan%26aufirst%3DR.%2BK.%26atitle%3DDevelopment%2520of%2520Enpp1%2520Inhibitors%2520as%2520a%2520Strategy%2520to%2520Activate%2520Stimulator%2520of%2520Interferon%2520Genes%2520%2528STING%2529%2520in%2520Cancers%2520and%2520Other%2520Diseases%26jtitle%3DInt.%2520J.%2520Cell%2520Sci.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D5%26spage%3D555655%26doi%3D10.19080%2FIJCSMB.2018.05.555655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Habsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honjo, T.</span></span> <span> </span><span class="NLM_article-title">Role of PD-1 in Immunity and Diseases</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1007/82_2017_67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1007%2F82_2017_67" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=28929192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGksLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2017&pages=75-97&author=K.+Chamotoauthor=M.+Al-Habsiauthor=T.+Honjo&title=Role+of+PD-1+in+Immunity+and+Diseases&doi=10.1007%2F82_2017_67"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Role of PD-1 in immunity and diseases</span></div><div class="casAuthors">Chamoto, Kenji; Al-Habsi, Muna; Honjo, Tasuku</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Microbiology and Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity</span>),
    <span class="NLM_cas:pages">75-97</span>CODEN:
                <span class="NLM_cas:coden">CTMIA3</span>;
        ISSN:<span class="NLM_cas:issn">2196-9965</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Immunity developed to defend our bodies from foreign particles, including bacteria and viruses.  Although effector cells responsible for acquired immunity, mainly T cells, and B cells, are able to distinguish self from non-self, they sometimes attack the body's tissues because of imperfect central tolerance.  Several immune check points developed to limit overactivation of these cells.  One of the most important immune checkpoints is programmed cell death-1 (PD-1), which is expressed mainly on activated lymphocytes.  As its ligands (PD-Ls) are expressed widely in the body and affect the responses against self and foreign antigens, controlling PD-1/PD-L interactions enables the management of several immune-related diseases such as autoimmune disease, virus infection, and cancers.  Currently, the strategy of PD-1/ PD-L1 blockade has already been applied to clin. cancer therapy, providing evidences that PD-1 signal is one of the main factors of cancer immune escape in humans.  The dramatic efficacy of PD-1 blockade in cancer immunotherapy, promises the control of other immune diseases by PD-1 signal modulation.  In this review, we summarize the history of PD-1, subsequent basic studies, and their application to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreF_VPlkOFyLVg90H21EOLACvtfcHk0lgQ5jhGS4plDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGksLjM&md5=1a9ff2a3fd06cf762c507966051dfba3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2F82_2017_67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2017_67%26sid%3Dliteratum%253Aachs%26aulast%3DChamoto%26aufirst%3DK.%26aulast%3DAl-Habsi%26aufirst%3DM.%26aulast%3DHonjo%26aufirst%3DT.%26atitle%3DRole%2520of%2520PD-1%2520in%2520Immunity%2520and%2520Diseases%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2017%26volume%3D410%26spage%3D75%26epage%3D97%26doi%3D10.1007%2F82_2017_67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minoura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodaira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiya, T.</span></span> <span> </span><span class="NLM_article-title">Loss of microRNA-27b Contributes to Breast Cancer Stem Cell Generation by Activating ENPP1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7318</span>, <span class="refDoi"> DOI: 10.1038/ncomms8318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fncomms8318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=26065921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2ktrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7318&author=R.+U.+Takahashiauthor=H.+Miyazakiauthor=F.+Takeshitaauthor=Y.+Yamamotoauthor=K.+Minouraauthor=M.+Onoauthor=M.+Kodairaauthor=K.+Tamuraauthor=M.+Moriauthor=T.+Ochiya&title=Loss+of+microRNA-27b+Contributes+to+Breast+Cancer+Stem+Cell+Generation+by+Activating+ENPP1&doi=10.1038%2Fncomms8318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1</span></div><div class="casAuthors">Takahashi, Ryou-u; Miyazaki, Hiroaki; Takeshita, Fumitaka; Yamamoto, Yusuke; Minoura, Kaho; Ono, Makiko; Kodaira, Makoto; Tamura, Kenji; Mori, Masaki; Ochiya, Takahiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7318</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer stem cells (CSCs) have been identified in various types of cancer; however, the mechanisms by which cells acquire CSC properties such as drug resistance and tumor seeding ability are not fully understood.  Here, we identified microRNA-27b (miR-27b) as a key regulator for the generation of a side-population in breast cancer cells that showed CSC properties, and also found that the anti-type II diabetes (T2D) drug metformin reduced this side-population via miR-27b-mediated repression of ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1), which is involved in T2D development.  ENPP1 induced the generation of the side-population via upregulation of the ABCG2 transporter.  ENPP1 was also identified as a substrate of the 26S proteasome, the activity of which is downregulated in CSCs.  Overall, these results demonstrate that a T2D-assocd. gene plays an important role in tumor development and that its expression is strictly controlled at the mRNA and protein levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw4loZNiIX9LVg90H21EOLACvtfcHk0lgQ5jhGS4plDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2ktrnF&md5=e754b2c55863fb9328525366fe6a47fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncomms8318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8318%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DR.%2BU.%26aulast%3DMiyazaki%26aufirst%3DH.%26aulast%3DTakeshita%26aufirst%3DF.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DMinoura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKodaira%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DOchiya%26aufirst%3DT.%26atitle%3DLoss%2520of%2520microRNA-27b%2520Contributes%2520to%2520Breast%2520Cancer%2520Stem%2520Cell%2520Generation%2520by%2520Activating%2520ENPP1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7318%26doi%3D10.1038%2Fncomms8318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bageritz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puccio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovestadt, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pankert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold-Mende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goidts, V.</span></span> <span> </span><span class="NLM_article-title">Stem Cell Characteristics in Glioblastoma are Maintained by the Ecto-Nucleotidase E-NPP1</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1038/cdd.2014.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fcdd.2014.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=24531536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=929-940&author=J.+Bageritzauthor=L.+Puccioauthor=R.+M.+Piroauthor=V.+Hovestadtauthor=E.+Phillipsauthor=T.+Pankertauthor=J.+Lohrauthor=C.+Herold-Mendeauthor=P.+Lichterauthor=V.+Goidts&title=Stem+Cell+Characteristics+in+Glioblastoma+are+Maintained+by+the+Ecto-Nucleotidase+E-NPP1&doi=10.1038%2Fcdd.2014.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1</span></div><div class="casAuthors">Bageritz, J.; Puccio, L.; Piro, R. M.; Hovestadt, V.; Phillips, E.; Pankert, T.; Lohr, J.; Herold-Mende, C.; Lichter, P.; Goidts, V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">929-940</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioblastomas are highly aggressive brain tumors and are characterized by substantial cellular heterogeneity within a single tumor.  A sub-population of glioblastoma stem-like cells (GSCs) that shares properties with neural precursor cells has been described, exhibiting resistance to therapy and therefore being considered responsible for the high recurrence rate in glioblastoma.  To elucidate the underlying cellular processes we investigated the role of phosphatases in the GSC phenotype, using an in vitro phosphatome-wide RNA interference screen.  We identified a set of genes, the knockdown of which induces a significant decrease in the glioma stem cell marker CD133, indicating a role in the glioblastoma stem-like phenotype.  Among these genes, the ecto-nucleotidase ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) was found to be highly expressed in GSCs compared with normal brain and neural stem cells.  Knockdown of ENPP1 in cultured GSCs resulted in an overall downregulation of stem cell-assocd. genes, induction of differentiation into astrocytic cell lineage, impairment of sphere formation, in addn. to increased cell death, accumulation of cells in G1/G0 cell cycle phase and sensitization to chemotherapeutic treatment.  Genome-wide gene expression anal. and nucleoside and nucleotide profiling revealed that knockdown of ENPP1 affects purine and pyrimidine metab., suggesting a link between ENPP1 expression and a balanced nucleoside-nucleotide pool in GSCs.  The phenotypic changes in E-NPP1-deficient GSCs are assumed to be a consequence of decreased transcriptional function of E2F1.  Together, these results reveal that E-NPP1, by acting upstream of E2F1, is indispensable for the maintenance of GSCs in vitro and hence required to keep GSCs in an undifferentiated, proliferative state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgLWv2HJ6-TLVg90H21EOLACvtfcHk0ligLAdOop4GIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgsLo%253D&md5=b10a6be7ee48eac24094a781331088b0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.12%26sid%3Dliteratum%253Aachs%26aulast%3DBageritz%26aufirst%3DJ.%26aulast%3DPuccio%26aufirst%3DL.%26aulast%3DPiro%26aufirst%3DR.%2BM.%26aulast%3DHovestadt%26aufirst%3DV.%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DPankert%26aufirst%3DT.%26aulast%3DLohr%26aufirst%3DJ.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DLichter%26aufirst%3DP.%26aulast%3DGoidts%26aufirst%3DV.%26atitle%3DStem%2520Cell%2520Characteristics%2520in%2520Glioblastoma%2520are%2520Maintained%2520by%2520the%2520Ecto-Nucleotidase%2520E-NPP1%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2014%26volume%3D21%26spage%3D929%26epage%3D940%26doi%3D10.1038%2Fcdd.2014.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aerts, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ginniken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ostade, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kockx, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dua, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slegers, H.</span></span> <span> </span><span class="NLM_article-title">The Expression of Ecto-Nucleotide Pyrophosphatase/ Phosphodiesterase 1 (E-NPP1) is Correlated with Astrocytic Tumor Grade</span>. <i>Clin. Neurol. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.clineuro.2010.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.clineuro.2010.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=21195542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BC3M3jvFynuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2011&pages=224-229&author=I.+Aertsauthor=J.+J.+Martinauthor=P.+P.+De+Deynauthor=C.+Van+Ginnikenauthor=X.+Van+Ostadeauthor=M.+Kockxauthor=G.+Duaauthor=H.+Slegers&title=The+Expression+of+Ecto-Nucleotide+Pyrophosphatase%2F+Phosphodiesterase+1+%28E-NPP1%29+is+Correlated+with+Astrocytic+Tumor+Grade&doi=10.1016%2Fj.clineuro.2010.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade</span></div><div class="casAuthors">Aerts Indra; Martin Jean-Jacques; De Deyn Peter Paul; Van Ginniken Chris; Van Ostade Xaveer; Kockx Mark; Dua Guido; Slegers Herman</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neurology and neurosurgery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">224-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Astrocytic brain tumors are subdivided in four grades.  The most aggressive and invasive one is grade IV or glioblastoma multiforme (GBM).  Ecto-nucleotide pyrophosphatase/phosphodiesterase-1 (E-NPP1), a membrane-bound enzyme, is involved in many cellular processes such as modulation of purinergic signalling, nucleotide recycling, regulation of extracellular pyrophosphate levels and stimulation of cell motility.  In this study, the use of anti-NPP1 antibody in the determination of astrocytic tumor grade is evaluated.  MATERIALS AND METHODS:  Paraffin-embedded surgical specimens from 41 primary human astrocytic brain tumors (grade I=2; grade II=10; grade III=9; grade IV=20) and 5 control samples are immunostained against NPP1 and glial fibrillary acid protein an astrocytic marker.  RESULTS:  In this communication, we report the expression of NPP1 in human astrocytic brain tumors.  No expression could be detected in control tissue.  We observed a remarkable up regulated expression of NPP1 in GBM.  Taking the latter as 100%, grade I has a relative NPP1 staining of 7%, whereas grade II and III have a similar NPP1 expression level of 53% and 47% respectively.  CONCLUSION:  A correlation is found between the up-regulated expression of NPP1 and the grade of the astrocytic tumor.  Further investigation of NPP1 expression, especially in GBM, is necessary to determine the role of NPP1 in astrocytic brain tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRAZSLGWDvoWmbXvSEQle5fW6udTcc2ebImhIdvtKvqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3jvFynuw%253D%253D&md5=1b1db009def9391a22668e28eb535e78</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.clineuro.2010.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clineuro.2010.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DAerts%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DJ.%2BJ.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26aulast%3DVan%2BGinniken%26aufirst%3DC.%26aulast%3DVan%2BOstade%26aufirst%3DX.%26aulast%3DKockx%26aufirst%3DM.%26aulast%3DDua%26aufirst%3DG.%26aulast%3DSlegers%26aufirst%3DH.%26atitle%3DThe%2520Expression%2520of%2520Ecto-Nucleotide%2520Pyrophosphatase%252F%2520Phosphodiesterase%25201%2520%2528E-NPP1%2529%2520is%2520Correlated%2520with%2520Astrocytic%2520Tumor%2520Grade%26jtitle%3DClin.%2520Neurol.%2520Neurosurg.%26date%3D2011%26volume%3D113%26spage%3D224%26epage%3D229%26doi%3D10.1016%2Fj.clineuro.2010.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span> <span> </span><span class="NLM_article-title">Dysregulated ENPP1 Increases the Malignancy of Human Lung Cancer by Inducing Epithelial-Mesenchymal Transition Phenotypes and Stem Cell Features</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30755817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BB3cfis1eltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=134-144&author=M.+Huauthor=W.+Guoauthor=Y.+Liaoauthor=D.+Xuauthor=B.+Sunauthor=H.+Songauthor=T.+Wangauthor=Y.+Kuangauthor=B.+Jingauthor=K.+Liauthor=J.+Lingauthor=F.+Yaoauthor=J.+Deng&title=Dysregulated+ENPP1+Increases+the+Malignancy+of+Human+Lung+Cancer+by+Inducing+Epithelial-Mesenchymal+Transition+Phenotypes+and+Stem+Cell+Features"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features</span></div><div class="casAuthors">Hu Min; Liao Yueling; Xu Dongliang; Song Hongyong; Wang Tong; Jing Bo; Li Kaimi; Deng Jiong; Hu Min; Liao Yueling; Xu Dongliang; Song Hongyong; Wang Tong; Jing Bo; Li Kaimi; Deng Jiong; Guo Wenzheng; Sun Beibei; Deng Jiong; Kuang Yanbin; Ling Jing; Yao Feng</div><div class="citationInfo"><span class="NLM_cas:title">American journal of cancer research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    </div><div class="casAbstract">Induction of cancer stem cell (CSC) characters and epithelial mesenchymal transition (EMT) features are crucial in tumor initiation, progression and metastasis.  However, underlying mechanisms remain incompletely understood.  Here, we showed that ENPP1 plays an important role in inducing and maintaining EMT phenotypes and CSC features in lung cancer.  ENPP1 is upregulated in lung cancer cells.  ENPP1-knockdown in lung cancer HCC827 cells and A549 cells resulted in suppressed colonogenic formation, anchorage-independent growth in vitro, and tumorigenicity in vivo.  ENPP1-knockdown also reduced expression of CSC makers, including ABCG2, SOX2, NANOG, and CD44.  Moreover, ENPP1-knockdown reversed TGFβ-induced EMT phenotypes, including cell migration, E-cadherin repression and vimentin induction.  Finally, upregulated ENPP1 was identified in majority of human lung tumor tissues compared to adjacent normal lung tissues.  Taken together, our study demonstrates that dysregulated ENPP1 contributes to increased malignancy of human lung cancer by inducing CSC-features, and EMT-like phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQc62oWEy_4I2y4bB4mnvYfW6udTcc2eZ-tQGvyO3YoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfis1eltg%253D%253D&md5=e857697b11c08fd08747598ba7cb70fc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DJing%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DJ.%26atitle%3DDysregulated%2520ENPP1%2520Increases%2520the%2520Malignancy%2520of%2520Human%2520Lung%2520Cancer%2520by%2520Inducing%2520Epithelial-Mesenchymal%2520Transition%2520Phenotypes%2520and%2520Stem%2520Cell%2520Features%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2019%26volume%3D9%26spage%3D134%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakehi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Molecular Characterization of a Novel Choline-Specific Glycerophosphodiester Phosphodiesterase Belonging to the Nucleotide Pyrophosphatase/Phosphodiesterase Family</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">23084</span>– <span class="NLM_lpage">23093</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413438200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1074%2Fjbc.M413438200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=15788404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVyhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23084-23093&author=H.+Sakagamiauthor=J.+Aokiauthor=Y.+Natoriauthor=K.+Nishikawaauthor=Y.+Kakehiauthor=Y.+Natoriauthor=H.+Arai&title=Biochemical+and+Molecular+Characterization+of+a+Novel+Choline-Specific+Glycerophosphodiester+Phosphodiesterase+Belonging+to+the+Nucleotide+Pyrophosphatase%2FPhosphodiesterase+Family&doi=10.1074%2Fjbc.M413438200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and Molecular Characterization of a Novel Choline-specific Glycerophosphodiester Phosphodiesterase Belonging to the Nucleotide Pyrophosphatase/Phosphodiesterase Family</span></div><div class="casAuthors">Sakagami, Hideki; Aoki, Junken; Natori, Yumiko; Nishikawa, Kiyotaka; Kakehi, Yoshiyuki; Natori, Yasuhiro; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">23084-23093</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatases/phosphodiesterases (NPPs) are ubiquitous membrane-assocd. or secreted ectoenzymes that release nucleoside 5'-monophosphate from a variety of nucleotides and nucleotide derivs.  The mammalian NPP family comprises seven members, but only three of these (NPP1-3) have been studied in some detail.  Previously we showed that lysophospholipase D, which hydrolyzes lysophosphatidylcholine (LPC) to produce lysophosphatidic acid, is identical to NPP2.  More recently an uncharacterized novel NPP member (NPP7) was shown to have alk. sphingomyelinase activity.  These findings raised the possibility that other members of the NPP family act on phospholipids.  Here we show that the sixth member of the NPP family, NPP6, is a choline-specific glycerophosphodiester phosphodiesterase.  The sequence of NPP6 encodes a transmembrane protein contg. an NPP domain with significant homol. to NPP4, NPP5, and NPP7/alk. sphingomyelinase.  When expressed in HeLa cells, NPP6 was detected in both the cells and the cell culture medium as judged by Western blotting and by enzymic activity.  Recombinant NPP6 efficiently hydrolyzed the classical substrate for phospholipase C, p-nitrophenyl phosphorylcholine, but not the classical nucleotide phosphodiesterase substrate, p-nitrophenyl thymidine 5'-monophosphate.  In addn., NPP6 hydrolyzed LPC to form monoacylglycerol and phosphorylcholine but not lysophosphatidic acid, showing it has a lysophospholipase C activity.  NPP6 showed a preference for LPC with short (12:0 and 14:0) or polyunsatd. (18:2 and 20:4) fatty acids.  It also hydrolyzed glycerophosphorylcholine and sphingosylphosphorylcholine efficiently.  In mice, NPP6 mRNA was predominantly detected in kidney with a lesser expression in brain and heart, and in human it was detected in kidney and brain.  The present results suggest that NPP6 has a specific role through the hydrolysis of polyunsatd. LPC, glycerophosphorylcholine, or sphingosylphosphorylcholine in these organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHQ_9JICt77Vg90H21EOLACvtfcHk0lhKUPFjNSVc1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVyhur4%253D&md5=21deb1792f7e76b3480289197466f146</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413438200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413438200%26sid%3Dliteratum%253Aachs%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNatori%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DKakehi%26aufirst%3DY.%26aulast%3DNatori%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DBiochemical%2520and%2520Molecular%2520Characterization%2520of%2520a%2520Novel%2520Choline-Specific%2520Glycerophosphodiester%2520Phosphodiesterase%2520Belonging%2520to%2520the%2520Nucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520Family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D23084%26epage%3D23093%26doi%3D10.1074%2Fjbc.M413438200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Fluorescence Probe for Lysophospholipase C/NPP6 Activity and a Potent NPP6 Inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">12021</span>– <span class="NLM_lpage">12030</span>, <span class="refDoi"> DOI: 10.1021/ja201028t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja201028t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVSku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=12021-12030&author=M.+Kawaguchiauthor=T.+Okabeauthor=S.+Okudairaauthor=K.+Hanaokaauthor=Y.+Fujikawaauthor=T.+Teraiauthor=T.+Komatsuauthor=H.+Kojimaauthor=J.+Aokiauthor=T.+Nagano&title=Fluorescence+Probe+for+Lysophospholipase+C%2FNPP6+Activity+and+a+Potent+NPP6+Inhibitor&doi=10.1021%2Fja201028t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence Probe for Lysophospholipase C/NPP6 Activity and a Potent NPP6 Inhibitor</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Okabe, Takayoshi; Okudaira, Shinichi; Hanaoka, Kenjiro; Fujikawa, Yuuta; Terai, Takuya; Komatsu, Toru; Kojima, Hirotatsu; Aoki, Junken; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12021-12030</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatases/phosphodiesterases (NPPs) are ubiquitous membrane-assocd. or secreted ectoenzymes that have a role in regulating extracellular nucleotide and phospholipid metab.  Among the members of the NPP family, NPP1 and -3 act on nucleotides such as ATP, while NPP2, -6, and -7 act on phospholipids such as lysophosphatidylcholine and sphingomyelin.  NPP6, a recently characterized NPP family member, is a choline-specific glycerophosphodiester phosphodiesterase, but its functions remain to be analyzed, partly due to the lack of highly sensitive activity assay systems and practical inhibitors.  Here we report synthesis of novel NPP6 fluorescence probes, TG-mPC and its analogs TG-mPC3C, TG-mPC5C, TG-mPENE, TG-mPEA, TG-mPhos, TG-mPA, TG-mPMe, and TG-mPPr.  Among the seven NPPs, only NPP6 hydrolyzed TG-mPC, TG-mPC3C, and TG-mPENE.  TG-mPC was hydrolyzed in the cell lysate from NPP6-transfected cells, but not control cells, showing that it is suitable for use in cell-based NPP6 assays.  We also examd. the usefulness of TG-mPC as a fluorescence imaging probe.  We further applied TG-mPC to carry out high-throughput NPP6 inhibitor screening and found several NPP6-selective inhibitors in a library of about 80 000 compds.  Through structure-activity relationship (SAR) anal., we identified a potent and selective NPP6 inhibitor with an IC50 value of 0.21 μM.  Our NPP6-selective fluorescence probe, TG-mPC, and the inhibitor are expected to be useful to elucidate the biol. function of NPP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6hKm4EqpmFrVg90H21EOLACvtfcHk0ljA1mJZA0u6TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVSku7k%253D&md5=3bbcd28152d54359aa6d8022de64cc08</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja201028t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja201028t%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DFujikawa%26aufirst%3DY.%26aulast%3DTerai%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DFluorescence%2520Probe%2520for%2520Lysophospholipase%2520C%252FNPP6%2520Activity%2520and%2520a%2520Potent%2520NPP6%2520Inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D12021%26epage%3D12030%26doi%3D10.1021%2Fja201028t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasheed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambreen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhary, M. I.</span></span> <span> </span><span class="NLM_article-title">1,3,4-Oxadiazole-2(3H)-thione and Its Analogues: a New Class of Non-Competitive Nucleotide Pyrophosphatases/Phosphodiesterases 1 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">7816</span>– <span class="NLM_lpage">–7822</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.bmc.2009.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=19822431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCrsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7816-%E2%80%937822&author=K.+M.+Khanauthor=N.+Fatimaauthor=M.+Rasheedauthor=S.+Jalilauthor=N.+Ambreenauthor=S.+Perveenauthor=M.+I.+Choudhary&title=1%2C3%2C4-Oxadiazole-2%283H%29-thione+and+Its+Analogues%3A+a+New+Class+of+Non-Competitive+Nucleotide+Pyrophosphatases%2FPhosphodiesterases+1+Inhibitors&doi=10.1016%2Fj.bmc.2009.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,4-Oxadiazole-2(3H)-thione and its analogues: A new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors</span></div><div class="casAuthors">Khan, Khalid M.; Fatima, Naheed; Rasheed, Maimona; Jalil, Saima; Ambreen, Nida; Perveen, Shahnaz; Choudhary, M. Iqbal</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7816-7822</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1,3,4-oxadiazole-2 (3H)-thiones and 1,3,4-thiadiazole-2 (3H)-thiones were evaluated for their inhibitory activities against the two nucleotide pyrophosphatase phosphodiesterase 1 enzymes.  Dixon, as well as Lineweaver-Burk plots, and their secondary replots have indicated that the inhibition was of pure non-competitive type, against both snake venom and pure human recombinant enzymes as the V max values decreases without affecting the K m values. 5-[4-(t-Butyldimethylsilyloxy)-phenyl]-1,3,4-thiadiazole-2 (3H)-thione (17) and [4-(t-butyldimethylsilyloxy)-phenyl]-1,3,4-oxadiazole-2 (3H)-thione (1) were found to be the most active compds. with IC50 values 66.47 and 368 μM, resp.  The K i values were 100 μM and 360 μM against the snake venom and human recombinant NPP1 enzyme, resp.  Most active compds. were found to be non-toxic in neutrophil viability assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKvy3RWj1pLVg90H21EOLACvtfcHk0ljA1mJZA0u6TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCrsb7N&md5=ee8117e86268c5596afd04b61ddca09f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DK.%2BM.%26aulast%3DFatima%26aufirst%3DN.%26aulast%3DRasheed%26aufirst%3DM.%26aulast%3DJalil%26aufirst%3DS.%26aulast%3DAmbreen%26aufirst%3DN.%26aulast%3DPerveen%26aufirst%3DS.%26aulast%3DChoudhary%26aufirst%3DM.%2BI.%26atitle%3D1%252C3%252C4-Oxadiazole-2%25283H%2529-thione%2520and%2520Its%2520Analogues%253A%2520a%2520New%2520Class%2520of%2520Non-Competitive%2520Nucleotide%2520Pyrophosphatases%252FPhosphodiesterases%25201%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7816%26epage%3D%25E2%2580%25937822%26doi%3D10.1016%2Fj.bmc.2009.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eliahu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigonnesse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lévesque, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Diadenosine 5′,5″-(Boranated)polyphosphonate Analogues as Selective Nucleotide Pyrophosphatase/Phosphodiesterase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8485</span>– <span class="NLM_lpage">8497</span>, <span class="refDoi"> DOI: 10.1021/jm100597c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100597c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8485-8497&author=S.+Eliahuauthor=J.+Leckaauthor=G.+Reiserauthor=M.+Haasauthor=F.+Bigonnesseauthor=S.+A.+L%C3%A9vesqueauthor=J.+Pelletierauthor=J.+S%C3%A9vignyauthor=B.+Fischer&title=Diadenosine+5%E2%80%B2%2C5%E2%80%B3-%28Boranated%29polyphosphonate+Analogues+as+Selective+Nucleotide+Pyrophosphatase%2FPhosphodiesterase+Inhibitors&doi=10.1021%2Fjm100597c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Diadenosine 5',5''-(Boranated)polyphosphonate Analogues as Selective Nucleotide Pyrophosphatase/Phosphodiesterase Inhibitors</span></div><div class="casAuthors">Eliahu, Shay; Lecka, Joanna; Reiser, Georg; Haas, Michael; Bigonnesse, Francois; Levesque, Sebastien A.; Pelletier, Julie; Sevigny, Jean; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8485-8497</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatase/phosphodiesterases (NPPs) hydrolyze extracellular nucleotides and dinucleotides and thus control purinergic signaling.  Enhanced NPP activity is implicated in health disorders such as osteoarthritis and cancer.  We designed novel diadenosine polyphosphonate derivs. as potential NPP inhibitors.  Analogs 1-4 bear a phosphonate and/or boranophosphate group and/or a 2'-H atom instead of a 2'-OH group.  In comparison to ATP, analogs 1-4 were barely hydrolyzed by human NTPDase1, -2, -3, and -8 (<5% hydrolysis) and NPP1 and -3 (≤13%) and were not hydrolyzed by ecto-5'-nucleotidase, unlike AMP.  These derivs. did not affect NTPDase activity, and analogs 1 and 2 did not inhibit ecto-5'-nucleotidase.  All analogs blocked ∼80% of the NPP2-dependent hydrolysis of pnp-TMP, a specific NPP substrate, and inhibited the catabolism of pnp-TMP (Ki and IC50 both found to be between 10 and 60 μM), Ap5A, and ATP by NPP1.  The activity of NPP3 was inhibited to a lesser extent by the new analogs, with compds. 1 and 4 being the most effective in that respect.  The analogs dramatically reduced the level of hydrolysis of pnp-TMP at the cell surface of both osteocarcinoma and colon cancer cells.  Importantly, analogs 1-4 exhibited significantly reduced agonistic activity toward human P2Y1,11 receptors (except for analog 1) and no activity with human P2Y2 receptor.  Our data provide strong evidence that analog 2 is the first specific NPP inhibitor to be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphntKHVUJrnbVg90H21EOLACvtfcHk0lgSINeAvei3fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbvE&md5=fcd1e3a2ac5714e5775bcae2ef1d4151</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100597c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100597c%26sid%3Dliteratum%253Aachs%26aulast%3DEliahu%26aufirst%3DS.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DHaas%26aufirst%3DM.%26aulast%3DBigonnesse%26aufirst%3DF.%26aulast%3DL%25C3%25A9vesque%26aufirst%3DS.%2BA.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DDiadenosine%25205%25E2%2580%25B2%252C5%25E2%2580%25B3-%2528Boranated%2529polyphosphonate%2520Analogues%2520as%2520Selective%2520Nucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8485%26epage%3D8497%26doi%3D10.1021%2Fjm100597c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-David, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simhaev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliahu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oscar, J.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyindula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">Nonhydrolyzable ATP Analogues as Selective Inhibitors of Human NPP1: a Combined Computational/Experimental Study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8308</span>– <span class="NLM_lpage">8320</span>, <span class="refDoi"> DOI: 10.1021/jm400918s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400918s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjtL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8308-8320&author=J.+Leckaauthor=G.+Ben-Davidauthor=L.+Simhaevauthor=S.+Eliahuauthor=J.+Oscarauthor=P.+Luyindulaauthor=J.+Pelletierauthor=B.+Fischerauthor=H.+Senderowitzauthor=J.+S%C3%A9vigny&title=Nonhydrolyzable+ATP+Analogues+as+Selective+Inhibitors+of+Human+NPP1%3A+a+Combined+Computational%2FExperimental+Study&doi=10.1021%2Fjm400918s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Nonhydrolyzable ATP Analogues as Selective Inhibitors of Human NPP1: A Combined Computational/Experimental Study</span></div><div class="casAuthors">Lecka, Joanna; Ben-David, Gal; Simhaev, Luba; Eliahu, Shay; Oscar, Jocelyn; Luyindula, Patrick; Pelletier, Julie; Fischer, Bilha; Senderowitz, Hanoch; Sevigny, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8308-8320</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Elevated nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) activity is implicated in health disorders including pathol. calcification.  Specific NPP1 inhibitors would therefore be valuable for studying this enzyme and as potential therapeutic agents.  Here we present a combined computational/exptl. study characterizing 13 nonhydrolyzable ATP analogs as selective human NPP1 inhibitors.  All analogs at 100 μM inhibited (66-99%) the hydrolysis of pnp-TMP by both recombinant NPP1 and cell surface NPP1 activity of osteocarcinoma (HTB-85) cells.  These analogs only slightly altered the activity of other ectonucleotidases, NPP3 and NTPDases.  The Ki,app values of the seven most potent and selective inhibitors were in the range of 0.5-56 μM, all with mixed type inhibition, predominantly competitive.  Those mols. were docked into a newly developed homol. model of human NPP1.  All adopted ATP-like binding modes, suggesting competitive inhibition with the endogenous ligand.  NPP1 selectivity vs. NPP3 could be explained in terms of the electrostatic potential of the two proteins that of NPP1 favoring neg. charged ligands.  Inhibitor 2 that had the lowest Ki,app (0.5 μM) was also inactive toward P2Y receptors.  Overall, analog 2 is the most potent and selective NPP1 inhibitor described so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1IlX9dJYJmbVg90H21EOLACvtfcHk0lgSINeAvei3fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjtL7P&md5=0f2c563bdbf44aceafe5c863e2ebcb3c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400918s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400918s%26sid%3Dliteratum%253Aachs%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DBen-David%26aufirst%3DG.%26aulast%3DSimhaev%26aufirst%3DL.%26aulast%3DEliahu%26aufirst%3DS.%26aulast%3DOscar%26aufirst%3DJ.%26aulast%3DLuyindula%26aufirst%3DP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3DNonhydrolyzable%2520ATP%2520Analogues%2520as%2520Selective%2520Inhibitors%2520of%2520Human%2520NPP1%253A%2520a%2520Combined%2520Computational%252FExperimental%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8308%26epage%3D8320%26doi%3D10.1021%2Fjm400918s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nadel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilad, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-David, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenigsberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisman, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Highly Potent and Selective Ectonucleotide Pyrophosphatase/Phosphodiesterase I Inhibitors Based on an Adenosine 5′-(α or γ)-Thio-(α,β- or β,γ)-methylenetriphosphate Scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4677</span>– <span class="NLM_lpage">–4691</span>, <span class="refDoi"> DOI: 10.1021/jm500196c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500196c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFOhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4677-%E2%80%934691&author=Y.+Nadelauthor=J.+Leckaauthor=Y.+Giladauthor=G.+Ben-Davidauthor=D.+F%C3%B6rsterauthor=G.+Reiserauthor=S.+Kenigsbergauthor=J.+Camdenauthor=G.+A.+Weismanauthor=H.+Senderowitzauthor=J.+S%C3%A9vignyauthor=B.+Fischer&title=Highly+Potent+and+Selective+Ectonucleotide+Pyrophosphatase%2FPhosphodiesterase+I+Inhibitors+Based+on+an+Adenosine+5%E2%80%B2-%28%CE%B1+or+%CE%B3%29-Thio-%28%CE%B1%2C%CE%B2-+or+%CE%B2%2C%CE%B3%29-methylenetriphosphate+Scaffold&doi=10.1021%2Fjm500196c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Selective Ectonucleotide Pyrophosphatase/Phosphodiesterase I Inhibitors Based on an Adenosine 5'-(α or γ)-Thio-(α,β- or β,γ)-methylenetriphosphate Scaffold</span></div><div class="casAuthors">Nadel, Yael; Lecka, Joanna; Gilad, Yocheved; Ben-David, Gal; Forster, Daniel; Reiser, Georg; Kenigsberg, Sarah; Camden, Jean; Weisman, Gary A.; Senderowitz, Hanoch; Sevigny, Jean; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4677-4691</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) activity is assocd. with chondrocalcinosis, osteoarthritis, and type 2 diabetes.  The potential of NPP1 inhibitors as therapeutic agents, and the scarceness of their structure-activity relationship, encouraged the authors to develop new NPP1 inhibitors.  Specifically, the authors synthesized ATP-α-thio-β,γ-CH2 (1), ATP-α-thio-β,γ-CCl2 (2), ATP-α-CH2-γ-thio (3), and 8-SH-ATP (4) and established their resistance to hydrolysis by NPP1,3 and NTPDase1,2,3,8 (<5% hydrolysis) (NTPDase = ectonucleoside triphosphate diphosphohydrolase).  Analogs 1-3 at 100 μM inhibited thymidine 5'-monophosphate p-nitrophenyl ester hydrolysis by NPP1 and NPP3 by >90% and 23-43%, resp., and only slightly affected (0-40%) hydrolysis of ATP by NTPDase1,2,3,8.  Analog 3 is the most potent NPP1 inhibitor currently known, Ki = 20 nM and IC50 = 0.39 μM.  Analog adenosine 5'-Pα-Thio-β,γ-(dichloromethylene)triphosphate (2a) is a selective NPP1 inhibitor with Ki = 685 nM and IC50 = 0.57 μM.  Analogs 1-3 were found mostly to be non-agonists of P2Y1/P2Y2/P2Y11 receptors.  Docking analogs 1-3 into the NPP1 model suggested that activity correlates with the no. of H-bonds with binding site residues.  In conclusion, the authors propose analogs 2a and 3 as highly promising NPP1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWOOTCi6AzlLVg90H21EOLACvtfcHk0ljNwYCPXIqY5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFOhtb4%253D&md5=5a379536437d324b53aa7a059fce9c65</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm500196c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500196c%26sid%3Dliteratum%253Aachs%26aulast%3DNadel%26aufirst%3DY.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DGilad%26aufirst%3DY.%26aulast%3DBen-David%26aufirst%3DG.%26aulast%3DF%25C3%25B6rster%26aufirst%3DD.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DKenigsberg%26aufirst%3DS.%26aulast%3DCamden%26aufirst%3DJ.%26aulast%3DWeisman%26aufirst%3DG.%2BA.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DHighly%2520Potent%2520and%2520Selective%2520Ectonucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520I%2520Inhibitors%2520Based%2520on%2520an%2520Adenosine%25205%25E2%2580%25B2-%2528%25CE%25B1%2520or%2520%25CE%25B3%2529-Thio-%2528%25CE%25B1%252C%25CE%25B2-%2520or%2520%25CE%25B2%252C%25CE%25B3%2529-methylenetriphosphate%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4677%26epage%3D%25E2%2580%25934691%26doi%3D10.1021%2Fjm500196c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonczak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridine- and Purine-Thioacetamide Derivatives: Potent Inhibitors of Nucleotide Pyrophosphatase/Phosphodiesterase 1 (NPP1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10080</span>– <span class="NLM_lpage">10100</span>, <span class="refDoi"> DOI: 10.1021/jm501434y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501434y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKmsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10080-10100&author=L.+Changauthor=S.+Y.+Leeauthor=P.+Leonczakauthor=J.+Rozenskiauthor=S.+De+Jongheauthor=T.+Hanckauthor=C.+E.+M%C3%BCllerauthor=P.+Herdewijn&title=Imidazopyridine-+and+Purine-Thioacetamide+Derivatives%3A+Potent+Inhibitors+of+Nucleotide+Pyrophosphatase%2FPhosphodiesterase+1+%28NPP1%29&doi=10.1021%2Fjm501434y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazopyridine- and Purine-Thioacetamide Derivatives: Potent Inhibitors of Nucleotide Pyrophosphatase/Phosphodiesterase 1 (NPP1)</span></div><div class="casAuthors">Chang, Lei; Lee, Sang-Yong; Leonczak, Piotr; Rozenski, Jef; De Jonghe, Steven; Hanck, Theodor; Muller, Christa E.; Herdewijn, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10080-10100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) belongs to the family of ecto-nucleotidases, which control extracellular nucleotide, nucleoside, and (di)phosphate levels.  To study the (patho)physiol. roles of NPP1 potent and selective inhibitors with drug-like properties are required.  Therefore, a compd. library was screened for NPP1 inhibitors using a colorimetric assay with p-nitrophenyl 5'-thymidine monophosphate (p-Nph-5'-TMP) as an artificial substrate.  This led to the discovery of 2-(3H-imidazo[4,5-b]pyridin-2-ylthio)-N-(3,4-dimethoxyphenyl)acetamide (5a) as a hit compd. with a Ki value of 217 nM.  Subsequent structure-activity relationship studies led to the development of purine and imidazo[4,5-b]pyridine analogs with high inhibitory potency (Ki values of 5.00 nM and 29.6 nM, resp.) when assayed with p-Nph-5'-TMP as a substrate.  Surprisingly, the compds. were significantly less potent when tested vs. ATP as a substrate, with Ki values in the low micromolar range.  A prototypic inhibitor was investigated for its mechanism of inhibition and found to be competitive vs. both substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1oH5noS-80LVg90H21EOLACvtfcHk0ljNwYCPXIqY5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmsb7O&md5=62c4add9c4e430b0c5a5d5efbbe54117</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501434y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501434y%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DLeonczak%26aufirst%3DP.%26aulast%3DRozenski%26aufirst%3DJ.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DHanck%26aufirst%3DT.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DHerdewijn%26aufirst%3DP.%26atitle%3DImidazopyridine-%2520and%2520Purine-Thioacetamide%2520Derivatives%253A%2520Potent%2520Inhibitors%2520of%2520Nucleotide%2520Pyrophosphatase%252FPhosphodiesterase%25201%2520%2528NPP1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10080%26epage%3D10100%26doi%3D10.1021%2Fjm501434y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Nucleotide Pyrophosphatase/Phosphodiesterase 1 (NPP1) and Its Inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1039/C7MD00015D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1039%2FC7MD00015D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30108800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=823-840&author=S.+Y.+Leeauthor=C.+E.+M%C3%BCller&title=Nucleotide+Pyrophosphatase%2FPhosphodiesterase+1+%28NPP1%29+and+Its+Inhibitors&doi=10.1039%2FC7MD00015D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors</span></div><div class="casAuthors">Lee, Sang-Yong; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-840</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1, EC 3.1.4.1) is a metalloenzyme that belongs to the NPP family, which comprises seven subtypes (NPP1-7).  NPP1 hydrolyzes a wide range of phosphodiester bonds, e.g. in nucleoside triphosphates, (cyclic) dinucleotides, and nucleotide sugars yielding nucleoside 5'-monophosphates as products.  Its main substrate is ATP which is cleaved to AMP and diphosphate.  The enzyme is involved in various biol. processes including bone mineralization, soft-tissue calcification, insulin receptor signalling, cancer cell proliferation and immune modulation.  Therefore, NPP1 inhibitors have potential as novel drugs, e.g. for (immuno)oncol.  In the last two decades several inhibitors of NPP1 derived from nucleotide- or non-nucleotide scaffolds have been developed.  The most potent and selective NPP1-inhibitory substrate analog is adenosine 5'-α,β-methylene-γ-thiotriphosphate (Ki = 20 nM vs. p-Nph-5'-TMP, human membrane-bound NPP1).  Non-nucleotide-derived NPP1 inhibitors comprise polysulfonates, polysaccharides, polyoxometalates and small heterocyclic compds.  The polyoxometalate [TiW11CoO40]8- (PSB-POM141) is the most potent and selective NPP1 inhibitor described to date (Ki = 1.46 nM vs. ATP, human sol. NPP1); it displays an allosteric mechanism of inhibition and represents a useful pharmacol. tool for evaluating the potential of NPP1 as a novel drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYX4x_-RuSKbVg90H21EOLACvtfcHk0ljPhDLAAQWVvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D&md5=59169b98f5f53799ae43cde20df7c000</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC7MD00015D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00015D%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DNucleotide%2520Pyrophosphatase%252FPhosphodiesterase%25201%2520%2528NPP1%2529%2520and%2520Its%2520Inhibitors%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D823%26epage%3D840%26doi%3D10.1039%2FC7MD00015D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zelikman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simhaev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sela, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arguin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5′-P<sub>α,α</sub>-Dithiophosphate Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3939</span>– <span class="NLM_lpage">–3951</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVaht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3939-%E2%80%933951&author=V.+Zelikmanauthor=J.+Pelletierauthor=L.+Simhaevauthor=A.+Selaauthor=F.+P.+Gendronauthor=G.+Arguinauthor=H.+Senderowitzauthor=J.+S%C3%A9vignyauthor=B.+Fischer&title=Highly+Selective+and+Potent+Ectonucleotide+Pyrophosphatase-1+%28NPP1%29+Inhibitors+Based+on+Uridine+5%E2%80%B2-P%CE%B1%2C%CE%B1-Dithiophosphate+Analogues&doi=10.1021%2Facs.jmedchem.7b01906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-Pα,α-Dithiophosphate Analogues</span></div><div class="casAuthors">Zelikman, Vadim; Pelletier, Julie; Simhaev, Luba; Sela, Aviad; Gendron, Fernand-Pierre; Arguin, Guillaume; Senderowitz, Hanoch; Sevigny, Jean; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3939-3951</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) hydrolyzes phosphodiester bonds of nucleotides such as ATP, resulting mainly in the formation of AMP and pyrophosphate.  NPP1 activity plays a deleterious function in calcified aortic valve disease and calcium pyrophosphate deposition disease.  Thus, inhibitors of NPP1 represent a medical need.  We developed novel NPP1 inhibitors based on uridine 5'-Pα,α-dithiophosphate analogs, 9-12.  All these analogs potently inhibited hNPP1 (80-100% inhibition) at 100 μM, with no, or minimal, inhibition of NPP3 and other ectonucleotidases (NTPDase1,2,3,8).  These compds. showed nearly no activity at uracil-nucleotide sensitive P2Y2,4,6-receptors and thus represent highly selective NPP1 inhibitors.  The most promising inhibitor was diuridine 5'-Pα,α,5''-Pα,α-tetrathiotetraphosphate, 12, exhibiting Ki of 27 nM.  Analogs 9-12 proved to be highly stable to air oxidn. and to acidic and basic pH.  Docking simulations suggested that the enhanced NPP1 inhibitory activity and selectivity of analog 12 could be attributed to the simultaneous occupancy of two sites (the AMP site and an alternative site) of NPP1 by this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooyDIcZpImjLVg90H21EOLACvtfcHk0ljPhDLAAQWVvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVaht74%253D&md5=1e25944172b3f431e854527d2360b4f6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01906%26sid%3Dliteratum%253Aachs%26aulast%3DZelikman%26aufirst%3DV.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSimhaev%26aufirst%3DL.%26aulast%3DSela%26aufirst%3DA.%26aulast%3DGendron%26aufirst%3DF.%2BP.%26aulast%3DArguin%26aufirst%3DG.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DHighly%2520Selective%2520and%2520Potent%2520Ectonucleotide%2520Pyrophosphatase-1%2520%2528NPP1%2529%2520Inhibitors%2520Based%2520on%2520Uridine%25205%25E2%2580%25B2-P%25CE%25B1%252C%25CE%25B1-Dithiophosphate%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3939%26epage%3D%25E2%2580%25933951%26doi%3D10.1021%2Facs.jmedchem.7b01906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Screening and X-ray Crystal Structure-Based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1713</span>– <span class="NLM_lpage">1721</span>, <span class="refDoi"> DOI: 10.1021/cb400150c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400150c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1713-1721&author=M.+Kawaguchiauthor=T.+Okabeauthor=S.+Okudairaauthor=H.+Nishimasuauthor=R.+Ishitaniauthor=H.+Kojimaauthor=O.+Nurekiauthor=J.+Aokiauthor=T.+Nagano&title=Screening+and+X-ray+Crystal+Structure-Based+Optimization+of+Autotaxin+%28ENPP2%29+Inhibitors%2C+Using+a+Newly+Developed+Fluorescence+Probe&doi=10.1021%2Fcb400150c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and X-ray Crystal Structure-based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Okabe, Takayoshi; Okudaira, Shinichi; Nishimasu, Hiroshi; Ishitani, Ryuichiro; Kojima, Hirotatsu; Nureki, Osamu; Aoki, Junken; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1713-1721</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), was originally identified as a tumor cell autocrine motility factor and is identical to plasma lysophospholipase D, which is the predominant contributor to lysophosphatidic acid (LPA) prodn. from lysophospholipids.  ATX is therefore considered to regulate the physiol. and pathol. roles of LPA, including angiogenesis, lymphocyte trafficking, tissue fibrosis, and cancer cell invasion and metastasis.  Thus, it is a potential therapeutic target.  Here, the authors first developed a sensitive and specific ATX fluorescence probe, TG-mTMP, and used it to screen ATX inhibitors in a large chem. library.  This probe, which is superior to previously available probes FS-3 and CPF4 in terms of sensitivity or specificity, enabled the authors to identify several novel ATX inhibitor scaffolds.  The authors solved the crystal structures of ATX complexes with the hit compds. at high resoln. (1.75-1.95 Å) and used this information to guide optimization of the structure of a selected inhibitor.  The optimized compds., 3BoA and its derivs., exhibited potent ATX-inhibitory activity both in vitro and in vivo.  These inhibitors are expected to be useful tools to understand the roles of ATX in vitro and in vivo and may also be candidate anti-ATX therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-DjhUd2uXULVg90H21EOLACvtfcHk0ljPhDLAAQWVvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D&md5=fdd7e4fcad2cda139edb17673fc4c829</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcb400150c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400150c%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DNureki%26aufirst%3DO.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DScreening%2520and%2520X-ray%2520Crystal%2520Structure-Based%2520Optimization%2520of%2520Autotaxin%2520%2528ENPP2%2529%2520Inhibitors%252C%2520Using%2520a%2520Newly%2520Developed%2520Fluorescence%2520Probe%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1713%26epage%3D1721%26doi%3D10.1021%2Fcb400150c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Evolution of Fluorescein as a Platform for Finely Tunable Fluorescence Probes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">4888</span>– <span class="NLM_lpage">4894</span>, <span class="refDoi"> DOI: 10.1021/ja043919h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja043919h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVyntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=4888-4894&author=Y.+Uranoauthor=M.+Kamiyaauthor=K.+Kandaauthor=T.+Uenoauthor=K.+Hiroseauthor=T.+Nagano&title=Evolution+of+Fluorescein+as+a+Platform+for+Finely+Tunable+Fluorescence+Probes&doi=10.1021%2Fja043919h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of fluorescein as a platform for finely tunable fluorescence probes</span></div><div class="casAuthors">Urano, Yasuteru; Kamiya, Mako; Kanda, Kojiro; Ueno, Tasuku; Hirose, Kenzo; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4888-4894</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fluorescence imaging is the most powerful technique currently available for continuous observation of dynamic intracellular processes in living cells.  Suitable fluorescence probes are naturally of crit. importance for fluorescence imaging, but only a very limited range of biomols. can currently be visualized because of the lack of flexible design strategies for fluorescence probes.  At present, design is largely empirical.  Here we show that the carboxylic group of traditional fluorescein dyes, formerly considered indispensable, has been replaced with other substituents, affording various kinds of new fluoresceins.  Further, by breaking out of the traditional structure of fluorescein, we developed the first and totally rational design strategy for novel fluorescence probes based on a strict photochem. basis.  The value of this approach is exemplified by its application to develop a novel, highly sensitive, and membrane-permeable fluorescence probe for β-galactosidase, which is the most widely used reporter enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqopW9kkNKKgrVg90H21EOLACvtfcHk0lipoZn7fZJNzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVyntLc%253D&md5=a9e9ad6046baac2efa11b078786bb26c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja043919h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja043919h%26sid%3Dliteratum%253Aachs%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DKamiya%26aufirst%3DM.%26aulast%3DKanda%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DK.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DEvolution%2520of%2520Fluorescein%2520as%2520a%2520Platform%2520for%2520Finely%2520Tunable%2520Fluorescence%2520Probes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D4888%26epage%3D4894%26doi%3D10.1021%2Fja043919h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata-Ninomiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurashima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karasuyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span> <span> </span><span class="NLM_article-title">The Ectoenzyme E-NPP3 Negatively Regulates ATP-Dependent Chronic Allergic Responses by Basophils and Mast Cells</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2015.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.immuni.2015.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25692702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=279-293&author=S.+H.+Tsaiauthor=M.+Kinoshitaauthor=T.+Kusuauthor=H.+Kayamaauthor=R.+Okumuraauthor=K.+Ikedaauthor=Y.+Shimadaauthor=A.+Takedaauthor=S.+Yoshikawaauthor=K.+Obata-Ninomiyaauthor=Y.+Kurashimaauthor=S.+Satoauthor=E.+Umemotoauthor=H.+Kiyonoauthor=H.+Karasuyamaauthor=K.+Takeda&title=The+Ectoenzyme+E-NPP3+Negatively+Regulates+ATP-Dependent+Chronic+Allergic+Responses+by+Basophils+and+Mast+Cells&doi=10.1016%2Fj.immuni.2015.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The Ectoenzyme E-NPP3 Negatively Regulates ATP-Dependent Chronic Allergic Responses by Basophils and Mast Cells</span></div><div class="casAuthors">Tsai, Shih Han; Kinoshita, Makoto; Kusu, Takashi; Kayama, Hisako; Okumura, Ryu; Ikeda, Kayo; Shimada, Yosuke; Takeda, Akira; Yoshikawa, Soichiro; Obata-Ninomiya, Kazushige; Kurashima, Yosuke; Sato, Shintaro; Umemoto, Eiji; Kiyono, Hiroshi; Karasuyama, Hajime; Takeda, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-293</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Crosslinking of the Ig receptor FcεRI activates basophils and mast cells to induce immediate and chronic allergic inflammation.  However, it remains unclear how the chronic allergic inflammation is regulated.  Here, we showed that ecto-nucleotide pyrophosphatase-phosphodiesterase 3 (E-NPP3), also known as CD203c, rapidly induced by FcεRI crosslinking, neg. regulated chronic allergic inflammation.  Basophil and mast cell nos. increased in Enpp3-/- mice with augmented serum ATP concns.  Enpp3-/- mice were highly sensitive to chronic allergic pathologies, which was reduced by ATP blockade.  FcεRI crosslinking induced ATP secretion from basophils and mast cells, and ATP activated both cells.  ATP clearance was impaired in Enpp3-/- cells.  Enpp3-/-P2rx7-/- mice showed decreased responses to FcεRI crosslinking.  Thus, ATP released by FcεRI crosslinking stimulates basophils and mast cells for further activation causing allergic inflammation.  E-NPP3 decreases ATP concn. and suppresses basophil and mast cell activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQtIKaELo5LVg90H21EOLACvtfcHk0lipoZn7fZJNzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSks7c%253D&md5=7339a66746243af611100875ee1ddfb1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2015.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2015.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BH.%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DKusu%26aufirst%3DT.%26aulast%3DKayama%26aufirst%3DH.%26aulast%3DOkumura%26aufirst%3DR.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DObata-Ninomiya%26aufirst%3DK.%26aulast%3DKurashima%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DUmemoto%26aufirst%3DE.%26aulast%3DKiyono%26aufirst%3DH.%26aulast%3DKarasuyama%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26atitle%3DThe%2520Ectoenzyme%2520E-NPP3%2520Negatively%2520Regulates%2520ATP-Dependent%2520Chronic%2520Allergic%2520Responses%2520by%2520Basophils%2520and%2520Mast%2520Cells%26jtitle%3DImmunity%26date%3D2015%26volume%3D42%26spage%3D279%26epage%3D293%26doi%3D10.1016%2Fj.immuni.2015.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Enpp1, an Extracellular Glycoprotein Involved in Bone Mineralization and Insulin Signaling</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16876</span>– <span class="NLM_lpage">16881</span>, <span class="refDoi"> DOI: 10.1073/pnas.1208017109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1073%2Fpnas.1208017109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23027977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16876-16881&author=K.+Katoauthor=H.+Nishimasuauthor=S.+Okudairaauthor=E.+Miharaauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+Structure+of+Enpp1%2C+an+Extracellular+Glycoprotein+Involved+in+Bone+Mineralization+and+Insulin+Signaling&doi=10.1073%2Fpnas.1208017109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling</span></div><div class="casAuthors">Kato, Kazuki; Nishimasu, Hiroshi; Okudaira, Shinichi; Mihara, Emiko; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16876-16881, S16876/1-S16876/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enpp1 is a membrane-bound glycoprotein that regulates bone mineralization by hydrolyzing extracellular nucleotide triphosphates to produce pyrophosphate.  Enpp1 dysfunction causes human diseases characterized by ectopic calcification.  Enpp1 also inhibits insulin signaling, and an Enpp1 polymorphism is assocd. with insulin resistance.  However, the precise mechanism by which Enpp1 functions in these cellular processes remains elusive.  Here, we report the crystal structures of the extracellular region of mouse Enpp1 in complex with four different nucleotide monophosphates, at resolns. of 2.7-3.2 Å.  The nucleotides are accommodated in a pocket formed by an insertion loop in the catalytic domain, explaining the preference of Enpp1 for an ATP substrate.  Structural mapping of disease-assocd. mutations indicated the functional importance of the interdomain interactions.  A structural comparison of Enpp1 with Enpp2, a lysophospholipase D, revealed marked differences in the domain arrangements and active-site architectures.  Notably, the Enppl mutant lacking the insertion loop lost the nucleotide-hydrolyzing activity but instead gained the lysophospholipid-hydrolyzing activity of Enpp2.  Our findings provide structural insights into how the Enpp family proteins evolved to exert their diverse cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox0R6ZUOJBc7Vg90H21EOLACvtfcHk0lipoZn7fZJNzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WksL7F&md5=ae06fa446ff3041f42b35cc9d0cc1a94</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1208017109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1208017109%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520Structure%2520of%2520Enpp1%252C%2520an%2520Extracellular%2520Glycoprotein%2520Involved%2520in%2520Bone%2520Mineralization%2520and%2520Insulin%2520Signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D16876%26epage%3D16881%26doi%3D10.1073%2Fpnas.1208017109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominsky, S. L.</span></span> <span> </span><span class="NLM_article-title">Enpp1: a Potential Facilitator of Breast Cancer Bone Metastasis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e66752</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0066752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1371%2Fjournal.pone.0066752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23861746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKktL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e66752&author=W.+M.+Lauauthor=M.+Doucetauthor=R.+Stadelauthor=D.+Huangauthor=K.+L.+Weberauthor=S.+L.+Kominsky&title=Enpp1%3A+a+Potential+Facilitator+of+Breast+Cancer+Bone+Metastasis&doi=10.1371%2Fjournal.pone.0066752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Enpp1: a potential facilitator of breast cancer bone metastasis</span></div><div class="casAuthors">Lau, Wen Min; Doucet, Michele; Stadel, Ryan; Huang, David; Weber, Kristy L.; Kominsky, Scott L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e66752</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Bone is the most common site of breast cancer metastasis and once established, it is frequently incurable.  Crit. to our ability to prevent and treat bone metastasis is the identification of the key factors mediating its establishment and understanding their biol. function.  To address this issue we previously carried out an in vivo selection process to isolate murine mammary tumor sublines possessing an enhanced ability to colonize the bone.  A comparison of gene expression between parental cells and sublines by genome-wide cDNA microarray anal. revealed several potential mediators of bone metastasis, including the pyrophosphate-generating ectoenzyme Enpp1.  By qRT-PCR and Western anal. we found that expression of Enpp1 was elevated in human breast cancer cell lines known to produce bone metastasis in animal models compared to non-metastatic and normal mammary epithelial cell lines.  Further, in clin. specimens, levels of Enpp1 were significantly elevated in human primary breast tumors relative to normal mammary epithelium, with highest levels obsd. in breast-bone metastasis as detd. by qRT-PCR and immunohistochem. anal.  To examine the potential role of Enpp1 in the development of bone metastasis, Enpp1 expression was stably increased in the breast cancer cell line MDA-MB-231 and the ability to colonize the bone following intracardiac and direct intratibial injection of athymic nude mice was detd.  By both routes of administration, increased expression of Enpp1 enhanced the ability of MDA-MB-231 cells to form tumors in the bone relative to cells expressing vector alone, as detd. by digital radiog. and histol. anal.  Taken together, these data suggest a potential role for Enpp1 in the development of breast cancer bone metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNHWinX3-OSrVg90H21EOLACvtfcHk0ljK8yzQZ3s62w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKktL3F&md5=8c7822315a968b59ee44d97ec1b25da2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0066752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0066752%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DW.%2BM.%26aulast%3DDoucet%26aufirst%3DM.%26aulast%3DStadel%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DWeber%26aufirst%3DK.%2BL.%26aulast%3DKominsky%26aufirst%3DS.%2BL.%26atitle%3DEnpp1%253A%2520a%2520Potential%2520Facilitator%2520of%2520Breast%2520Cancer%2520Bone%2520Metastasis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De66752%26doi%3D10.1371%2Fjournal.pone.0066752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grobben, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slegers, H.</span></span> <span> </span><span class="NLM_article-title">Rat C6 Glioma as Experimental Model System for the Study of Glioblastoma Growth and Invasion</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1007/s00441-002-0651-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1007%2Fs00441-002-0651-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12457224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2002&pages=257-270&author=B.+Grobbenauthor=P.+P.+De+Deynauthor=H.+Slegers&title=Rat+C6+Glioma+as+Experimental+Model+System+for+the+Study+of+Glioblastoma+Growth+and+Invasion&doi=10.1007%2Fs00441-002-0651-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion</span></div><div class="casAuthors">Grobben, Bert; De Deyn, Peter Paul; Slegers, Herman</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-270</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  Infiltration of the central nervous system by neoplastic cells in patients with glioblastoma multiforme (GBM) leads to neurol. dysfunction and eventually to death.  The elucidation of the mechanisms underlying the aggressive nature of GBM aims at improving radio-, chemo- and gene therapy.  This review is focused on the use of rat C6 glioma as an exptl. model system for GBM and provides an overview of the exptl. data published in the literature using this cell line in elucidating the mechanism of tumor growth, angiogenesis and invasion, and in the design and evaluation of anticancer therapies.  Understanding the stages of malignant brain tumor progression requires a series of exptl. approaches with a varying degree of complexity.  Implantation of malignant cells into animal brain tissue closely resembles in vivo tumor growth and has the advantage over simplified models that inflammatory and vascular mechanisms are activated.  However, the complexity of these models makes it difficult to identify the individual processes involved in sustained tumor growth, angiogenesis and invasion.  In cell culture models, the effect of growth factors, extracellular matrix components, proteases and adhesion mols. can be investigated.  The secretion of tumor-derived factors into the medium can also be analyzed when simplified models are used.  This review is a compilation of exptl. data focused on the characterization of tumor-related processes and on the evaluation of new therapies for the treatment of malignant glial neoplasms using rat C6 glioma as a model system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhBTbKj6JnbVg90H21EOLACvtfcHk0ljK8yzQZ3s62w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cruw%253D%253D&md5=e3745b59b0a152ded9784a09647d47cb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs00441-002-0651-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-002-0651-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrobben%26aufirst%3DB.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26aulast%3DSlegers%26aufirst%3DH.%26atitle%3DRat%2520C6%2520Glioma%2520as%2520Experimental%2520Model%2520System%2520for%2520the%2520Study%2520of%2520Glioblastoma%2520Growth%2520and%2520Invasion%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2002%26volume%3D310%26spage%3D257%26epage%3D270%26doi%3D10.1007%2Fs00441-002-0651-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Development of a Highly Selective Fluorescence Probe for Alkaline Phosphatase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5088</span>– <span class="NLM_lpage">5091</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.bmcl.2011.03.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=21482108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaisLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5088-5091&author=M.+Kawaguchiauthor=K.+Hanaokaauthor=T.+Komatsuauthor=T.+Teraiauthor=T.+Nagano&title=Development+of+a+Highly+Selective+Fluorescence+Probe+for+Alkaline+Phosphatase&doi=10.1016%2Fj.bmcl.2011.03.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a highly selective fluorescence probe for alkaline phosphatase</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Hanaoka, Kenjiro; Komatsu, Toru; Terai, Takuya; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5088-5091</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed the first highly selective fluorescence probe for alk. phosphatase (ALP), TG-mPhos.  This probe shows selectivity for ALP over protein tyrosine phosphatase and protein serine/threonine phosphatase.  Our previously developed TG-Phos, which has a phenolic phosphate linkage in place of the alc. phosphate linkage of TG-mPhos, lacks this selectivity.  TG-mPhos should enable precise fluorescence imaging of ALP activity in biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVyaOhwpX_LVg90H21EOLACvtfcHk0ljK8yzQZ3s62w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaisLrJ&md5=8f795af8c6009bb3fd2382f9e058aa1c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DT.%26aulast%3DTerai%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520a%2520Highly%2520Selective%2520Fluorescence%2520Probe%2520for%2520Alkaline%2520Phosphatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5088%26epage%3D5091%26doi%3D10.1016%2Fj.bmcl.2011.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Acker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyten, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Structure of NPP1, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Involved in Tissue Calcification</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.str.2012.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23041369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKrtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1948-1959&author=S.+Jansenauthor=A.+Perrakisauthor=C.+Ulensauthor=C.+Winklerauthor=M.+Andriesauthor=R.+P.+Joostenauthor=M.+Van+Ackerauthor=F.+P.+Luytenauthor=W.+H.+Moolenaarauthor=M.+Bollen&title=Structure+of+NPP1%2C+an+Ectonucleotide+Pyrophosphatase%2FPhosphodiesterase+Involved+in+Tissue+Calcification&doi=10.1016%2Fj.str.2012.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of NPP1, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Involved in Tissue Calcification</span></div><div class="casAuthors">Jansen, Silvia; Perrakis, Anastassis; Ulens, Chris; Winkler, Claudia; Andries, Maria; Joosten, Robbie P.; Van Acker, Maarten; Luyten, Frank P.; Moolenaar, Wouter H.; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1959</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) converts extracellular nucleotides into inorg. pyrophosphate, whereas its close relative NPP2/autotaxin hydrolyzes lysophospholipids.  NPP1 regulates calcification in mineralization-competent tissues, and a lack of NPP1 function underlies calcification disorders.  Here, we show that NPP1 forms homodimers via intramembrane disulfide bonding, but is also processed intracellularly to a secreted monomer.  The structure of secreted NPP1 reveals a characteristic bimetallic active site and a nucleotide-binding groove, but it lacks the lipid-binding pocket and open tunnel present in NPP2.  A loop adjacent to the nucleotide-binding site, which is disordered in NPP2, is well ordered in NPP1 and might promote nucleotide binding.  Remarkably, the N-terminal somatomedin B-like domains of NPP1, unlike those in NPP2, are flexible and do not contact the catalytic domain.  Our results provide a structural basis for the nucleotide pyrophosphatase activity of NPP1 and help to understand how disease-causing mutations may affect NPP1 structure and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYawdR58GvWbVg90H21EOLACvtfcHk0lizbCB_8TqkWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKrtbvM&md5=ea22feb6c6d2d047b6d8780fd2c54a17</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DS.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DUlens%26aufirst%3DC.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DAndries%26aufirst%3DM.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DVan%2BAcker%26aufirst%3DM.%26aulast%3DLuyten%26aufirst%3DF.%2BP.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DStructure%2520of%2520NPP1%252C%2520an%2520Ectonucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520Involved%2520in%2520Tissue%2520Calcification%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D1948%26epage%3D1959%26doi%3D10.1016%2Fj.str.2012.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oikawa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuya, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into cGAMP Degradation by Ecto-Nucleotide Pyrophosphatase Phosphodiesterase 1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4424</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06922-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fs41467-018-06922-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30356045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BB3cvivVWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4424&author=K.+Katoauthor=H.+Nishimasuauthor=D.+Oikawaauthor=S.+Hiranoauthor=H.+Hiranoauthor=G.+Kasuyaauthor=R.+Ishitaniauthor=F.+Tokunagaauthor=O.+Nureki&title=Structural+Insights+into+cGAMP+Degradation+by+Ecto-Nucleotide+Pyrophosphatase+Phosphodiesterase+1&doi=10.1038%2Fs41467-018-06922-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1</span></div><div class="casAuthors">Kato Kazuki; Nishimasu Hiroshi; Hirano Seiichi; Hirano Hisato; Kasuya Go; Ishitani Ryuichiro; Nureki Osamu; Oikawa Daisuke; Tokunaga Fuminori</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">ENPP1 (Ecto-nucleotide pyrophosphatase phosphodiesterase 1), a type II transmembrane glycoprotein, hydrolyzes ATP to produce AMP and diphosphate, thereby inhibiting bone mineralization.  A recent study showed that ENPP1 also preferentially hydrolyzes 2'3'-cGAMP (cyclic GMP-AMP) but not its linkage isomer 3'3'-cGAMP, and negatively regulates the cGAS-STING pathway in the innate immune system.  Here, we present the high-resolution crystal structures of ENPP1 in complex with 3'3'-cGAMP and the reaction intermediate pA(3',5')pG.  The structures revealed that the adenine and guanine bases of the dinucleotides are recognized by nucleotide- and guanine-pockets, respectively.  Furthermore, the structures indicate that 2'3'-cGAMP, but not 3'3'-cGAMP, binds to the active site in a conformation suitable for catalysis, thereby explaining the specific degradation of 2'3'-cGAMP by ENPP1.  Our findings provide insights into how ENPP1 hydrolyzes both ATP and cGAMP to participate in the two distinct biological processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMhgmGs8bVbxKDYG3bNImrfW6udTcc2eZP7dltC5kzrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvivVWjsQ%253D%253D&md5=09b877db90b775fab733e5e301bb9fb1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06922-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06922-7%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOikawa%26aufirst%3DD.%26aulast%3DHirano%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DH.%26aulast%3DKasuya%26aufirst%3DG.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTokunaga%26aufirst%3DF.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DStructural%2520Insights%2520into%2520cGAMP%2520Degradation%2520by%2520Ecto-Nucleotide%2520Pyrophosphatase%2520Phosphodiesterase%25201%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4424%26doi%3D10.1038%2Fs41467-018-06922-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allred, D. C.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Status by Immunohistochemistry is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1474</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1200/JCO.1999.17.5.1474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1200%2FJCO.1999.17.5.1474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10334533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADyaK1M3msFOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=1474-1481&author=J.+M.+Harveyauthor=G.+M.+Clarkauthor=C.+K.+Osborneauthor=D.+C.+Allred&title=Estrogen+Receptor+Status+by+Immunohistochemistry+is+Superior+to+the+Ligand-Binding+Assay+for+Predicting+Response+to+Adjuvant+Endocrine+Therapy+in+Breast+Cancer&doi=10.1200%2FJCO.1999.17.5.1474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer</span></div><div class="casAuthors">Harvey J M; Clark G M; Osborne C K; Allred D C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1474-81</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the traditional ligand-binding assay (LBA).  The purpose of this study was to evaluate the ability of ER status determination by IHC, compared with LBA, to predict clinical outcome-especially response to adjuvant endocrine therapy-in a large number of patients with long-term clinical follow-up.  PATIENTS AND METHODS:  ER status was evaluated in 1,982 primary breast cancers by IHC on formalin-fixed paraffin-embedded tissue sections, using antibody 6F11 and standard methodology.  Slides were scored on a scale representing the estimated proportion and intensity of positive-staining tumor cells (range, 0 to 8).  Results were compared with ER values obtained by the LBA in the same tumors and to clinical outcome.  RESULTS:  An IHC score of greater than 2 (corresponding to as few as 1% to 10% weakly positive cells) was used to define ER positivity on the basis of a univariate cut-point analysis of all possible scores and disease-free survival (DFS) in patients receiving any adjuvant endocrine therapy.  Using this definition, 71% of all tumors were determined to be ER-positive by IHC, and the level of agreement with the LBA was 86%.  In multivariate analyses of patients receiving adjuvant endocrine therapy alone, ER status determined by IHC was better than that determined by the LBA at predicting improved DFS (hazard ratios/P = 0.474/.0008 and 0.707/.3214, respectively) and equivalent at predicting overall survival (0.379/.0001 and 0.381/.0003, respectively).  CONCLUSION:  IHC is superior to the LBA for assessing ER status in primary breast cancer because it is easier, safer, and less expensive, and has an equivalent or better ability to predict response to adjuvant endocrine therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7IXUUuibgZ4USrryheKE6fW6udTcc2eb8R645Tzmhdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3msFOjsA%253D%253D&md5=3d682260f5876081bea69d26dabf43c8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1200%2FJCO.1999.17.5.1474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.1999.17.5.1474%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DG.%2BM.%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DAllred%26aufirst%3DD.%2BC.%26atitle%3DEstrogen%2520Receptor%2520Status%2520by%2520Immunohistochemistry%2520is%2520Superior%2520to%2520the%2520Ligand-Binding%2520Assay%2520for%2520Predicting%2520Response%2520to%2520Adjuvant%2520Endocrine%2520Therapy%2520in%2520Breast%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1999%26volume%3D17%26spage%3D1474%26epage%3D1481%26doi%3D10.1200%2FJCO.1999.17.5.1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mitsuyasu Kawaguchi, Eriko Sekimoto, Yuhei Ohta, Naoya Ieda, Takashi Murakami, <span class="NLM_string-name hlFld-ContribAuthor">Hidehiko Nakagawa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Fluorescent Probes Targeting Tumor-Suppressor Protein FHIT and Identification of Apoptosis-Inducing FHIT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9567-9576. <a href="https://doi.org/10.1021/acs.jmedchem.1c00874" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00874%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BFluorescent%252BProbes%252BTargeting%252BTumor-Suppressor%252BProtein%252BFHIT%252Band%252BIdentification%252Bof%252BApoptosis-Inducing%252BFHIT%252BInhibitors%26aulast%3DKawaguchi%26aufirst%3DMitsuyasu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18052021%26date%3D23062021%26volume%3D64%26issue%3D13%26spage%3D9567%26epage%3D9576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Caroline W. Karanja, Kofi S. Yeboah, <span class="NLM_string-name hlFld-ContribAuthor">Herman O. Sintim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a Mycobacterium tuberculosis Cyclic Dinucleotide Phosphodiesterase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (2)
                                     , 309-317. <a href="https://doi.org/10.1021/acsinfecdis.0c00444" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00444%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DIdentification%252Bof%252Ba%252BMycobacterium%252Btuberculosis%252BCyclic%252BDinucleotide%252BPhosphodiesterase%252BInhibitor%26aulast%3DKaranja%26aufirst%3DCaroline%2BW.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22062020%26date%3D25012021%26volume%3D7%26issue%3D2%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong  Shao</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Jingqi  Shi</span>, <span class="hlFld-ContribAuthor ">Lifang  Ma</span>, <span class="hlFld-ContribAuthor ">Ziyuan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synergetic copper/TEMPO-catalysed benzylic C–H imidation with
              N
              -fluorobenzenesulfonimide at room temperature and tandem conversions with alcohols or arenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (13)
                                     , 3298-3307. <a href="https://doi.org/10.1039/D1QO00340B" title="DOI URL">https://doi.org/10.1039/D1QO00340B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00340B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00340B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynergetic%252Bcopper%25252FTEMPO-catalysed%252Bbenzylic%252BC%2525E2%252580%252593H%252Bimidation%252Bwith%252BN%252B-fluorobenzenesulfonimide%252Bat%252Broom%252Btemperature%252Band%252Btandem%252Bconversions%252Bwith%252Balcohols%252Bor%252Barenes%26aulast%3DShao%26aufirst%3DZhong%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D13%26spage%3D3298%26epage%3D3307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meera  Kumar</span>, <span class="hlFld-ContribAuthor ">Robert G.  Lowery</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a High-Throughput Assay to Identify Inhibitors of ENPP1. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 740-746. <a href="https://doi.org/10.1177/2472555220982321" title="DOI URL">https://doi.org/10.1177/2472555220982321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555220982321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555220982321%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DDevelopment%252Bof%252Ba%252BHigh-Throughput%252BAssay%252Bto%252BIdentify%252BInhibitors%252Bof%252BENPP1%26aulast%3DKumar%26aufirst%3DMeera%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D740%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saif  Ullah</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Randa  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Julie  Pelletier</span>, <span class="hlFld-ContribAuthor ">Jean  Sévigny</span>, <span class="hlFld-ContribAuthor ">Mahmoud K.  Shehata</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>217 </em>, 113339. <a href="https://doi.org/10.1016/j.ejmech.2021.113339" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113339%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bdocking%252Bstudies%252Bof%252Bnovel%252Bpyrrolo%25255B2%25252C3-b%25255Dpyridine%252Bderivatives%252Bas%252Bboth%252Bectonucleotide%252Bpyrophosphatase%25252Fphosphodiesterase%252Binhibitors%252Band%252Bantiproliferative%252Bagents%26aulast%3DUllah%26aufirst%3DSaif%26date%3D2021%26volume%3D217%26spage%3D113339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Randa  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Saif  Ullah</span>, <span class="hlFld-ContribAuthor ">Seyed-Omar  Zaraei</span>, <span class="hlFld-ContribAuthor ">Mariya  al-Rashida</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Julie  Pelletier</span>, <span class="hlFld-ContribAuthor ">Jean  Sévigny</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>104 </em>, 104305. <a href="https://doi.org/10.1016/j.bioorg.2020.104305" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104305%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DEvaluation%252Bof%252Bsulfonate%252Band%252Bsulfamate%252Bderivatives%252Bpossessing%252Bbenzofuran%252Bor%252Bbenzothiophene%252Bnucleus%252Bas%252Binhibitors%252Bof%252Bnucleotide%252Bpyrophosphatases%25252Fphosphodiesterases%252Band%252Banticancer%252Bagents%26aulast%3DAnbar%26aufirst%3DHanan%2BS.%26date%3D2020%26volume%3D104%26spage%3D104305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saif  Ullah</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Seyed-Omar  Zaraei</span>, <span class="hlFld-ContribAuthor ">Rawan M.  Sbenati</span>, <span class="hlFld-ContribAuthor ">Julie  Pelletier</span>, <span class="hlFld-ContribAuthor ">Jean  Sévigny</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103783. <a href="https://doi.org/10.1016/j.bioorg.2020.103783" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103783%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bdocking%252Bstudies%252Bof%252Bnew%252Bpyrazole-based%252Bthiourea%252Band%252Bsulfonamide%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bnucleotide%252Bpyrophosphatase%25252Fphosphodiesterase%26aulast%3DUllah%26aufirst%3DSaif%26date%3D2020%26volume%3D99%26spage%3D103783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nattha  Yongwattana</span>, <span class="hlFld-ContribAuthor ">Nutsara  Mekjinda</span>, <span class="hlFld-ContribAuthor ">Tulyapruek  Tawonsawatruk</span>, <span class="hlFld-ContribAuthor ">Itaru  Hamachi</span>, <span class="hlFld-ContribAuthor ">Akio  Ojida</span>, <span class="hlFld-ContribAuthor ">Jirarut  Wongkongkatep</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescence Differentiation of ATP-Related Multiple Enzymatic Activities in Synovial Fluid as a Marker of Calcium Pyrophosphate Deposition Disease Using Kyoto Green. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1116. <a href="https://doi.org/10.3390/molecules25051116" title="DOI URL">https://doi.org/10.3390/molecules25051116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051116%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFluorescence%252BDifferentiation%252Bof%252BATP-Related%252BMultiple%252BEnzymatic%252BActivities%252Bin%252BSynovial%252BFluid%252Bas%252Ba%252BMarker%252Bof%252BCalcium%252BPyrophosphate%252BDeposition%252BDisease%252BUsing%252BKyoto%252BGreen%26aulast%3DYongwattana%26aufirst%3DNattha%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of TG-mAMP and TG-mGMP<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloromethyl chlorosulfate, <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C to rt, 46%; (b) AMP, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 4.8%; (c) GMP·2Na salt, <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, rt, 2.7%.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of TG-AMP and TG-GMP<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AMP, EDCI, DMAP, NEt<sub>3</sub>, <i>t</i>BuOH/H<sub>2</sub>O, reflux, 15%; (b) GMP·2Na salt, EDCI, DMAP, NEt<sub>3</sub>, <i>t</i>BuOH/H<sub>2</sub>O, reflux, 18%.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>A</b>, <b>B</b>, <b>C</b>, and <b>E</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>t</i>BuOK, benzyl bromide (for compound <b>2</b>), 4-nitrobenzyl bromide (for compound <b>4</b>), 3-nitrobenzyl bromide (for compound <b>8</b>), THF, 0 °C, then reflux, 72% for compound <b>2</b>, 38% for compound <b>4</b>, 48% for compound <b>8</b>; (b) 3-amino-1,2,4-triazole, AcOH, reflux, 73% for compound <b>E</b>, 71% for compound <b>5</b>, 77% for compound <b>9</b>; (c) POCl<sub>3</sub>, reflux, 57% for compound <b>3</b>, 44% for compound <b>6</b>, 38% for compound <b>10</b>; (d) 50% NHMe<sub>2</sub>, EtOH, rt, 78% for compound <b>A</b>, 97% for <b>7</b>, 97% for compound <b>11</b>; (e) Pd/C, H<sub>2</sub>, MeOH/CH<sub>2</sub>Cl<sub>2</sub>, rt, 56% for compound <b>B</b>, 38% for compound <b>C</b>.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>D</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-amino-1,2,4-triazole, AcOH, reflux, 53%; (b) POCl<sub>3</sub>, reflux, 46%; (c) 50% NHMe<sub>2</sub>, EtOH, rt, 73%.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reaction of ENPP1 with (A) native substrates ATP and 2′,3′-cGAMP and with (B) an artificial substrate, <i>p</i>NP-TMP, and the fluorescence probes TG-mAMP and TG-AMP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Fluorescence enhancement of TG-mAMP upon hydrolysis by ENPP1. Fluorescence enhancement (FI<sub>30min</sub>/FI<sub>0min</sub>) due to enzymatic reactions of (A) TG-mAMP and (B) TG-mGMP with various ENPPs at 30 min. Reactions were performed with 1 μM TG-mAMP or TG-mGMP and 1 μg/mL ENPPs in ENPP assay buffer (100 mM Tris-HCl (pH 9.0), 150 mM NaCl, 5 mM MgCl<sub>2</sub>, and 0.05% Triton X-100) at 37 °C. Excitation and emission wavelengths were 485 and 535 nm, respectively. The results are shown as the mean ± SD (<i>n</i> = 3). (C) HPLC analyses of the enzymatic reaction of 5 μM TG-mAMP and 1 μg/mL ENPP1. Absorbance at 490 nm was monitored.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Results of chemical screening of ENPP1 inhibitors and structural optimization. (A) Scheme of chemical screening and hit compounds in the three screens. (B) Structure of compound <b>A</b> and inhibitory activity and selectivity (10 μM) toward ENPP1 over other ENPP family members. The results are shown as the mean ± SD (<i>n</i> = 3). (C) Structures of compounds <b>B</b>–<b>E</b>. (D) IC<sub>50</sub> values of compounds <b>A</b>–<b>E</b> toward ENPP1 and ENPP3 evaluated by means of TG-mAMP, <i>p</i>NP-TMP, and ATP assays (at least two experiments). N.D. = not determined. For details, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf" class="ext-link">Figure S9</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In cellulo detection of ENPP1 activity using TG-mAMP. (A) Fluorescence enhancements of TG-mAMP upon incubation with 10 cell lines (TNBC lines are shown in bold). Reactions were performed with 2 μM TG-mAMP in the presence or absence of 50 μM compound <b>C</b> in DPBS at 37 °C for 2 h in 96-well microplates. The results are shown as the mean ± SD (<i>n</i> = 3). (B, C) Expression levels of ENPP1 in MDA-MB-231, MCF7, rat C6, and HEK293 cells. The molecular weights of human ENPP1 (red arrows) and rat ENPP1 (red arrowhead) are 140 and 110 kDa, respectively. β-Actin and α-tubulin were used as loading controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of methyleneoxy linker on reactivity and selectivity in MDA-MB-231 cells. (A) Fluorescence enhancements of TG-AMP, TG-GMP, TG-mAMP, and TG-mGMP upon incubation with MDA-MB-231 cells. Reactions were performed with 2 μM fluorescence probes in the presence or absence of 50 μM compound <b>C</b> in DPBS at 37 °C for 2 h in 96-well microplates. The results are shown as the mean ± SD (<i>n</i> = 3). (B) Differences in the linker structures of the four ENPP fluorescence probes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Fluorescence microscopic imaging of ENPP1 activity in living cells with TG-mAMP. (A) MDA-MB-231 and (C) rat C6 cells were incubated with 2 μM TG-mAMP in DPBS in the presence or absence of 10 μM compounds <b>A</b>–<b>C</b> and <b>E</b> at 37 °C. Confocal fluorescence and DIC images were acquired at 1 h after addition of TG-mAMP. Comparison of the fluorescence intensities of (B) MDA-MB-231 and (D) rat C6 cells treated with DMSO and compounds <b>A</b>–<b>C</b> and <b>E</b>. Fluorescence intensities of regions of interest (inside cells) under each condition were calculated with ImageJ. The results are shown as the mean ± SD (<i>n</i> = 10): ***<i>P</i> < 0.001, NS = not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/medium/jm9b01213_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. High expression of <i>ENPP1</i> mRNA is significantly correlated with poor prognosis in triple-negative breast cancers. Kaplan–Meier representations of (A) recurrence-free survival and (B) overall survival in 53 TNBC patients classified according to the expression level of <i>ENPP1</i>. (C) Fluorescence intensities of breast cancer specimens obtained with 2 μM TG-mAMP in the presence or absence of 50 μM compound <b>C</b>. Patients 1, 2, 3, 4, and 13 are TNBC. (D) Comparison of normalized fluorescence intensities in TG-mAMP assay (a.u./g tumor tissue) between ENPP1 low- and high-expressing specimens. (E) Correlation between mRNA expression (<i>ENPP1</i>/<i>GAPDH</i>) and ENPP1 activity measured with TG-mAMP, normalized by the activity of patient 2. Red circles: low <i>ENPP1</i> expression and low ENPP1 activity. Blue open triangles: high <i>ENPP1</i> expression but low ENPP1 activity, which might be false-negative. Blue squares: high <i>ENPP1</i> expression and high ENPP1 activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01213/20191018/images/large/jm9b01213_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01213&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritzker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span> <span> </span><span class="NLM_article-title">Matrix Vesicle Plasma Cell Membrane Glycoprotein-1 Regulates Mineralization by Murine Osteoblastic MC3T3 Cells</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1359/jbmr.1999.14.6.883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1359%2Fjbmr.1999.14.6.883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10352096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=883-892&author=K.+Johnsonauthor=A.+Moffaauthor=Y.+Chenauthor=K.+Pritzkerauthor=J.+Godingauthor=R.+Terkeltaub&title=Matrix+Vesicle+Plasma+Cell+Membrane+Glycoprotein-1+Regulates+Mineralization+by+Murine+Osteoblastic+MC3T3+Cells&doi=10.1359%2Fjbmr.1999.14.6.883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells</span></div><div class="casAuthors">Johnson, Kristen; Moffa, Allison; Chen, Ying; Pritzker, Kenneth; Goding, James; Terkeltaub, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-892</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">A naturally occurring nonsense truncation mutation of the inorg. pyrophosphate (PPi)-generating nucleoside triphosphate pyrophosphohydrolase (NTPPPH) PC-1 is assocd. with spinal and periarticular ligament hyperostosis and cartilage calcification in "tiptoe walking" (ttw) mice.  Thus, we tested the hypothesis that PC-1 acts directly in the extracellular matrix to restrain mineralization.  Cultured osteoblastic MC3T3 cells expressed PC-1 mRNA and produced hydroxyapatite deposits at 12-14 days.  NTPPPH activity increased steadily over 14 days.  Transforming growth factor-β and 1,25-dihydroxyvitamin D3 increased PC-1 and NTPPPH in matrix vesicles (MVs).  Because PC-1/NTPPPH was regulated in mineralizing MC3T3 cells, we stably transfected or infected cells with recombinant adenovirus, in order to express 2- to 6-fold more PC-1.  PC-1/NTPPPH and PPi content increased severalfold in MVs derived from cells transfected with PC-1.  Furthermore, MC3T3 cells transfected with PC-1 deposited ∼80-90% less hydroxyapatite (by wt.) than cells transfected with empty plasmid or enzymically inactive PC-1.  ATP-dependent 45Ca pptn. by MVs from cells overexpressing active PC-1 was comparably diminished.  Thus, regulation of PC-1 controls the PPi content and function of osteoblast-derived MVs and matrix hydroxyapatite deposition.  PC-1 may provide a novel therapeutic target in certain disorders of bone mineralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol0dQhA3qcyLVg90H21EOLACvtfcHk0lh0ZrQ42A7iZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFKqtbw%253D&md5=cd5a14bda9ada2ab63e13069b1ee987c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.1999.14.6.883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.1999.14.6.883%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DMoffa%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPritzker%26aufirst%3DK.%26aulast%3DGoding%26aufirst%3DJ.%26aulast%3DTerkeltaub%26aufirst%3DR.%26atitle%3DMatrix%2520Vesicle%2520Plasma%2520Cell%2520Membrane%2520Glycoprotein-1%2520Regulates%2520Mineralization%2520by%2520Murine%2520Osteoblastic%2520MC3T3%2520Cells%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1999%26volume%3D14%26spage%3D883%26epage%3D892%26doi%3D10.1359%2Fjbmr.1999.14.6.883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Etten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span> <span> </span><span class="NLM_article-title">Linked Deficiencies in Extracellular PP<sub>i</sub> and Osteopontin Mediate Pathologic Calcification Associated with Defective PC-1 and ANK Expression</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1359/jbmr.2003.18.6.994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1359%2Fjbmr.2003.18.6.994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12817751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslOhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=994-1004&author=K.+Johnsonauthor=J.+Godingauthor=D.+Van+Ettenauthor=A.+Saliauthor=S.+I.+Huauthor=D.+Farleyauthor=H.+Krugauthor=L.+Hessleauthor=J.+L.+Mill%C3%A1nauthor=R.+Terkeltaub&title=Linked+Deficiencies+in+Extracellular+PPi+and+Osteopontin+Mediate+Pathologic+Calcification+Associated+with+Defective+PC-1+and+ANK+Expression&doi=10.1359%2Fjbmr.2003.18.6.994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression</span></div><div class="casAuthors">Johnson, Kristen; Goding, James; Van Etten, Deborah; Sali, Adnan; Hu, Shou-Ih; Farley, David; Krug, Hollis; Hessle, Lovisa; Millan, Jose Luis; Terkeltaub, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">994-1004</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Osteopontin and pyrophosphate (PPi) both suppress hydroxyapatite deposition.  Extracellular PPi deficiency causes spontaneous hypercalcification, yet unchallenged osteopontin knockout mice have only subtle mineralization abnormalities.  We report that extracellular PPi deficiency promotes osteopontin deficiency and correction of osteopontin deficiency prevents hypercalcification, suggesting synergistic inhibition of hydroxyapatite deposition.  Nucleotide pyrophosphatase phosphodiesterase (NPP) isoenzymes including PC-1 (NPP1) function partly to generate PPi, a physiol. calcification inhibitor.  PPi transport is modulated by the membrane channel protein ANK.  Spontaneous articular cartilage calcification, increased vertebral cortical bone formation, and peripheral joint and intervertebral ossific ankylosis are assocd. with both PC-1 deficiency and expression of truncated ANK in ank/ank mice.  To assess how PC-1, ANK, and PPi regulate both calcification and cell differentiation, we studied cultured PC-1-/- and ank/ank mouse calvarial osteoblasts.  PC-1-/- osteoblasts demonstrated ∼50% depressed NPP activity and markedly lowered extracellular PPi assocd. with hypercalcification.  These abnormalities were rescued by transfection of PC-1 but not of the NPP isoenzyme B10/NPP3.  PC-1-/- and ank/ank cultured osteoblasts demonstrated not only comparable extracellular PPi depression and hypercalcification but also marked redn. in expression of osteopontin (OPN), another direct calcification inhibitor.  Sol. PC-1 (which cor. extracellular PPi and OPN), and OPN itself (≥15 pg/mL), cor. hypercalcification by PC-1-/- and ank/ank osteoblasts.  Thus, linked regulatory effects on extracellular PPi and OPN expression mediate the ability of PC-1 and ANK to regulate calcification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtSEw6YYGtN7Vg90H21EOLACvtfcHk0lh0ZrQ42A7iZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslOhsLY%253D&md5=d9d41489d04f15c80e2126da63c7a82d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.6.994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.6.994%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DGoding%26aufirst%3DJ.%26aulast%3DVan%2BEtten%26aufirst%3DD.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DS.%2BI.%26aulast%3DFarley%26aufirst%3DD.%26aulast%3DKrug%26aufirst%3DH.%26aulast%3DHessle%26aufirst%3DL.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26aulast%3DTerkeltaub%26aufirst%3DR.%26atitle%3DLinked%2520Deficiencies%2520in%2520Extracellular%2520PPi%2520and%2520Osteopontin%2520Mediate%2520Pathologic%2520Calcification%2520Associated%2520with%2520Defective%2520PC-1%2520and%2520ANK%2520Expression%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D994%26epage%3D1004%26doi%3D10.1359%2Fjbmr.2003.18.6.994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Cellular Function and Molecular Structure of Ecto-Nucleotidases</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9309-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1007%2Fs11302-012-9309-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=22555564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=437-502&author=H.+Zimmermannauthor=M.+Zebischauthor=N.+Str%C3%A4ter&title=Cellular+Function+and+Molecular+Structure+of+Ecto-Nucleotidases&doi=10.1007%2Fs11302-012-9309-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular function and molecular structure of ecto-nucleotidases</span></div><div class="casAuthors">Zimmermann, Herbert; Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-502</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotidases play a pivotal role in purinergic signal transmission.  They hydrolyze extracellular nucleotides and thus can control their availability at purinergic P2 receptors.  They generate extracellular nucleosides for cellular reuptake and salvage via nucleoside transporters of the plasma membrane.  The extracellular adenosine formed acts as an agonist of purinergic P1 receptors.  They also can produce and hydrolyze extracellular inorg. pyrophosphate that is of major relevance in the control of bone mineralization.  This review discusses and compares four major groups of ecto-nucleotidases: the ecto-nucleoside triphosphate diphosphohydrolases, ecto-5'-nucleotidase, ecto-nucleotide pyrophosphatase/phosphodiesterases, and alk. phosphatases.  Only recently and based on crystal structures, detailed information regarding the spatial structures and catalytic mechanisms has become available for members of these four ecto-nucleotidase families.  This permits detailed predictions of their catalytic mechanisms and a comparison between the individual enzyme groups.  The review focuses on the principal biochem., cell biol., catalytic, and structural properties of the enzymes and provides brief ref. to tissue distribution, and physiol. and pathophysiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwf4PFcTEl0LVg90H21EOLACvtfcHk0liWGPzvqrPH1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D&md5=d36e58f25676e47b9749e43896ac4cb2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9309-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9309-4%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCellular%2520Function%2520and%2520Molecular%2520Structure%2520of%2520Ecto-Nucleotidases%26jtitle%3DPurinergic%2520Signalling%26date%3D2012%26volume%3D8%26spage%3D437%26epage%3D502%26doi%3D10.1007%2Fs11302-012-9309-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addison, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaartinen, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, M. D.</span></span> <span> </span><span class="NLM_article-title">Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15872</span>– <span class="NLM_lpage">15883</span>, <span class="refDoi"> DOI: 10.1074/jbc.M701116200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1074%2Fjbc.M701116200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=17383965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2nsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15872-15883&author=W.+N.+Addisonauthor=F.+Azariauthor=E.+S.+Sorensenauthor=M.+T.+Kaartinenauthor=M.+D.+McKee&title=Pyrophosphate+Inhibits+Mineralization+of+Osteoblast+Cultures+by+Binding+to+Mineral%2C+Up-regulating+Osteopontin%2C+and+Inhibiting+Alkaline+Phosphatase+Activity&doi=10.1074%2Fjbc.M701116200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity</span></div><div class="casAuthors">Addison, William N.; Azari, Fereshteh; Sorensen, Esben S.; Kaartinen, Mari T.; McKee, Marc D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15872-15883</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inorg. pyrophosphate (PPi) produced by cells inhibits mineralization by binding to crystals.  Its ubiquitous presence is thought to prevent "soft" tissues from mineralizing, whereas its degrdn. to Pi in bones and teeth by tissue-nonspecific alk. phosphatase (Tnap, Tnsalp, Alpl, Akp2) may facilitate crystal growth.  Whereas the crystal binding properties of PPi are largely understood, less is known about its effects on osteoblast activity.  We have used MC3T3-E1 osteoblast cultures to investigate the effect of PPi on osteoblast function and matrix mineralization.  Mineralization in the cultures was dose-dependently inhibited by PPi.  This inhibition could be reversed by Tnap, but not if PPi was bound to mineral.  PPi also led to increased levels of osteopontin (Opn) induced via the Erk1/2 and p38 MAPK signaling pathways.  Opn regulation by PPi was also insensitive to foscarnet (an inhibitor of phosphate uptake) and levamisole (an inhibitor of Tnap enzymic activity), suggesting that increased Opn levels did not result from changes in phosphate.  Exogenous OPN inhibited mineralization, but dephosphorylation by Tnap reversed this effect, suggesting that OPN inhibits mineralization via its neg. charged phosphate residues and that like PPi, hydrolysis by Tnap reduces its mineral inhibiting potency.  Using enzyme kinetic studies, we have shown that PPi inhibits Tnap-mediated Pi release from β-glycerophosphate (a commonly used source of org. phosphate for culture mineralization studies) through a mixed type of inhibition.  In summary, PPi prevents mineralization in MC3T3-E1 osteoblast cultures by at least three different mechanisms that include direct binding to growing crystals, induction of Opn expression, and inhibition of Tnap activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzGXuSBMwdgbVg90H21EOLACvtfcHk0liWGPzvqrPH1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2nsL0%253D&md5=17e136605a85bae22502720f5d6a9a9d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M701116200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M701116200%26sid%3Dliteratum%253Aachs%26aulast%3DAddison%26aufirst%3DW.%2BN.%26aulast%3DAzari%26aufirst%3DF.%26aulast%3DSorensen%26aufirst%3DE.%2BS.%26aulast%3DKaartinen%26aufirst%3DM.%2BT.%26aulast%3DMcKee%26aufirst%3DM.%2BD.%26atitle%3DPyrophosphate%2520Inhibits%2520Mineralization%2520of%2520Osteoblast%2520Cultures%2520by%2520Binding%2520to%2520Mineral%252C%2520Up-regulating%2520Osteopontin%252C%2520and%2520Inhibiting%2520Alkaline%2520Phosphatase%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15872%26epage%3D15883%26doi%3D10.1074%2Fjbc.M701116200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harmey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narisawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span> <span> </span><span class="NLM_article-title">Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by akp2, enpp1, and ank: An Integrated Model of the Pathogenesis of Mineralization Disorders</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1209</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63208-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2FS0002-9440%2810%2963208-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=15039209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFemur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2004&pages=1199-1209&author=D.+Harmeyauthor=L.+Hessleauthor=S.+Narisawaauthor=K.+A.+Johnsonauthor=R.+Terkeltaubauthor=J.+L.+Mill%C3%A1n&title=Concerted+Regulation+of+Inorganic+Pyrophosphate+and+Osteopontin+by+akp2%2C+enpp1%2C+and+ank%3A+An+Integrated+Model+of+the+Pathogenesis+of+Mineralization+Disorders&doi=10.1016%2FS0002-9440%2810%2963208-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank: An integrated model of the pathogenesis of mineralization disorders</span></div><div class="casAuthors">Harmey, Dympna; Hessle, Lovisa; Narisawa, Sonoko; Johnson, Kristen A.; Terkeltaub, Robert; Millan, Jose Luis</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1199-1209</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Tissue-nonspecific alk. phosphatase (TNAP) hydrolyzes the mineralization inhibitor inorg. pyrophosphate (PPi).  Deletion of the TNAP gene (Akp2) in mice results in hypophosphatasia characterized by elevated levels of PPi and poorly mineralized bones, which are rescued by deletion of nucleotide pyrophosphatase phosphodiesterase 1 (NPP1) that generates PPi.  Mice deficient in NPP1 (Enpp1-/-), or defective in the PPi channeling function of ANK (ank/ank), have decreased levels of extracellular PPi and are hypermineralized.  Given the similarity in function between ANK and NPP1 we crossbred Akp2-/- mice to ank/ank mice and found a partial normalization of the mineralization phenotypes and PPi levels.  Examn. of Enpp1-/- and ank/ank mice revealed that Enpp1-/- mice have a more severe hypermineralized phenotype than ank/ank mice and that NPP1 but not ANK localizes to matrix vesicles, suggesting that failure of ANK deficiency to correct hypomineralization in Akp2-/- mice reflects the lack of ANK activity in the matrix vesicle compartment.  We also found that the mineralization inhibitor osteopontin (OPN) was increased in Akp2-/-, and decreased in ank/ank mice.  PPi and OPN levels were normalized in [Akp2-/-; Enpp1-/-] and [Akp2-/-; ank/ank] mice, at both the mRNA level and in serum.  Wild-type osteoblasts treated with PPi showed an increase in OPN, and a decrease in Enpp1 and Ank expression.  Thus TNAP, NPP1, and ANK coordinately regulate PPi and OPN levels.  The hypomineralization obsd. in Akp2-/- mice arises from the combined inhibitory effects of PPi and OPN.  In contrast, NPP1 or ANK deficiencies cause a decrease in the PPi and OPN pools that leads to hypermineralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrke3ClmgGYOLVg90H21EOLACvtfcHk0liWGPzvqrPH1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFemur0%253D&md5=a2949f01d80e3723bb80d3b508e91329</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963208-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963208-7%26sid%3Dliteratum%253Aachs%26aulast%3DHarmey%26aufirst%3DD.%26aulast%3DHessle%26aufirst%3DL.%26aulast%3DNarisawa%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26atitle%3DConcerted%2520Regulation%2520of%2520Inorganic%2520Pyrophosphate%2520and%2520Osteopontin%2520by%2520akp2%252C%2520enpp1%252C%2520and%2520ank%253A%2520An%2520Integrated%2520Model%2520of%2520the%2520Pathogenesis%2520of%2520Mineralization%2520Disorders%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D164%26spage%3D1199%26epage%3D1209%26doi%3D10.1016%2FS0002-9440%2810%2963208-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hessle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narisawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goding, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span> <span> </span><span class="NLM_article-title">Tissue-Nonspecific Alkaline Phosphatase and Pasma Cell Membrane Glycoprotein-1 are Central Antagonistic Regulators of Bone Mineralization</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">9445</span>– <span class="NLM_lpage">9449</span>, <span class="refDoi"> DOI: 10.1073/pnas.142063399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1073%2Fpnas.142063399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12082181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVGgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=9445-9449&author=L.+Hessleauthor=K.+A.+Johnsonauthor=H.+C.+Andersonauthor=S.+Narisawaauthor=A.+Saliauthor=J.+W.+Godingauthor=R.+Terkeltaubauthor=J.+L.+Mill%C3%A1n&title=Tissue-Nonspecific+Alkaline+Phosphatase+and+Pasma+Cell+Membrane+Glycoprotein-1+are+Central+Antagonistic+Regulators+of+Bone+Mineralization&doi=10.1073%2Fpnas.142063399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization</span></div><div class="casAuthors">Hessle, Lovisa; Johnson, Kristen A.; Anderson, H. Clarke; Narisawa, Sonoko; Sali, Adnan; Goding, James W.; Terkeltaub, Robert; Millan, Jose Luis</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9445-9449</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Osteoblasts mineralize bone matrix by promoting hydroxyapatite crystal formation and growth in the interior of membrane-limited matrix vesicles (MVs) and by propagating the crystals onto the collagenous extracellular matrix.  Two osteoblast proteins, tissue-nonspecific alk. phosphatase (TNAP) and plasma cell membrane glycoprotein-1 (PC-1) are involved in this process.  Mutations in the TNAP gene result in the inborn error of metab. known as hypophosphatasia, characterized by poorly mineralized bones, spontaneous fractures, and elevated extracellular concns. of inorg. pyrophosphate (PPi).  PPi suppresses the formation and growth of hydroxyapatite crystals.  PPi is produced by the nucleoside triphosphate pyrophosphohydrolase activity of a family of isoenzymes, with PC-1 being the only member present in MVs.  Mice with spontaneous mutations in the PC-1 gene have hypermineralization abnormalities that include osteoarthritis and ossification of the posterior longitudinal ligament of the spine.  Here, we show the resp. correction of bone mineralization abnormalities in knockout mice null for both the TNAP (Akp2) and PC-1 (Enpp1) genes.  Each allele of Akp2 and Enpp1 has a measurable influence on mineralization status in vivo.  Ex vivo expts. using cultured double-knockout osteoblasts and their MVs demonstrate normalization of PPi content and mineral deposition.  Our data provide evidence that TNAP and PC-1 are key regulators of the extracellular PPi concns. required for controlled bone mineralization.  Our results suggest that inhibiting PC-1 function may be a viable therapeutic strategy for hypophosphatasia.  Conversely, interfering with TNAP activity may correct pathol. hyperossification because of PPi insufficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa0UKJ_EUwN7Vg90H21EOLACvtfcHk0lgWbHe3eom2Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVGgt70%253D&md5=a7b4d685857661f31505e39ba3985e5a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.142063399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.142063399%26sid%3Dliteratum%253Aachs%26aulast%3DHessle%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DAnderson%26aufirst%3DH.%2BC.%26aulast%3DNarisawa%26aufirst%3DS.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DGoding%26aufirst%3DJ.%2BW.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26atitle%3DTissue-Nonspecific%2520Alkaline%2520Phosphatase%2520and%2520Pasma%2520Cell%2520Membrane%2520Glycoprotein-1%2520are%2520Central%2520Antagonistic%2520Regulators%2520of%2520Bone%2520Mineralization%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D9445%26epage%3D9449%26doi%3D10.1073%2Fpnas.142063399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutsch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaingankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toliat, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höhne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roscioli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnabel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epplen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knisely, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinaiko, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallance, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nürnberg, P.</span></span> <span> </span><span class="NLM_article-title">Mutations in ENPP1 are Associated with 'Idiopathic' Infantile Arterial Calcification</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1038/ng1221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fng1221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12881724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Skurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=379-381&author=F.+Rutschauthor=N.+Rufauthor=S.+Vaingankarauthor=M.+R.+Toliatauthor=A.+Sukauthor=W.+H%C3%B6hneauthor=G.+Schauerauthor=M.+Lehmannauthor=T.+Roscioliauthor=D.+Schnabelauthor=J.+T.+Epplenauthor=A.+Kniselyauthor=A.+Superti-Furgaauthor=J.+McGillauthor=M.+Filipponeauthor=A.+R.+Sinaikoauthor=H.+Vallanceauthor=B.+Hinrichsauthor=W.+Smithauthor=M.+Ferreauthor=R.+Terkeltaubauthor=P.+N%C3%BCrnberg&title=Mutations+in+ENPP1+are+Associated+with+%27Idiopathic%27+Infantile+Arterial+Calcification&doi=10.1038%2Fng1221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in ENPP1 are associated with "idiopathic" infantile arterial calcification</span></div><div class="casAuthors">Rutsch, Frank; Ruf, Nico; Vaingankar, Sucheta; Toliat, Mohammad R.; Suk, Anita; Hoehne, Wolfgang; Schauer, Galen; Lehmann, Mandy; Roscioli, Tony; Schnabel, Dirk; Epplen, Joerg T.; Knisely, Alex; Superti-Furga, Andrea; McGill, James; Filippone, Marco; Sinaiko, Alan R.; Vallance, Hillary; Hinrichs, Bernd; Smith, Wendy; Ferre, Merry; Terkeltaub, Robert; Nuernberg, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-381</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with an emphasis on the authors' research.  Idiopathic infantile arterial calcification (IIAC; OMIM 208000) is characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation.  We analyzed affected individuals from 11 unrelated kindreds and found that IIAC was assocd. with mutations that inactivated ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1).  This cell surface enzyme generates inorg. pyrophosphate (PPi), a solute that regulates cell differentiation and serves as an essential physiol. inhibitor of calcification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEzkAL5KKqTbVg90H21EOLACvtfcHk0lgWbHe3eom2Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Skurg%253D&md5=79a84beb933ce5274445cf6b5ec70d22</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng1221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1221%26sid%3Dliteratum%253Aachs%26aulast%3DRutsch%26aufirst%3DF.%26aulast%3DRuf%26aufirst%3DN.%26aulast%3DVaingankar%26aufirst%3DS.%26aulast%3DToliat%26aufirst%3DM.%2BR.%26aulast%3DSuk%26aufirst%3DA.%26aulast%3DH%25C3%25B6hne%26aufirst%3DW.%26aulast%3DSchauer%26aufirst%3DG.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DRoscioli%26aufirst%3DT.%26aulast%3DSchnabel%26aufirst%3DD.%26aulast%3DEpplen%26aufirst%3DJ.%2BT.%26aulast%3DKnisely%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DA.%26aulast%3DMcGill%26aufirst%3DJ.%26aulast%3DFilippone%26aufirst%3DM.%26aulast%3DSinaiko%26aufirst%3DA.%2BR.%26aulast%3DVallance%26aufirst%3DH.%26aulast%3DHinrichs%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DW.%26aulast%3DFerre%26aufirst%3DM.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DN%25C3%25BCrnberg%26aufirst%3DP.%26atitle%3DMutations%2520in%2520ENPP1%2520are%2520Associated%2520with%2520%2527Idiopathic%2527%2520Infantile%2520Arterial%2520Calcification%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D379%26epage%3D381%26doi%3D10.1038%2Fng1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkeltaub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nürnberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutsch, F.</span></span> <span> </span><span class="NLM_article-title">The Mutational Spectrum of ENPP1 as Arising after the Analysis of 23 Unrelated Patients with Generalized Arterial Calcification of Infancy (GACI)</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">98</span>, <span class="refDoi"> DOI: 10.1002/humu.9297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1002%2Fhumu.9297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=15605415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BD2cnjslGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=98&author=N.+Rufauthor=B.+Uhlenbergauthor=R.+Terkeltaubauthor=P.+N%C3%BCrnbergauthor=F.+Rutsch&title=The+Mutational+Spectrum+of+ENPP1+as+Arising+after+the+Analysis+of+23+Unrelated+Patients+with+Generalized+Arterial+Calcification+of+Infancy+%28GACI%29&doi=10.1002%2Fhumu.9297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI)</span></div><div class="casAuthors">Ruf Nico; Uhlenberg Birgit; Terkeltaub Robert; Nurnberg Peter; Rutsch Frank</div><div class="citationInfo"><span class="NLM_cas:title">Human mutation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Generalized arterial calcification of infancy (GACI), is characterized by calcification of the internal elastic lamina of large and medium-sized arteries and stenosis due to myointimal proliferation.  Although survival to adulthood has been reported, most patients die within the first six months of life.  Recently, we found mutations of ENPP1 coding for ecto-nucleotide pyrophosphatase/phosphodiesterase 1 to be associated with GACI in 8 of 11 families.  In this study, we analyzed ENPP1 in affected individuals of another 12 unrelated families.  We identified 11 novel homozygous or compound heterozygous mutations in 10 of the 12 new families.  The mutations (1 nonsense, 7 missense, 1 single amino acid deletion, and 2 frame shift mutations) were scattered over the whole coding region with a slightly more condensed distribution within the catalytic and nuclease-like domain as compared to the first survey.  In this study, three mutations were found repeatedly in apparently unrelated patients, 7 x c.913C>A (p.Pro305Thr) and c.2662C [corrected]>T (p.Arg888Trp) as well as c.2320C>T (p.Arg774Cys) each twice.  However, haplotype analysis suggested a founder effect of British extraction for mutation c.913C>A (p.Pro305Thr).  The fact that the two other mutations c.2662C [corrected]>T (p.Arg888Trp) and c.2320C>T (p.Arg774Cys) occurred twice within a single allele also suggests a single founder.  This study confirms the role of ENPP1 mutations as the main cause of GACI and adds considerably to the mutational spectrum of ENPP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyydZBW41YW0h5eUSa2oe_fW6udTcc2eYABkY_EDqbWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnjslGnsw%253D%253D&md5=b8df93e6e89c72f67556c3f96a0908d6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fhumu.9297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.9297%26sid%3Dliteratum%253Aachs%26aulast%3DRuf%26aufirst%3DN.%26aulast%3DUhlenberg%26aufirst%3DB.%26aulast%3DTerkeltaub%26aufirst%3DR.%26aulast%3DN%25C3%25BCrnberg%26aufirst%3DP.%26aulast%3DRutsch%26aufirst%3DF.%26atitle%3DThe%2520Mutational%2520Spectrum%2520of%2520ENPP1%2520as%2520Arising%2520after%2520the%2520Analysis%2520of%252023%2520Unrelated%2520Patients%2520with%2520Generalized%2520Arterial%2520Calcification%2520of%2520Infancy%2520%2528GACI%2529%26jtitle%3DHum.%2520Mutat.%26date%3D2005%26volume%3D25%26spage%3D98%26doi%3D10.1002%2Fhumu.9297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, I. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusis, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deb, A.</span></span> <span> </span><span class="NLM_article-title">Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification</span>. <i>Cell Stem Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/j.stem.2016.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.stem.2016.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=27867037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWgurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=218-232&author=I.+C.+L.+Pillaiauthor=S.+Liauthor=M.+Romayauthor=L.+Lamauthor=Y.+Luauthor=J.+Huangauthor=N.+Dillardauthor=M.+Zemanovaauthor=L.+Rubbiauthor=Y.+Wangauthor=J.+Leeauthor=M.+Xiaauthor=O.+Liangauthor=Y.+H.+Xieauthor=M.+Pellegriniauthor=A.+J.+Lusisauthor=A.+Deb&title=Cardiac+Fibroblasts+Adopt+Osteogenic+Fates+and+Can+Be+Targeted+to+Attenuate+Pathological+Heart+Calcification&doi=10.1016%2Fj.stem.2016.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification</span></div><div class="casAuthors">Pillai, Indulekha C. L.; Li, Shen; Romay, Milagros; Lam, Larry; Lu, Yan; Huang, Jie; Dillard, Nathaniel; Zemanova, Marketa; Rubbi, Liudmilla; Wang, Yibin; Lee, Jason; Xia, Ming; Liang, Owen; Xie, Ya-Hong; Pellegrini, Matteo; Lusis, Aldons J.; Deb, Arjun</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-232.e5</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1875-9777</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mammalian tissues calcify with age and injury.  Analogous to bone formation, osteogenic cells are thought to be recruited to the affected tissue and induce mineralization.  In the heart, calcification of cardiac muscle leads to conduction system disturbances and is one of the most common pathologies underlying heart blocks.  However the cell identity and mechanisms contributing to pathol. heart muscle calcification remain unknown.  Using lineage tracing, murine models of heart calcification and in vivo transplantation assays, we show that cardiac fibroblasts (CFs) adopt an osteoblast cell-like fate and contribute directly to heart muscle calcification.  Small-mol. inhibition of ENPP1, an enzyme that is induced upon injury and regulates bone mineralization, significantly attenuated cardiac calcification.  Inhibitors of bone mineralization completely prevented ectopic cardiac calcification and improved post injury heart function.  Taken together, these findings highlight the plasticity of fibroblasts in contributing to ectopic calcification and identify pharmacol. targets for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiuSkDz5INS7Vg90H21EOLACvtfcHk0lipF9B8T54wpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWgurvK&md5=eebbf2c530effe407be3145e97394284</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2016.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2016.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DI.%2BC.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRomay%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDillard%26aufirst%3DN.%26aulast%3DZemanova%26aufirst%3DM.%26aulast%3DRubbi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DO.%26aulast%3DXie%26aufirst%3DY.%2BH.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26aulast%3DDeb%26aufirst%3DA.%26atitle%3DCardiac%2520Fibroblasts%2520Adopt%2520Osteogenic%2520Fates%2520and%2520Can%2520Be%2520Targeted%2520to%2520Attenuate%2520Pathological%2520Heart%2520Calcification%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2017%26volume%3D20%26spage%3D218%26epage%3D232%26doi%3D10.1016%2Fj.stem.2016.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maddux, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grupe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henzel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reaven, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, I. D.</span></span> <span> </span><span class="NLM_article-title">Membrane Glycoprotein PC-1 and Insulin Resistance in Non-Insulin-Dependent Diabetes Mellitus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1038/373448a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2F373448a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=7830796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADyaK2MXjsFCjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=1995&pages=448-451&author=B.+A.+Madduxauthor=P.+Sbracciaauthor=S.+Kumakuraauthor=S.+Sassonauthor=J.+Youngrenauthor=A.+Fisherauthor=S.+Spencerauthor=A.+Grupeauthor=W.+Henzelauthor=T.+A.+Stewartauthor=G.+M.+Reavenauthor=I.+D.+Goldfine&title=Membrane+Glycoprotein+PC-1+and+Insulin+Resistance+in+Non-Insulin-Dependent+Diabetes+Mellitus&doi=10.1038%2F373448a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus</span></div><div class="casAuthors">Maddux, Betty A.; Sbraccia, Paolo; Kumakura, Shinobu; Sasson, Shiomo; Youngren, Jack; Fisher, Alexander; Spencer, Steven; Grupe, Andrew; Henzel, William; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">6513</span>),
    <span class="NLM_cas:pages">448-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Most patients with non-insulin-dependent diabetes mellitus are resistant to both endogenous and exogenous insulin.  Insulin resistance precedes the onset of this disease, suggesting that it may be an initial abnormality.  Insulin-receptor kinase activity is impaired in muscle, fibroblasts and other tissues of many patients with non-insulin-dependent diabetes mellitus, but abnormalities in the insulin-receptor gene do not appear to be the cause of this decreased kinase activity.  Skin fibroblasts from certain insulin-resistant patients contain an inhibitor of insulin-receptor tyrosine kinase.  Here we show that this inhibitor is a membrane glycoprotein, termed PC-1.  We find that PC-1 activity is increased in fibroblasts from seven of nine patients with typical non-insulin-dependent diabetes mellitus.  In addn. overexpression of PC-1 in transfected cultured cells reduces insulin-stimulated tyrosine kinase activity.  These studies raise the possibility that PC-1 has a role in the insulin resistance of non-insulin-dependent diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVPl5dEjSWSbVg90H21EOLACvtfcHk0lipF9B8T54wpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsFCjsL0%253D&md5=3e266cc35cf6013d9f325629b0ed57f8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F373448a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F373448a0%26sid%3Dliteratum%253Aachs%26aulast%3DMaddux%26aufirst%3DB.%2BA.%26aulast%3DSbraccia%26aufirst%3DP.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DSasson%26aufirst%3DS.%26aulast%3DYoungren%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DSpencer%26aufirst%3DS.%26aulast%3DGrupe%26aufirst%3DA.%26aulast%3DHenzel%26aufirst%3DW.%26aulast%3DStewart%26aufirst%3DT.%2BA.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26atitle%3DMembrane%2520Glycoprotein%2520PC-1%2520and%2520Insulin%2520Resistance%2520in%2520Non-Insulin-Dependent%2520Diabetes%2520Mellitus%26jtitle%3DNature%26date%3D1995%26volume%3D373%26spage%3D448%26epage%3D451%26doi%3D10.1038%2F373448a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grupe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alleman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, T. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Insulin Receptor Phosphorylation by PC-1 is not Mediated by the Hydrolysis of Adenosine Triphosphate or the Generation of Adenosine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">22085</span>– <span class="NLM_lpage">22088</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.38.22085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1074%2Fjbc.270.38.22085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=7673181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADyaK2MXot1Giu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=22085-22088&author=A.+Grupeauthor=J.+Allemanauthor=I.+D.+Goldfineauthor=M.+Sadickauthor=T.+A.+Stewart&title=Inhibition+of+Insulin+Receptor+Phosphorylation+by+PC-1+is+not+Mediated+by+the+Hydrolysis+of+Adenosine+Triphosphate+or+the+Generation+of+Adenosine&doi=10.1074%2Fjbc.270.38.22085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine</span></div><div class="casAuthors">Grupe, Andrew; Alleman, Jennifer; Goldfine, Ira D.; Sadick, Mike; Stewart, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">22085-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Individuals with insulin resistance show increased levels of PC-1 expression in skeletal muscle and fibroblasts, and in transfected cell lines that overexpress PC-1 there is a redn. in the insulin-stimulated insulin receptor tyrosine phosphorylation.  As PC-1 is a type II transmembrane protein with extracellular phosphodiesterase and pyrophosphatase activity, increased expression of PC-1 at the cell surface will decrease extracellular ATP levels and increase extracellular adenosine levels.  Consequently it is possible that PC-1-mediated insulin resistance could be caused either by a decrease in ATP or an indirect increase in adenosine levels.  The authors have tested this hypothesis and find that the PC-1-mediated inhibition of insulin-stimulated insulin receptor autophosphorylation is not altered by agents that alter the level or action of adenosine.  Further, a mutated PC-1 with a single amino acid change that abolishes the phosphodiesterase and pyrophosphatase activities is still able to inhibit insulin-stimulated insulin receptor phosphorylation.  The results of these expts. indicate that the phosphodiesterase activity of PC-1 is not involved in the inhibition of insulin receptor autophosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAijMXH0BearVg90H21EOLACvtfcHk0lipF9B8T54wpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXot1Giu7Y%253D&md5=e01547283cc0bb10acdf11028e1089fe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.38.22085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.38.22085%26sid%3Dliteratum%253Aachs%26aulast%3DGrupe%26aufirst%3DA.%26aulast%3DAlleman%26aufirst%3DJ.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DSadick%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DT.%2BA.%26atitle%3DInhibition%2520of%2520Insulin%2520Receptor%2520Phosphorylation%2520by%2520PC-1%2520is%2520not%2520Mediated%2520by%2520the%2520Hydrolysis%2520of%2520Adenosine%2520Triphosphate%2520or%2520the%2520Generation%2520of%2520Adenosine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D22085%26epage%3D22088%26doi%3D10.1074%2Fjbc.270.38.22085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abate, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandalia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundy, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trischitta, V.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Disease: Ectonucleotide Pyrophosphatase Phosphodiesterase 1 as a 'Gatekeeper' of Insulin Receptors</span>. <i>Nat. Clin. Pract. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1038/ncpendmet0367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fncpendmet0367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=17143316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=694-701&author=N.+Abateauthor=M.+Chandaliaauthor=R.+Di+Paolaauthor=D.+W.+Fosterauthor=S.+M.+Grundyauthor=V.+Trischitta&title=Mechanisms+of+Disease%3A+Ectonucleotide+Pyrophosphatase+Phosphodiesterase+1+as+a+%27Gatekeeper%27+of+Insulin+Receptors&doi=10.1038%2Fncpendmet0367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors</span></div><div class="casAuthors">Abate, Nicola; Chandalia, Manisha; Di Paola, Rosa; Foster, Daniel W.; Grundy, Scott M.; Trischitta, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">694-701</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Insulin resistance is pathogenic for type 2 diabetes and cardiovascular disease.  Several inhibitors of insulin signaling have a role in human insulin resistance.  The transmembrane glycoprotein ectonucleotide pyrophosphatase phosphodiesterase 1 (E-NPP1; also known as plasma cell membrane glycoprotein PC-1) interacts with the insulin receptor and inhibits subsequent signaling by decreasing its β-subunit autophosphorylation.  E-NPP1 is overexpressed in skeletal muscle, adipose tissue and cultured skin fibroblasts of insulin-resistant individuals who are not yet obese or diabetic, which indicates that excessive E-NPP1 expression is an early, intrinsic defect in human insulin resistance.  Genetic studies also support a primary role of E-NPP1 in insulin resistance.  Among other variants, a missense polymorphism, Lys121Gln, has been described.  The Gln121 variant is a stronger inhibitor than Lys121 of insulin receptor function, and is assocd. with insulin resistance, type 2 diabetes and both cardiovascular and nephrovascular complications in diabetic patients.  E-NPP1 is measurable in human serum, where it might represent a valuable biomarker of insulin resistance, but its relationship to tissue and systemic insulin resistance remains to be thoroughly elucidated.  Understanding the mechanisms that regulate E-NPP1 expression and/or function might render this protein a new target for strategies to treat and prevent type 2 diabetes and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_8d1m1gbqPbVg90H21EOLACvtfcHk0lia0xq8vr5slw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntA%253D%253D&md5=2a8cf7f987081c122f5567e4fee940e5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fncpendmet0367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpendmet0367%26sid%3Dliteratum%253Aachs%26aulast%3DAbate%26aufirst%3DN.%26aulast%3DChandalia%26aufirst%3DM.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DD.%2BW.%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26aulast%3DTrischitta%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520Disease%253A%2520Ectonucleotide%2520Pyrophosphatase%2520Phosphodiesterase%25201%2520as%2520a%2520%2527Gatekeeper%2527%2520of%2520Insulin%2520Receptors%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Endocrinol.%2520Metab.%26date%3D2006%26volume%3D2%26spage%3D694%26epage%3D701%26doi%3D10.1038%2Fncpendmet0367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frittitta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercolino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozzali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiolas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santagati, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spampinato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigneri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trischitta, V.</span></span> <span> </span><span class="NLM_article-title">A Cluster of Three Single Nucleotide Polymorphisms in the 3′-Untranslated Region of Human Glycoprotein PC-1 Gene Stabilizes PC-1 mRNA and is Associated with Increased PC-1 Protein Content and Insulin Resistance-Related Abnormalities</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1952</span>– <span class="NLM_lpage">1955</span>, <span class="refDoi"> DOI: 10.2337/diabetes.50.8.1952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.2337%2Fdiabetes.50.8.1952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=11473061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslKms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=1952-1955&author=L.+Frittittaauthor=T.+Ercolinoauthor=M.+Bozzaliauthor=A.+Argiolasauthor=S.+Graciauthor=M.+G.+Santagatiauthor=D.+Spampinatoauthor=R.+Di+Paolaauthor=C.+Cisterninoauthor=V.+Tassiauthor=R.+Vigneriauthor=A.+Pizzutiauthor=V.+Trischitta&title=A+Cluster+of+Three+Single+Nucleotide+Polymorphisms+in+the+3%E2%80%B2-Untranslated+Region+of+Human+Glycoprotein+PC-1+Gene+Stabilizes+PC-1+mRNA+and+is+Associated+with+Increased+PC-1+Protein+Content+and+Insulin+Resistance-Related+Abnormalities&doi=10.2337%2Fdiabetes.50.8.1952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A cluster of three single nucleotide polymorphisms in the 3'-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities</span></div><div class="casAuthors">Frittitta, Lucia; Ercolino, Tonino; Bozzali, Maura; Argiolas, Alessandra; Graci, Salvo; Santagati, Maria G.; Spampinato, Daniela; Di Paola, Rosa; Cisternino, Carmela; Tassi, Vittorio; Vigneri, Riccardo; Pizzuti, Antonio; Trischitta, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1952-1955</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Glycoprotein PC-1 inhibits insulin signaling and, when overexpressed, plays a role in human insulin resistance.  Mechanisms of PC-1 overexpression are unknown.  The authors have identified a haplotype in the 3'-untranslated region of the PC-1 gene that may modulate PC-1 expression and confer an increased risk for insulin resistance.  Individuals from Sicily, Italy, carrying the "P" haplotype (i.e., a cluster of three single nucleotide polymorphisms: G2897A, G2906C, and C2948T) were at higher risk for insulin resistance and had higher levels of plasma glucose and insulin during an oral glucose tolerance test and higher levels of cholesterol, HDL cholesterol, and systolic blood pressure.  They also had higher PC-1 protein content in both skeletal muscle and cultured skin fibroblasts.  In CHO cells transfected with either P or wild-type cDNA, specific PC-1 mRNA half-life was increased for those transfected with P (t/2=3.73 vs. 1.57 h).  In a population of different ethnicity (Gargano, East Coast Italy), patients with type 2 diabetes (the most likely clin. outcome of insulin resistance) had a higher P haplotype frequency than healthy control subjects (7.8 vs. 1.5%), thus replicating the assocn. between the P allele and the insulin resistance-related abnormalities obsd. among Sicilians.  In conclusion, the authors have identified a possible mol. mechanism for PC-1 overexpression that confers an increased risk for insulin resistance-related abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA7LTeCpnkzLVg90H21EOLACvtfcHk0lhdzXF3FlPFMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslKms7o%253D&md5=73790ec972015d9d8f09768fceb7a5ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.50.8.1952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.50.8.1952%26sid%3Dliteratum%253Aachs%26aulast%3DFrittitta%26aufirst%3DL.%26aulast%3DErcolino%26aufirst%3DT.%26aulast%3DBozzali%26aufirst%3DM.%26aulast%3DArgiolas%26aufirst%3DA.%26aulast%3DGraci%26aufirst%3DS.%26aulast%3DSantagati%26aufirst%3DM.%2BG.%26aulast%3DSpampinato%26aufirst%3DD.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DCisternino%26aufirst%3DC.%26aulast%3DTassi%26aufirst%3DV.%26aulast%3DVigneri%26aufirst%3DR.%26aulast%3DPizzuti%26aufirst%3DA.%26aulast%3DTrischitta%26aufirst%3DV.%26atitle%3DA%2520Cluster%2520of%2520Three%2520Single%2520Nucleotide%2520Polymorphisms%2520in%2520the%25203%25E2%2580%25B2-Untranslated%2520Region%2520of%2520Human%2520Glycoprotein%2520PC-1%2520Gene%2520Stabilizes%2520PC-1%2520mRNA%2520and%2520is%2520Associated%2520with%2520Increased%2520PC-1%2520Protein%2520Content%2520and%2520Insulin%2520Resistance-Related%2520Abnormalities%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D1952%26epage%3D1955%26doi%3D10.2337%2Fdiabetes.50.8.1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belisário, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sales, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velloso-Rodrigues, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, M. B.</span></span> <span> </span><span class="NLM_article-title">Association Between ENPP1 K173Q and Stroke in a Newborn Cohort of 395 Brazilian Children with Sickle Cell Anemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-05-645176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1182%2Fblood-2015-05-645176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=26337355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGisrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1259-1260&author=A.+R.+Belis%C3%A1rioauthor=R.+R.+Salesauthor=N.+E.+Toledoauthor=C.+Velloso-Rodriguesauthor=C.+M.+Silvaauthor=M.+B.+Viana&title=Association+Between+ENPP1+K173Q+and+Stroke+in+a+Newborn+Cohort+of+395+Brazilian+Children+with+Sickle+Cell+Anemia&doi=10.1182%2Fblood-2015-05-645176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Association between ENPP1 K173Q and stroke in a newborn cohort of 395 Brazilian children with sickle cell anemia</span></div><div class="casAuthors">Belisario, Andre Rolim; Sales, Rahyssa Rodrigues; Toledo, Nayara Evelin; Velloso-Rodrigues, Cibele; Silva, Celia Maria; Viana, Marcos Borato</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1259-1260</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The aim of this article is to evaluate the influence of GOLGB1 Y1212C (rs3732410) and ENPP1 K173Q (rs104449) mutations on the risk of developing overt ischemic stroke in a newborn cohort with sickle cell anemia from Minas Gerais, Brazil.  There was no assocn. was obsd. between mutations GOLGB1 Y1212C (rs3732410) and PON1 Q192R with stroke.  While Q genetic variant of ENPP1 K173Q mutation in children with sickle cell anemia was assocd. with an increased risk of stroke and possibly, with the development of high-risk transcranial doppler readings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-M7vw-RpGrVg90H21EOLACvtfcHk0lhdzXF3FlPFMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGisrjK&md5=91a109108cf69a908a77182f77bc68f0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-05-645176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-05-645176%26sid%3Dliteratum%253Aachs%26aulast%3DBelis%25C3%25A1rio%26aufirst%3DA.%2BR.%26aulast%3DSales%26aufirst%3DR.%2BR.%26aulast%3DToledo%26aufirst%3DN.%2BE.%26aulast%3DVelloso-Rodrigues%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DC.%2BM.%26aulast%3DViana%26aufirst%3DM.%2BB.%26atitle%3DAssociation%2520Between%2520ENPP1%2520K173Q%2520and%2520Stroke%2520in%2520a%2520Newborn%2520Cohort%2520of%2520395%2520Brazilian%2520Children%2520with%2520Sickle%2520Cell%2520Anemia%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D1259%26epage%3D1260%26doi%3D10.1182%2Fblood-2015-05-645176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maliga, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span> <span> </span><span class="NLM_article-title">Hydrolysis of 2’3′-cGAMP by ENPP1 and Design of Nonhydrolyzable Analogs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fnchembio.1661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25344812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1043-1048&author=L.+Liauthor=Q.+Yinauthor=P.+Kussauthor=Z.+Maligaauthor=J.+L.+Mill%C3%A1nauthor=H.+Wuauthor=T.+J.+Mitchison&title=Hydrolysis+of+2%E2%80%993%E2%80%B2-cGAMP+by+ENPP1+and+Design+of+Nonhydrolyzable+Analogs&doi=10.1038%2Fnchembio.1661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs</span></div><div class="casAuthors">Li, Lingyin; Yin, Qian; Kuss, Pia; Maliga, Zoltan; Millan, Jose L.; Wu, Hao; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1043-1048</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Agonists of mouse STING (TMEM173) shrink and even cure solid tumors by activating innate immunity; human STING (hSTING) agonists are needed to test this therapeutic hypothesis in humans.  The endogenous STING agonist is 2'3'-cGAMP, a second messenger that signals the presence of cytosolic double-stranded DNA.  We report activity-guided partial purifn. and identification of ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP1) to be the dominant 2'3'-cGAMP hydrolyzing activity in cultured cells.  The hydrolysis activity of ENPP1 was confirmed using recombinant protein and was depleted in tissue exts. and plasma from Enpp1-/- mice.  We synthesized a hydrolysis-resistant bisphosphothioate analog of 2'3'-cGAMP (2'3'-cGsAsMP) that has similar affinity for hSTINGin vitro and is ten times more potent at inducing IFN-β secretion from human THP1 monocytes.  Studies in mouse Enpp1-/- lung fibroblasts indicate that resistance to hydrolysis contributes substantially to its higher potency.  2'3'-CGsAsMP is therefore improved over natural 2'3'-cGAMP as a model agonist and has potential as a vaccine adjuvant and cancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruGzJ050f3CbVg90H21EOLACvtfcHk0lhdzXF3FlPFMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbnO&md5=31000472bd11db78afdb00abedae78b1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1661%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DQ.%26aulast%3DKuss%26aufirst%3DP.%26aulast%3DMaliga%26aufirst%3DZ.%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DHydrolysis%2520of%25202%25E2%2580%25993%25E2%2580%25B2-cGAMP%2520by%2520ENPP1%2520and%2520Design%2520of%2520Nonhydrolyzable%2520Analogs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D1043%26epage%3D1048%26doi%3D10.1038%2Fnchembio.1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic GMP-AMP Synthase is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1126/science.1232458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscience.1232458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23258413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ygurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=786-791&author=L.+Sunauthor=J.+Wuauthor=F.+Duauthor=X.+Chenauthor=Z.+J.+Chen&title=Cyclic+GMP-AMP+Synthase+is+a+Cytosolic+DNA+Sensor+That+Activates+the+Type+I+Interferon+Pathway&doi=10.1126%2Fscience.1232458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway</span></div><div class="casAuthors">Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6121</span>),
    <span class="NLM_cas:pages">786-791</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The presence of DNA in the cytoplasm of mammalian cells is a danger signal that triggers host immune responses such as the prodn. of type I interferons.  Cytosolic DNA induces interferons through the prodn. of cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP), which binds to and activates the adaptor protein STING.  Through biochem. fractionation and quant. mass spectrometry, we identified a cGAMP synthase (cGAS), which belongs to the nucleotidyltransferase family.  Overexpression of cGAS activated the transcription factor IRF3 and induced interferon-β in a STING-dependent manner.  Knockdown of cGAS inhibited IRF3 activation and interferon-β induction by DNA transfection or DNA virus infection.  CGAS bound to DNA in the cytoplasm and catalyzed cGAMP synthesis.  These results indicate that cGAS is a cytosolic DNA sensor that induces interferons by producing the second messenger cGAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxxUcksTNZRbVg90H21EOLACvtfcHk0lhdzXF3FlPFMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ygurw%253D&md5=fe9a64a9c0441eb00852900be8d683bf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232458%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26atitle%3DCyclic%2520GMP-AMP%2520Synthase%2520is%2520a%2520Cytosolic%2520DNA%2520Sensor%2520That%2520Activates%2520the%2520Type%2520I%2520Interferon%2520Pathway%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D786%26epage%3D791%26doi%3D10.1126%2Fscience.1232458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic GMP-AMP is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">826</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1126/science.1229963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscience.1229963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23258412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ygtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=826-830&author=J.+Wuauthor=L.+Sunauthor=X.+Chenauthor=F.+Duauthor=H.+Shiauthor=C.+Chenauthor=Z.+J.+Chen&title=Cyclic+GMP-AMP+is+an+Endogenous+Second+Messenger+in+Innate+Immune+Signaling+by+Cytosolic+DNA&doi=10.1126%2Fscience.1229963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA</span></div><div class="casAuthors">Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Shi, Heping; Chen, Chuo; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6121</span>),
    <span class="NLM_cas:pages">826-830</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cytosolic DNA induces type I interferons and other cytokines that are important for antimicrobial defense but can also result in autoimmunity.  This DNA signaling pathway requires the adaptor protein STING and the transcription factor IRF3, but the mechanism of DNA sensing is unclear.  We found that mammalian cytosolic exts. synthesized cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP) in vitro from ATP and guanosine triphosphate in the presence of DNA but not RNA.  DNA transfection or DNA virus infection of mammalian cells also triggered cGAMP prodn.  CGAMP bound to STING, leading to the activation of IRF3 and induction of interferon-β.  Thus, cGAMP functions as an endogenous second messenger in metazoans and triggers interferon prodn. in response to cytosolic DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0CH1aDO6v5bVg90H21EOLACvtfcHk0lgISuXF3mSJvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ygtbs%253D&md5=2d59a6c9c71eb7188e3e9fd01b2c7e84</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1229963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1229963%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26atitle%3DCyclic%2520GMP-AMP%2520is%2520an%2520Endogenous%2520Second%2520Messenger%2520in%2520Innate%2520Immune%2520Signaling%2520by%2520Cytosolic%2520DNA%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D826%26epage%3D830%26doi%3D10.1126%2Fscience.1229963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portnoy, D. A.</span></span> <span> </span><span class="NLM_article-title">c-di-AMP Secreted by Intracellular Listeria Monocytogenes Activates a Host Type I Interferon Response</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>328</i></span>,  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1705</span>, <span class="refDoi"> DOI: 10.1126/science.1189801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscience.1189801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=20508090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=1703-1705&author=J.+J.+Woodwardauthor=A.+T.+Iavaroneauthor=D.+A.+Portnoy&title=c-di-AMP+Secreted+by+Intracellular+Listeria+Monocytogenes+Activates+a+Host+Type+I+Interferon+Response&doi=10.1126%2Fscience.1189801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response</span></div><div class="casAuthors">Woodward, Joshua J.; Iavarone, Anthony T.; Portnoy, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">5986</span>),
    <span class="NLM_cas:pages">1703-1705</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Intracellular bacterial pathogens, such as Listeria monocytogenes, are detected in the cytosol of host immune cells.  Induction of this host response is often dependent on microbial secretion systems and, in L. monocytogenes, is dependent on multidrug efflux pumps (MDRs).  Using L. monocytogenes mutants that overexpressed MDRs, the authors identified cyclic diadenosine monophosphate (c-di-AMP) as a secreted mol. able to trigger the cytosolic host response.  Overexpression of the di-adenylate cyclase, dacA (lmo2120), resulted in elevated levels of the host response during infection.  C-di-AMP thus represents a putative bacterial secondary signaling mol. that triggers a cytosolic pathway of innate immunity and is predicted to be present in a wide variety of bacteria and archea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPoYB1SaNJ27Vg90H21EOLACvtfcHk0lgISuXF3mSJvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVektbY%253D&md5=d71cb2a70f01266a46bc9c93c78ab6d8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1189801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1189801%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DJ.%2BJ.%26aulast%3DIavarone%26aufirst%3DA.%2BT.%26aulast%3DPortnoy%26aufirst%3DD.%2BA.%26atitle%3Dc-di-AMP%2520Secreted%2520by%2520Intracellular%2520Listeria%2520Monocytogenes%2520Activates%2520a%2520Host%2520Type%2520I%2520Interferon%2520Response%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D1703%26epage%3D1705%26doi%3D10.1126%2Fscience.1189801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroe, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo-Troha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwig, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyodo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, R. E.</span></span> <span> </span><span class="NLM_article-title">STING is a Direct Innate Immune Sensor of Cyclic di-GMP</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>478</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1038/nature10429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fnature10429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=21947006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WltLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=515-518&author=D.+L.+Burdetteauthor=K.+M.+Monroeauthor=K.+Sotelo-Trohaauthor=J.+S.+Iwigauthor=B.+Eckertauthor=M.+Hyodoauthor=Y.+Hayakawaauthor=R.+E.+Vance&title=STING+is+a+Direct+Innate+Immune+Sensor+of+Cyclic+di-GMP&doi=10.1038%2Fnature10429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">STING is a direct innate immune sensor of cyclic di-GMP</span></div><div class="casAuthors">Burdette, Dara L.; Monroe, Kathryn M.; Sotelo-Troha, Katia; Iwig, Jeff S.; Eckert, Barbara; Hyodo, Mamoru; Hayakawa, Yoshihiro; Vance, Russell E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">515-518</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The innate immune system detects infection by using germline-encoded receptors that are specific for conserved microbial mols.  The recognition of microbial ligands leads to the prodn. of cytokines, such as type I interferons (IFNs), that are essential for successful pathogen elimination.  Cytosolic detection of pathogen-derived DNA is one major mechanism of inducing IFN prodn., and this process requires signaling through TANK binding kinase 1 (TBK1) and its downstream transcription factor, IFN-regulatory factor 3 (IRF3).  In addn., a transmembrane protein called STING (stimulator of IFN genes; also known as MITA, ERIS, MPYS and TMEM173) functions as an essential signaling adaptor, linking the cytosolic detection of DNA to the TBK1-IRF3 signaling axis.  Recently, unique nucleic acids called cyclic dinucleotides, which function as conserved signaling mols. in bacteria, have also been shown to induce a STING-dependent type I IFN response.  However, a mammalian sensor of cyclic dinucleotides has not been identified.  Here the authors report evidence that STING itself is an innate immune sensor of cyclic dinucleotides.  The authors demonstrate that STING binds directly to radiolabeled cyclic diguanylate monophosphate (c-di-GMP), and the authors show that unlabeled cyclic dinucleotides, but not other nucleotides or nucleic acids, compete with c-di-GMP for binding to STING.  Furthermore, the authors identify mutations in STING that selectively affect the response to cyclic dinucleotides without affecting the response to DNA.  Thus, STING seems to function as a direct sensor of cyclic dinucleotides, in addn. to its established role as a signaling adaptor in the IFN response to cytosolic DNA.  Cyclic dinucleotides have shown promise as novel vaccine adjuvants and immunotherapeutics, and the authors' results provide insight into the mechanism by which cyclic dinucleotides are sensed by the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvnzueDcwVnrVg90H21EOLACvtfcHk0lgISuXF3mSJvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WltLbL&md5=179c4ebb96c6e0385de0370ac42c9bbe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature10429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10429%26sid%3Dliteratum%253Aachs%26aulast%3DBurdette%26aufirst%3DD.%2BL.%26aulast%3DMonroe%26aufirst%3DK.%2BM.%26aulast%3DSotelo-Troha%26aufirst%3DK.%26aulast%3DIwig%26aufirst%3DJ.%2BS.%26aulast%3DEckert%26aufirst%3DB.%26aulast%3DHyodo%26aufirst%3DM.%26aulast%3DHayakawa%26aufirst%3DY.%26aulast%3DVance%26aufirst%3DR.%2BE.%26atitle%3DSTING%2520is%2520a%2520Direct%2520Innate%2520Immune%2520Sensor%2520of%2520Cyclic%2520di-GMP%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D515%26epage%3D518%26doi%3D10.1038%2Fnature10429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corrales, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhirter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivick, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katibah, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metchette, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubensky, T. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.celrep.2015.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25959818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVCmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=1018-1030&author=L.+Corralesauthor=L.+H.+Glickmanauthor=S.+M.+McWhirterauthor=D.+B.+Kanneauthor=K.+E.+Sivickauthor=G.+E.+Katibahauthor=S.+R.+Wooauthor=E.+Lemmensauthor=T.+Bandaauthor=J.+J.+Leongauthor=K.+Metchetteauthor=T.+W.+Dubenskyauthor=T.+F.+Gajewski&title=Direct+Activation+of+STING+in+the+Tumor+Microenvironment+Leads+to+Potent+and+Systemic+Tumor+Regression+and+Immunity&doi=10.1016%2Fj.celrep.2015.04.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity</span></div><div class="casAuthors">Corrales, Leticia; Glickman, Laura Hix; McWhirter, Sarah M.; Kanne, David B.; Sivick, Kelsey E.; Katibah, George E.; Woo, Seng-Ryong; Lemmens, Edward; Banda, Tamara; Leong, Justin J.; Metchette, Ken; Dubensky, Thomas W., Jr.; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1018-1030</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Spontaneous tumor-initiated T cell priming is dependent on IFN-β prodn. by tumor-resident dendritic cells.  On the basis of recent observations indicating that IFN-β expression was dependent upon activation of the host STING pathway, we hypothesized that direct engagement of STING through intratumoral (IT) administration of specific agonists would result in effective anti-tumor therapy.  After proof-of-principle studies using the mouse STING agonist DMXAA showed a potent therapeutic effect, we generated synthetic cyclic dinucleotide (CDN) derivs. that activated all human STING alleles as well as murine STING.  IT injection of STING agonists induced profound regression of established tumors in mice and generated substantial systemic immune responses capable of rejecting distant metastases and providing long-lived immunol. memory.  Synthetic CDNs have high translational potential as a cancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBJFLJqaY27Vg90H21EOLACvtfcHk0ljPaHBn4sx__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVCmtbc%253D&md5=0c3516ed7a91a9b3e3d90ccdf0555644</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DCorrales%26aufirst%3DL.%26aulast%3DGlickman%26aufirst%3DL.%2BH.%26aulast%3DMcWhirter%26aufirst%3DS.%2BM.%26aulast%3DKanne%26aufirst%3DD.%2BB.%26aulast%3DSivick%26aufirst%3DK.%2BE.%26aulast%3DKatibah%26aufirst%3DG.%2BE.%26aulast%3DWoo%26aufirst%3DS.%2BR.%26aulast%3DLemmens%26aufirst%3DE.%26aulast%3DBanda%26aufirst%3DT.%26aulast%3DLeong%26aufirst%3DJ.%2BJ.%26aulast%3DMetchette%26aufirst%3DK.%26aulast%3DDubensky%26aufirst%3DT.%2BW.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DDirect%2520Activation%2520of%2520STING%2520in%2520the%2520Tumor%2520Microenvironment%2520Leads%2520to%2520Potent%2520and%2520Systemic%2520Tumor%2520Regression%2520and%2520Immunity%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D11%26spage%3D1018%26epage%3D1030%26doi%3D10.1016%2Fj.celrep.2015.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhirter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechette, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivick, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portnoy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubensky, T. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span> <span> </span><span class="NLM_article-title">STING Agonist Formulated Cancer Vaccines Can Cure Established Tumors Resistant to PD-1 Blockade</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">283ra52</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa4306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1126%2Fscitranslmed.aaa4306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25877890" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=283ra52&author=J.+Fuauthor=D.+B.+Kanneauthor=M.+Leongauthor=L.+H.+Glickmanauthor=S.+M.+McWhirterauthor=E.+Lemmensauthor=K.+Mechetteauthor=J.+J.+Leongauthor=P.+Lauerauthor=W.+Liuauthor=K.+E.+Sivickauthor=Q.+Zengauthor=K.+C.+Soaresauthor=L.+Zhengauthor=D.+A.+Portnoyauthor=J.+J.+Woodwardauthor=D.+M.+Pardollauthor=T.+W.+Dubenskyauthor=Y.+Kim&title=STING+Agonist+Formulated+Cancer+Vaccines+Can+Cure+Established+Tumors+Resistant+to+PD-1+Blockade&doi=10.1126%2Fscitranslmed.aaa4306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa4306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa4306%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DKanne%26aufirst%3DD.%2BB.%26aulast%3DLeong%26aufirst%3DM.%26aulast%3DGlickman%26aufirst%3DL.%2BH.%26aulast%3DMcWhirter%26aufirst%3DS.%2BM.%26aulast%3DLemmens%26aufirst%3DE.%26aulast%3DMechette%26aufirst%3DK.%26aulast%3DLeong%26aufirst%3DJ.%2BJ.%26aulast%3DLauer%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSivick%26aufirst%3DK.%2BE.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DSoares%26aufirst%3DK.%2BC.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DPortnoy%26aufirst%3DD.%2BA.%26aulast%3DWoodward%26aufirst%3DJ.%2BJ.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DDubensky%26aufirst%3DT.%2BW.%26aulast%3DKim%26aufirst%3DY.%26atitle%3DSTING%2520Agonist%2520Formulated%2520Cancer%2520Vaccines%2520Can%2520Cure%2520Established%2520Tumors%2520Resistant%2520to%2520PD-1%2520Blockade%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D283ra52%26doi%3D10.1126%2Fscitranslmed.aaa4306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanjulu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesiridis, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muelbaier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graybill, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charnley, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnia, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puhl, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopson, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smothers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Design of Amidobenzimidazole STING Receptor Agonists with Systemic Activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>564</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">–443</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0705-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fs41586-018-0705-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30405246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFejsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=564&publication_year=2018&pages=439-%E2%80%93443&author=J.+M.+Ramanjuluauthor=G.+S.+Pesiridisauthor=J.+Yangauthor=N.+Conchaauthor=R.+Singhausauthor=S.+Y.+Zhangauthor=J.+L.+Tranauthor=P.+Mooreauthor=S.+Lehmannauthor=H.+C.+Eberlauthor=M.+Muelbaierauthor=J.+L.+Schneckauthor=J.+Clemensauthor=M.+Adamauthor=J.+Mehlmannauthor=J.+Romanoauthor=A.+Moralesauthor=J.+Kangauthor=L.+Leisterauthor=T.+L.+Graybillauthor=A.+K.+Charnleyauthor=G.+Yeauthor=N.+Nevinsauthor=K.+Behniaauthor=A.+I.+Wolfauthor=V.+Kasparcovaauthor=K.+Nurseauthor=L.+Wangauthor=A.+C.+Puhlauthor=Y.+Liauthor=M.+Kleinauthor=C.+B.+Hopsonauthor=J.+Gussauthor=M.+Bantscheffauthor=G.+Bergaminiauthor=M.+A.+Reillyauthor=Y.+Lianauthor=K.+J.+Duffyauthor=J.+Adamsauthor=K.+P.+Foleyauthor=P.+J.+Goughauthor=R.+W.+Marquisauthor=J.+Smothersauthor=A.+Hoosauthor=J.+Bertin&title=Design+of+Amidobenzimidazole+STING+Receptor+Agonists+with+Systemic+Activity&doi=10.1038%2Fs41586-018-0705-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design of amidobenzimidazole STING receptor agonists with systemic activity</span></div><div class="casAuthors">Ramanjulu, Joshi M.; Pesiridis, G. Scott; Yang, Jingsong; Concha, Nestor; Singhaus, Robert; Zhang, Shu-Yun; Tran, Jean-Luc; Moore, Patrick; Lehmann, Stephanie; Eberl, H. Christian; Muelbaier, Marcel; Schneck, Jessica L.; Clemens, Jim; Adam, Michael; Mehlmann, John; Romano, Joseph; Morales, Angel; Kang, James; Leister, Lara; Graybill, Todd L.; Charnley, Adam K.; Ye, Guosen; Nevins, Neysa; Behnia, Kamelia; Wolf, Amaya I.; Kasparcova, Viera; Nurse, Kelvin; Wang, Liping; Li, Yue; Klein, Michael; Hopson, Christopher B.; Guss, Jeffrey; Bantscheff, Marcus; Bergamini, Giovanna; Reilly, Michael A.; Lian, Yiqian; Duffy, Kevin J.; Adams, Jerry; Foley, Kevin P.; Gough, Peter J.; Marquis, Robert W.; Smothers, James; Hoos, Axel; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">564</span>
        (<span class="NLM_cas:issue">7736</span>),
    <span class="NLM_cas:pages">439-443</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Stimulator of interferon genes (STING) is a receptor in the endoplasmic reticulum that propagates innate immune sensing of cytosolic pathogen-derived and self DNA1.  The development of compds. that modulate STING has recently been the focus of intense research for the treatment of cancer and infectious diseases and as vaccine adjuvants2.  To our knowledge, current efforts are focused on the development of modified cyclic dinucleotides that mimic the endogenous STING ligand cGAMP; these have progressed into clin. trials in patients with solid accessible tumors amenable to intratumoral delivery3.  Here we report the discovery of a small mol. STING agonist that is not a cyclic dinucleotide and is systemically efficacious for treating tumors in mice.  We developed a linking strategy to synergize the effect of two symmetry-related amidobenzimidazole (ABZI)-based compds. to create linked ABZIs (diABZIs) with enhanced binding to STING and cellular function.  I.v. administration of a diABZI STING agonist to immunocompetent mice with established syngeneic colon tumors elicited strong anti-tumor activity, with complete and lasting regression of tumors.  Our findings represent a milestone in the rapidly growing field of immune-modifying cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jb61D9fGkLVg90H21EOLACvtfcHk0ljPaHBn4sx__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFejsb7N&md5=bc8d64d74f22300a4bebe718c0e440ce</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0705-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0705-y%26sid%3Dliteratum%253Aachs%26aulast%3DRamanjulu%26aufirst%3DJ.%2BM.%26aulast%3DPesiridis%26aufirst%3DG.%2BS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DSinghaus%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26aulast%3DTran%26aufirst%3DJ.%2BL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DLehmann%26aufirst%3DS.%26aulast%3DEberl%26aufirst%3DH.%2BC.%26aulast%3DMuelbaier%26aufirst%3DM.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DM.%26aulast%3DMehlmann%26aufirst%3DJ.%26aulast%3DRomano%26aufirst%3DJ.%26aulast%3DMorales%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DLeister%26aufirst%3DL.%26aulast%3DGraybill%26aufirst%3DT.%2BL.%26aulast%3DCharnley%26aufirst%3DA.%2BK.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DA.%2BI.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DNurse%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPuhl%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DM.%26aulast%3DHopson%26aufirst%3DC.%2BB.%26aulast%3DGuss%26aufirst%3DJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DLian%26aufirst%3DY.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DSmothers%26aufirst%3DJ.%26aulast%3DHoos%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520Amidobenzimidazole%2520STING%2520Receptor%2520Agonists%2520with%2520Systemic%2520Activity%26jtitle%3DNature%26date%3D2018%26volume%3D564%26spage%3D439%26epage%3D%25E2%2580%2593443%26doi%3D10.1038%2Fs41586-018-0705-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. Y.</span></span> <span> </span><span class="NLM_article-title">Role of the cGAS-STING Pathway in Cancer Development and Oncotherapeutic Approaches</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">e46935</span>, <span class="refDoi"> DOI: 10.15252/embr.201846935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.15252%2Fembr.201846935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30446584" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=e46935&author=L.+T.+Khooauthor=L.+Y.+Chen&title=Role+of+the+cGAS-STING+Pathway+in+Cancer+Development+and+Oncotherapeutic+Approaches&doi=10.15252%2Fembr.201846935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.15252%2Fembr.201846935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembr.201846935%26sid%3Dliteratum%253Aachs%26aulast%3DKhoo%26aufirst%3DL.%2BT.%26aulast%3DChen%26aufirst%3DL.%2BY.%26atitle%3DRole%2520of%2520the%2520cGAS-STING%2520Pathway%2520in%2520Cancer%2520Development%2520and%2520Oncotherapeutic%2520Approaches%26jtitle%3DEMBO%2520Rep.%26date%3D2018%26spage%3De46935%26doi%3D10.15252%2Fembr.201846935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trason, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R. K.</span></span> <span> </span><span class="NLM_article-title">Development of Enpp1 Inhibitors as a Strategy to Activate Stimulator of Interferon Genes (STING) in Cancers and Other Diseases</span>. <i>Int. J. Cell Sci. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">555655</span>, <span class="refDoi"> DOI: 10.19080/IJCSMB.2018.05.555655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.19080%2FIJCSMB.2018.05.555655" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=555655&author=S.+Manasauthor=T.+Trasonauthor=W.+Alexisauthor=R.+K.+Mohan&title=Development+of+Enpp1+Inhibitors+as+a+Strategy+to+Activate+Stimulator+of+Interferon+Genes+%28STING%29+in+Cancers+and+Other+Diseases&doi=10.19080%2FIJCSMB.2018.05.555655"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.19080%2FIJCSMB.2018.05.555655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.19080%252FIJCSMB.2018.05.555655%26sid%3Dliteratum%253Aachs%26aulast%3DManas%26aufirst%3DS.%26aulast%3DTrason%26aufirst%3DT.%26aulast%3DAlexis%26aufirst%3DW.%26aulast%3DMohan%26aufirst%3DR.%2BK.%26atitle%3DDevelopment%2520of%2520Enpp1%2520Inhibitors%2520as%2520a%2520Strategy%2520to%2520Activate%2520Stimulator%2520of%2520Interferon%2520Genes%2520%2528STING%2529%2520in%2520Cancers%2520and%2520Other%2520Diseases%26jtitle%3DInt.%2520J.%2520Cell%2520Sci.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D5%26spage%3D555655%26doi%3D10.19080%2FIJCSMB.2018.05.555655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Habsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honjo, T.</span></span> <span> </span><span class="NLM_article-title">Role of PD-1 in Immunity and Diseases</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1007/82_2017_67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1007%2F82_2017_67" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=28929192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGksLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2017&pages=75-97&author=K.+Chamotoauthor=M.+Al-Habsiauthor=T.+Honjo&title=Role+of+PD-1+in+Immunity+and+Diseases&doi=10.1007%2F82_2017_67"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Role of PD-1 in immunity and diseases</span></div><div class="casAuthors">Chamoto, Kenji; Al-Habsi, Muna; Honjo, Tasuku</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Microbiology and Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue">Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity</span>),
    <span class="NLM_cas:pages">75-97</span>CODEN:
                <span class="NLM_cas:coden">CTMIA3</span>;
        ISSN:<span class="NLM_cas:issn">2196-9965</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Immunity developed to defend our bodies from foreign particles, including bacteria and viruses.  Although effector cells responsible for acquired immunity, mainly T cells, and B cells, are able to distinguish self from non-self, they sometimes attack the body's tissues because of imperfect central tolerance.  Several immune check points developed to limit overactivation of these cells.  One of the most important immune checkpoints is programmed cell death-1 (PD-1), which is expressed mainly on activated lymphocytes.  As its ligands (PD-Ls) are expressed widely in the body and affect the responses against self and foreign antigens, controlling PD-1/PD-L interactions enables the management of several immune-related diseases such as autoimmune disease, virus infection, and cancers.  Currently, the strategy of PD-1/ PD-L1 blockade has already been applied to clin. cancer therapy, providing evidences that PD-1 signal is one of the main factors of cancer immune escape in humans.  The dramatic efficacy of PD-1 blockade in cancer immunotherapy, promises the control of other immune diseases by PD-1 signal modulation.  In this review, we summarize the history of PD-1, subsequent basic studies, and their application to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreF_VPlkOFyLVg90H21EOLACvtfcHk0lhswYGnjc-4KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGksLjM&md5=1a9ff2a3fd06cf762c507966051dfba3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2F82_2017_67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2017_67%26sid%3Dliteratum%253Aachs%26aulast%3DChamoto%26aufirst%3DK.%26aulast%3DAl-Habsi%26aufirst%3DM.%26aulast%3DHonjo%26aufirst%3DT.%26atitle%3DRole%2520of%2520PD-1%2520in%2520Immunity%2520and%2520Diseases%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2017%26volume%3D410%26spage%3D75%26epage%3D97%26doi%3D10.1007%2F82_2017_67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minoura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodaira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiya, T.</span></span> <span> </span><span class="NLM_article-title">Loss of microRNA-27b Contributes to Breast Cancer Stem Cell Generation by Activating ENPP1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7318</span>, <span class="refDoi"> DOI: 10.1038/ncomms8318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fncomms8318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=26065921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2ktrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7318&author=R.+U.+Takahashiauthor=H.+Miyazakiauthor=F.+Takeshitaauthor=Y.+Yamamotoauthor=K.+Minouraauthor=M.+Onoauthor=M.+Kodairaauthor=K.+Tamuraauthor=M.+Moriauthor=T.+Ochiya&title=Loss+of+microRNA-27b+Contributes+to+Breast+Cancer+Stem+Cell+Generation+by+Activating+ENPP1&doi=10.1038%2Fncomms8318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1</span></div><div class="casAuthors">Takahashi, Ryou-u; Miyazaki, Hiroaki; Takeshita, Fumitaka; Yamamoto, Yusuke; Minoura, Kaho; Ono, Makiko; Kodaira, Makoto; Tamura, Kenji; Mori, Masaki; Ochiya, Takahiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7318</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer stem cells (CSCs) have been identified in various types of cancer; however, the mechanisms by which cells acquire CSC properties such as drug resistance and tumor seeding ability are not fully understood.  Here, we identified microRNA-27b (miR-27b) as a key regulator for the generation of a side-population in breast cancer cells that showed CSC properties, and also found that the anti-type II diabetes (T2D) drug metformin reduced this side-population via miR-27b-mediated repression of ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1), which is involved in T2D development.  ENPP1 induced the generation of the side-population via upregulation of the ABCG2 transporter.  ENPP1 was also identified as a substrate of the 26S proteasome, the activity of which is downregulated in CSCs.  Overall, these results demonstrate that a T2D-assocd. gene plays an important role in tumor development and that its expression is strictly controlled at the mRNA and protein levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw4loZNiIX9LVg90H21EOLACvtfcHk0lhswYGnjc-4KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2ktrnF&md5=e754b2c55863fb9328525366fe6a47fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncomms8318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8318%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DR.%2BU.%26aulast%3DMiyazaki%26aufirst%3DH.%26aulast%3DTakeshita%26aufirst%3DF.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DMinoura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKodaira%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DOchiya%26aufirst%3DT.%26atitle%3DLoss%2520of%2520microRNA-27b%2520Contributes%2520to%2520Breast%2520Cancer%2520Stem%2520Cell%2520Generation%2520by%2520Activating%2520ENPP1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7318%26doi%3D10.1038%2Fncomms8318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bageritz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puccio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovestadt, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pankert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold-Mende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goidts, V.</span></span> <span> </span><span class="NLM_article-title">Stem Cell Characteristics in Glioblastoma are Maintained by the Ecto-Nucleotidase E-NPP1</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1038/cdd.2014.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fcdd.2014.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=24531536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=929-940&author=J.+Bageritzauthor=L.+Puccioauthor=R.+M.+Piroauthor=V.+Hovestadtauthor=E.+Phillipsauthor=T.+Pankertauthor=J.+Lohrauthor=C.+Herold-Mendeauthor=P.+Lichterauthor=V.+Goidts&title=Stem+Cell+Characteristics+in+Glioblastoma+are+Maintained+by+the+Ecto-Nucleotidase+E-NPP1&doi=10.1038%2Fcdd.2014.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1</span></div><div class="casAuthors">Bageritz, J.; Puccio, L.; Piro, R. M.; Hovestadt, V.; Phillips, E.; Pankert, T.; Lohr, J.; Herold-Mende, C.; Lichter, P.; Goidts, V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">929-940</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioblastomas are highly aggressive brain tumors and are characterized by substantial cellular heterogeneity within a single tumor.  A sub-population of glioblastoma stem-like cells (GSCs) that shares properties with neural precursor cells has been described, exhibiting resistance to therapy and therefore being considered responsible for the high recurrence rate in glioblastoma.  To elucidate the underlying cellular processes we investigated the role of phosphatases in the GSC phenotype, using an in vitro phosphatome-wide RNA interference screen.  We identified a set of genes, the knockdown of which induces a significant decrease in the glioma stem cell marker CD133, indicating a role in the glioblastoma stem-like phenotype.  Among these genes, the ecto-nucleotidase ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) was found to be highly expressed in GSCs compared with normal brain and neural stem cells.  Knockdown of ENPP1 in cultured GSCs resulted in an overall downregulation of stem cell-assocd. genes, induction of differentiation into astrocytic cell lineage, impairment of sphere formation, in addn. to increased cell death, accumulation of cells in G1/G0 cell cycle phase and sensitization to chemotherapeutic treatment.  Genome-wide gene expression anal. and nucleoside and nucleotide profiling revealed that knockdown of ENPP1 affects purine and pyrimidine metab., suggesting a link between ENPP1 expression and a balanced nucleoside-nucleotide pool in GSCs.  The phenotypic changes in E-NPP1-deficient GSCs are assumed to be a consequence of decreased transcriptional function of E2F1.  Together, these results reveal that E-NPP1, by acting upstream of E2F1, is indispensable for the maintenance of GSCs in vitro and hence required to keep GSCs in an undifferentiated, proliferative state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgLWv2HJ6-TLVg90H21EOLACvtfcHk0lgOUywtsdvdYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgsLo%253D&md5=b10a6be7ee48eac24094a781331088b0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.12%26sid%3Dliteratum%253Aachs%26aulast%3DBageritz%26aufirst%3DJ.%26aulast%3DPuccio%26aufirst%3DL.%26aulast%3DPiro%26aufirst%3DR.%2BM.%26aulast%3DHovestadt%26aufirst%3DV.%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DPankert%26aufirst%3DT.%26aulast%3DLohr%26aufirst%3DJ.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DLichter%26aufirst%3DP.%26aulast%3DGoidts%26aufirst%3DV.%26atitle%3DStem%2520Cell%2520Characteristics%2520in%2520Glioblastoma%2520are%2520Maintained%2520by%2520the%2520Ecto-Nucleotidase%2520E-NPP1%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2014%26volume%3D21%26spage%3D929%26epage%3D940%26doi%3D10.1038%2Fcdd.2014.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aerts, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ginniken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ostade, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kockx, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dua, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slegers, H.</span></span> <span> </span><span class="NLM_article-title">The Expression of Ecto-Nucleotide Pyrophosphatase/ Phosphodiesterase 1 (E-NPP1) is Correlated with Astrocytic Tumor Grade</span>. <i>Clin. Neurol. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.clineuro.2010.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.clineuro.2010.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=21195542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BC3M3jvFynuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2011&pages=224-229&author=I.+Aertsauthor=J.+J.+Martinauthor=P.+P.+De+Deynauthor=C.+Van+Ginnikenauthor=X.+Van+Ostadeauthor=M.+Kockxauthor=G.+Duaauthor=H.+Slegers&title=The+Expression+of+Ecto-Nucleotide+Pyrophosphatase%2F+Phosphodiesterase+1+%28E-NPP1%29+is+Correlated+with+Astrocytic+Tumor+Grade&doi=10.1016%2Fj.clineuro.2010.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade</span></div><div class="casAuthors">Aerts Indra; Martin Jean-Jacques; De Deyn Peter Paul; Van Ginniken Chris; Van Ostade Xaveer; Kockx Mark; Dua Guido; Slegers Herman</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neurology and neurosurgery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">224-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Astrocytic brain tumors are subdivided in four grades.  The most aggressive and invasive one is grade IV or glioblastoma multiforme (GBM).  Ecto-nucleotide pyrophosphatase/phosphodiesterase-1 (E-NPP1), a membrane-bound enzyme, is involved in many cellular processes such as modulation of purinergic signalling, nucleotide recycling, regulation of extracellular pyrophosphate levels and stimulation of cell motility.  In this study, the use of anti-NPP1 antibody in the determination of astrocytic tumor grade is evaluated.  MATERIALS AND METHODS:  Paraffin-embedded surgical specimens from 41 primary human astrocytic brain tumors (grade I=2; grade II=10; grade III=9; grade IV=20) and 5 control samples are immunostained against NPP1 and glial fibrillary acid protein an astrocytic marker.  RESULTS:  In this communication, we report the expression of NPP1 in human astrocytic brain tumors.  No expression could be detected in control tissue.  We observed a remarkable up regulated expression of NPP1 in GBM.  Taking the latter as 100%, grade I has a relative NPP1 staining of 7%, whereas grade II and III have a similar NPP1 expression level of 53% and 47% respectively.  CONCLUSION:  A correlation is found between the up-regulated expression of NPP1 and the grade of the astrocytic tumor.  Further investigation of NPP1 expression, especially in GBM, is necessary to determine the role of NPP1 in astrocytic brain tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRAZSLGWDvoWmbXvSEQle5fW6udTcc2eZCPurvAyCMFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3jvFynuw%253D%253D&md5=1b1db009def9391a22668e28eb535e78</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.clineuro.2010.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clineuro.2010.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DAerts%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DJ.%2BJ.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26aulast%3DVan%2BGinniken%26aufirst%3DC.%26aulast%3DVan%2BOstade%26aufirst%3DX.%26aulast%3DKockx%26aufirst%3DM.%26aulast%3DDua%26aufirst%3DG.%26aulast%3DSlegers%26aufirst%3DH.%26atitle%3DThe%2520Expression%2520of%2520Ecto-Nucleotide%2520Pyrophosphatase%252F%2520Phosphodiesterase%25201%2520%2528E-NPP1%2529%2520is%2520Correlated%2520with%2520Astrocytic%2520Tumor%2520Grade%26jtitle%3DClin.%2520Neurol.%2520Neurosurg.%26date%3D2011%26volume%3D113%26spage%3D224%26epage%3D229%26doi%3D10.1016%2Fj.clineuro.2010.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span> <span> </span><span class="NLM_article-title">Dysregulated ENPP1 Increases the Malignancy of Human Lung Cancer by Inducing Epithelial-Mesenchymal Transition Phenotypes and Stem Cell Features</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30755817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BB3cfis1eltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=134-144&author=M.+Huauthor=W.+Guoauthor=Y.+Liaoauthor=D.+Xuauthor=B.+Sunauthor=H.+Songauthor=T.+Wangauthor=Y.+Kuangauthor=B.+Jingauthor=K.+Liauthor=J.+Lingauthor=F.+Yaoauthor=J.+Deng&title=Dysregulated+ENPP1+Increases+the+Malignancy+of+Human+Lung+Cancer+by+Inducing+Epithelial-Mesenchymal+Transition+Phenotypes+and+Stem+Cell+Features"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features</span></div><div class="casAuthors">Hu Min; Liao Yueling; Xu Dongliang; Song Hongyong; Wang Tong; Jing Bo; Li Kaimi; Deng Jiong; Hu Min; Liao Yueling; Xu Dongliang; Song Hongyong; Wang Tong; Jing Bo; Li Kaimi; Deng Jiong; Guo Wenzheng; Sun Beibei; Deng Jiong; Kuang Yanbin; Ling Jing; Yao Feng</div><div class="citationInfo"><span class="NLM_cas:title">American journal of cancer research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    </div><div class="casAbstract">Induction of cancer stem cell (CSC) characters and epithelial mesenchymal transition (EMT) features are crucial in tumor initiation, progression and metastasis.  However, underlying mechanisms remain incompletely understood.  Here, we showed that ENPP1 plays an important role in inducing and maintaining EMT phenotypes and CSC features in lung cancer.  ENPP1 is upregulated in lung cancer cells.  ENPP1-knockdown in lung cancer HCC827 cells and A549 cells resulted in suppressed colonogenic formation, anchorage-independent growth in vitro, and tumorigenicity in vivo.  ENPP1-knockdown also reduced expression of CSC makers, including ABCG2, SOX2, NANOG, and CD44.  Moreover, ENPP1-knockdown reversed TGFβ-induced EMT phenotypes, including cell migration, E-cadherin repression and vimentin induction.  Finally, upregulated ENPP1 was identified in majority of human lung tumor tissues compared to adjacent normal lung tissues.  Taken together, our study demonstrates that dysregulated ENPP1 contributes to increased malignancy of human lung cancer by inducing CSC-features, and EMT-like phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQc62oWEy_4I2y4bB4mnvYfW6udTcc2eZCPurvAyCMFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfis1eltg%253D%253D&md5=e857697b11c08fd08747598ba7cb70fc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DJing%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DJ.%26atitle%3DDysregulated%2520ENPP1%2520Increases%2520the%2520Malignancy%2520of%2520Human%2520Lung%2520Cancer%2520by%2520Inducing%2520Epithelial-Mesenchymal%2520Transition%2520Phenotypes%2520and%2520Stem%2520Cell%2520Features%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2019%26volume%3D9%26spage%3D134%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakehi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Molecular Characterization of a Novel Choline-Specific Glycerophosphodiester Phosphodiesterase Belonging to the Nucleotide Pyrophosphatase/Phosphodiesterase Family</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">23084</span>– <span class="NLM_lpage">23093</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413438200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1074%2Fjbc.M413438200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=15788404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVyhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23084-23093&author=H.+Sakagamiauthor=J.+Aokiauthor=Y.+Natoriauthor=K.+Nishikawaauthor=Y.+Kakehiauthor=Y.+Natoriauthor=H.+Arai&title=Biochemical+and+Molecular+Characterization+of+a+Novel+Choline-Specific+Glycerophosphodiester+Phosphodiesterase+Belonging+to+the+Nucleotide+Pyrophosphatase%2FPhosphodiesterase+Family&doi=10.1074%2Fjbc.M413438200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and Molecular Characterization of a Novel Choline-specific Glycerophosphodiester Phosphodiesterase Belonging to the Nucleotide Pyrophosphatase/Phosphodiesterase Family</span></div><div class="casAuthors">Sakagami, Hideki; Aoki, Junken; Natori, Yumiko; Nishikawa, Kiyotaka; Kakehi, Yoshiyuki; Natori, Yasuhiro; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">23084-23093</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatases/phosphodiesterases (NPPs) are ubiquitous membrane-assocd. or secreted ectoenzymes that release nucleoside 5'-monophosphate from a variety of nucleotides and nucleotide derivs.  The mammalian NPP family comprises seven members, but only three of these (NPP1-3) have been studied in some detail.  Previously we showed that lysophospholipase D, which hydrolyzes lysophosphatidylcholine (LPC) to produce lysophosphatidic acid, is identical to NPP2.  More recently an uncharacterized novel NPP member (NPP7) was shown to have alk. sphingomyelinase activity.  These findings raised the possibility that other members of the NPP family act on phospholipids.  Here we show that the sixth member of the NPP family, NPP6, is a choline-specific glycerophosphodiester phosphodiesterase.  The sequence of NPP6 encodes a transmembrane protein contg. an NPP domain with significant homol. to NPP4, NPP5, and NPP7/alk. sphingomyelinase.  When expressed in HeLa cells, NPP6 was detected in both the cells and the cell culture medium as judged by Western blotting and by enzymic activity.  Recombinant NPP6 efficiently hydrolyzed the classical substrate for phospholipase C, p-nitrophenyl phosphorylcholine, but not the classical nucleotide phosphodiesterase substrate, p-nitrophenyl thymidine 5'-monophosphate.  In addn., NPP6 hydrolyzed LPC to form monoacylglycerol and phosphorylcholine but not lysophosphatidic acid, showing it has a lysophospholipase C activity.  NPP6 showed a preference for LPC with short (12:0 and 14:0) or polyunsatd. (18:2 and 20:4) fatty acids.  It also hydrolyzed glycerophosphorylcholine and sphingosylphosphorylcholine efficiently.  In mice, NPP6 mRNA was predominantly detected in kidney with a lesser expression in brain and heart, and in human it was detected in kidney and brain.  The present results suggest that NPP6 has a specific role through the hydrolysis of polyunsatd. LPC, glycerophosphorylcholine, or sphingosylphosphorylcholine in these organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHQ_9JICt77Vg90H21EOLACvtfcHk0lh0k3i3RkKdkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVyhur4%253D&md5=21deb1792f7e76b3480289197466f146</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413438200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413438200%26sid%3Dliteratum%253Aachs%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNatori%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DKakehi%26aufirst%3DY.%26aulast%3DNatori%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DBiochemical%2520and%2520Molecular%2520Characterization%2520of%2520a%2520Novel%2520Choline-Specific%2520Glycerophosphodiester%2520Phosphodiesterase%2520Belonging%2520to%2520the%2520Nucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520Family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D23084%26epage%3D23093%26doi%3D10.1074%2Fjbc.M413438200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Fluorescence Probe for Lysophospholipase C/NPP6 Activity and a Potent NPP6 Inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">12021</span>– <span class="NLM_lpage">12030</span>, <span class="refDoi"> DOI: 10.1021/ja201028t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja201028t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVSku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=12021-12030&author=M.+Kawaguchiauthor=T.+Okabeauthor=S.+Okudairaauthor=K.+Hanaokaauthor=Y.+Fujikawaauthor=T.+Teraiauthor=T.+Komatsuauthor=H.+Kojimaauthor=J.+Aokiauthor=T.+Nagano&title=Fluorescence+Probe+for+Lysophospholipase+C%2FNPP6+Activity+and+a+Potent+NPP6+Inhibitor&doi=10.1021%2Fja201028t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence Probe for Lysophospholipase C/NPP6 Activity and a Potent NPP6 Inhibitor</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Okabe, Takayoshi; Okudaira, Shinichi; Hanaoka, Kenjiro; Fujikawa, Yuuta; Terai, Takuya; Komatsu, Toru; Kojima, Hirotatsu; Aoki, Junken; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12021-12030</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatases/phosphodiesterases (NPPs) are ubiquitous membrane-assocd. or secreted ectoenzymes that have a role in regulating extracellular nucleotide and phospholipid metab.  Among the members of the NPP family, NPP1 and -3 act on nucleotides such as ATP, while NPP2, -6, and -7 act on phospholipids such as lysophosphatidylcholine and sphingomyelin.  NPP6, a recently characterized NPP family member, is a choline-specific glycerophosphodiester phosphodiesterase, but its functions remain to be analyzed, partly due to the lack of highly sensitive activity assay systems and practical inhibitors.  Here we report synthesis of novel NPP6 fluorescence probes, TG-mPC and its analogs TG-mPC3C, TG-mPC5C, TG-mPENE, TG-mPEA, TG-mPhos, TG-mPA, TG-mPMe, and TG-mPPr.  Among the seven NPPs, only NPP6 hydrolyzed TG-mPC, TG-mPC3C, and TG-mPENE.  TG-mPC was hydrolyzed in the cell lysate from NPP6-transfected cells, but not control cells, showing that it is suitable for use in cell-based NPP6 assays.  We also examd. the usefulness of TG-mPC as a fluorescence imaging probe.  We further applied TG-mPC to carry out high-throughput NPP6 inhibitor screening and found several NPP6-selective inhibitors in a library of about 80 000 compds.  Through structure-activity relationship (SAR) anal., we identified a potent and selective NPP6 inhibitor with an IC50 value of 0.21 μM.  Our NPP6-selective fluorescence probe, TG-mPC, and the inhibitor are expected to be useful to elucidate the biol. function of NPP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6hKm4EqpmFrVg90H21EOLACvtfcHk0lh0k3i3RkKdkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVSku7k%253D&md5=3bbcd28152d54359aa6d8022de64cc08</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja201028t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja201028t%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DFujikawa%26aufirst%3DY.%26aulast%3DTerai%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DFluorescence%2520Probe%2520for%2520Lysophospholipase%2520C%252FNPP6%2520Activity%2520and%2520a%2520Potent%2520NPP6%2520Inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D12021%26epage%3D12030%26doi%3D10.1021%2Fja201028t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasheed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambreen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhary, M. I.</span></span> <span> </span><span class="NLM_article-title">1,3,4-Oxadiazole-2(3H)-thione and Its Analogues: a New Class of Non-Competitive Nucleotide Pyrophosphatases/Phosphodiesterases 1 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">7816</span>– <span class="NLM_lpage">–7822</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.bmc.2009.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=19822431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCrsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7816-%E2%80%937822&author=K.+M.+Khanauthor=N.+Fatimaauthor=M.+Rasheedauthor=S.+Jalilauthor=N.+Ambreenauthor=S.+Perveenauthor=M.+I.+Choudhary&title=1%2C3%2C4-Oxadiazole-2%283H%29-thione+and+Its+Analogues%3A+a+New+Class+of+Non-Competitive+Nucleotide+Pyrophosphatases%2FPhosphodiesterases+1+Inhibitors&doi=10.1016%2Fj.bmc.2009.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,4-Oxadiazole-2(3H)-thione and its analogues: A new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors</span></div><div class="casAuthors">Khan, Khalid M.; Fatima, Naheed; Rasheed, Maimona; Jalil, Saima; Ambreen, Nida; Perveen, Shahnaz; Choudhary, M. Iqbal</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7816-7822</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1,3,4-oxadiazole-2 (3H)-thiones and 1,3,4-thiadiazole-2 (3H)-thiones were evaluated for their inhibitory activities against the two nucleotide pyrophosphatase phosphodiesterase 1 enzymes.  Dixon, as well as Lineweaver-Burk plots, and their secondary replots have indicated that the inhibition was of pure non-competitive type, against both snake venom and pure human recombinant enzymes as the V max values decreases without affecting the K m values. 5-[4-(t-Butyldimethylsilyloxy)-phenyl]-1,3,4-thiadiazole-2 (3H)-thione (17) and [4-(t-butyldimethylsilyloxy)-phenyl]-1,3,4-oxadiazole-2 (3H)-thione (1) were found to be the most active compds. with IC50 values 66.47 and 368 μM, resp.  The K i values were 100 μM and 360 μM against the snake venom and human recombinant NPP1 enzyme, resp.  Most active compds. were found to be non-toxic in neutrophil viability assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKvy3RWj1pLVg90H21EOLACvtfcHk0lh0k3i3RkKdkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCrsb7N&md5=ee8117e86268c5596afd04b61ddca09f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DK.%2BM.%26aulast%3DFatima%26aufirst%3DN.%26aulast%3DRasheed%26aufirst%3DM.%26aulast%3DJalil%26aufirst%3DS.%26aulast%3DAmbreen%26aufirst%3DN.%26aulast%3DPerveen%26aufirst%3DS.%26aulast%3DChoudhary%26aufirst%3DM.%2BI.%26atitle%3D1%252C3%252C4-Oxadiazole-2%25283H%2529-thione%2520and%2520Its%2520Analogues%253A%2520a%2520New%2520Class%2520of%2520Non-Competitive%2520Nucleotide%2520Pyrophosphatases%252FPhosphodiesterases%25201%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7816%26epage%3D%25E2%2580%25937822%26doi%3D10.1016%2Fj.bmc.2009.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eliahu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigonnesse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lévesque, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Diadenosine 5′,5″-(Boranated)polyphosphonate Analogues as Selective Nucleotide Pyrophosphatase/Phosphodiesterase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8485</span>– <span class="NLM_lpage">8497</span>, <span class="refDoi"> DOI: 10.1021/jm100597c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100597c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8485-8497&author=S.+Eliahuauthor=J.+Leckaauthor=G.+Reiserauthor=M.+Haasauthor=F.+Bigonnesseauthor=S.+A.+L%C3%A9vesqueauthor=J.+Pelletierauthor=J.+S%C3%A9vignyauthor=B.+Fischer&title=Diadenosine+5%E2%80%B2%2C5%E2%80%B3-%28Boranated%29polyphosphonate+Analogues+as+Selective+Nucleotide+Pyrophosphatase%2FPhosphodiesterase+Inhibitors&doi=10.1021%2Fjm100597c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Diadenosine 5',5''-(Boranated)polyphosphonate Analogues as Selective Nucleotide Pyrophosphatase/Phosphodiesterase Inhibitors</span></div><div class="casAuthors">Eliahu, Shay; Lecka, Joanna; Reiser, Georg; Haas, Michael; Bigonnesse, Francois; Levesque, Sebastien A.; Pelletier, Julie; Sevigny, Jean; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8485-8497</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatase/phosphodiesterases (NPPs) hydrolyze extracellular nucleotides and dinucleotides and thus control purinergic signaling.  Enhanced NPP activity is implicated in health disorders such as osteoarthritis and cancer.  We designed novel diadenosine polyphosphonate derivs. as potential NPP inhibitors.  Analogs 1-4 bear a phosphonate and/or boranophosphate group and/or a 2'-H atom instead of a 2'-OH group.  In comparison to ATP, analogs 1-4 were barely hydrolyzed by human NTPDase1, -2, -3, and -8 (<5% hydrolysis) and NPP1 and -3 (≤13%) and were not hydrolyzed by ecto-5'-nucleotidase, unlike AMP.  These derivs. did not affect NTPDase activity, and analogs 1 and 2 did not inhibit ecto-5'-nucleotidase.  All analogs blocked ∼80% of the NPP2-dependent hydrolysis of pnp-TMP, a specific NPP substrate, and inhibited the catabolism of pnp-TMP (Ki and IC50 both found to be between 10 and 60 μM), Ap5A, and ATP by NPP1.  The activity of NPP3 was inhibited to a lesser extent by the new analogs, with compds. 1 and 4 being the most effective in that respect.  The analogs dramatically reduced the level of hydrolysis of pnp-TMP at the cell surface of both osteocarcinoma and colon cancer cells.  Importantly, analogs 1-4 exhibited significantly reduced agonistic activity toward human P2Y1,11 receptors (except for analog 1) and no activity with human P2Y2 receptor.  Our data provide strong evidence that analog 2 is the first specific NPP inhibitor to be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphntKHVUJrnbVg90H21EOLACvtfcHk0ljys1HA0Fvt1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGktbvE&md5=fcd1e3a2ac5714e5775bcae2ef1d4151</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100597c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100597c%26sid%3Dliteratum%253Aachs%26aulast%3DEliahu%26aufirst%3DS.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DHaas%26aufirst%3DM.%26aulast%3DBigonnesse%26aufirst%3DF.%26aulast%3DL%25C3%25A9vesque%26aufirst%3DS.%2BA.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DDiadenosine%25205%25E2%2580%25B2%252C5%25E2%2580%25B3-%2528Boranated%2529polyphosphonate%2520Analogues%2520as%2520Selective%2520Nucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8485%26epage%3D8497%26doi%3D10.1021%2Fjm100597c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-David, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simhaev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliahu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oscar, J.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyindula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">Nonhydrolyzable ATP Analogues as Selective Inhibitors of Human NPP1: a Combined Computational/Experimental Study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8308</span>– <span class="NLM_lpage">8320</span>, <span class="refDoi"> DOI: 10.1021/jm400918s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400918s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjtL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8308-8320&author=J.+Leckaauthor=G.+Ben-Davidauthor=L.+Simhaevauthor=S.+Eliahuauthor=J.+Oscarauthor=P.+Luyindulaauthor=J.+Pelletierauthor=B.+Fischerauthor=H.+Senderowitzauthor=J.+S%C3%A9vigny&title=Nonhydrolyzable+ATP+Analogues+as+Selective+Inhibitors+of+Human+NPP1%3A+a+Combined+Computational%2FExperimental+Study&doi=10.1021%2Fjm400918s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Nonhydrolyzable ATP Analogues as Selective Inhibitors of Human NPP1: A Combined Computational/Experimental Study</span></div><div class="casAuthors">Lecka, Joanna; Ben-David, Gal; Simhaev, Luba; Eliahu, Shay; Oscar, Jocelyn; Luyindula, Patrick; Pelletier, Julie; Fischer, Bilha; Senderowitz, Hanoch; Sevigny, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8308-8320</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Elevated nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) activity is implicated in health disorders including pathol. calcification.  Specific NPP1 inhibitors would therefore be valuable for studying this enzyme and as potential therapeutic agents.  Here we present a combined computational/exptl. study characterizing 13 nonhydrolyzable ATP analogs as selective human NPP1 inhibitors.  All analogs at 100 μM inhibited (66-99%) the hydrolysis of pnp-TMP by both recombinant NPP1 and cell surface NPP1 activity of osteocarcinoma (HTB-85) cells.  These analogs only slightly altered the activity of other ectonucleotidases, NPP3 and NTPDases.  The Ki,app values of the seven most potent and selective inhibitors were in the range of 0.5-56 μM, all with mixed type inhibition, predominantly competitive.  Those mols. were docked into a newly developed homol. model of human NPP1.  All adopted ATP-like binding modes, suggesting competitive inhibition with the endogenous ligand.  NPP1 selectivity vs. NPP3 could be explained in terms of the electrostatic potential of the two proteins that of NPP1 favoring neg. charged ligands.  Inhibitor 2 that had the lowest Ki,app (0.5 μM) was also inactive toward P2Y receptors.  Overall, analog 2 is the most potent and selective NPP1 inhibitor described so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1IlX9dJYJmbVg90H21EOLACvtfcHk0ljys1HA0Fvt1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjtL7P&md5=0f2c563bdbf44aceafe5c863e2ebcb3c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400918s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400918s%26sid%3Dliteratum%253Aachs%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DBen-David%26aufirst%3DG.%26aulast%3DSimhaev%26aufirst%3DL.%26aulast%3DEliahu%26aufirst%3DS.%26aulast%3DOscar%26aufirst%3DJ.%26aulast%3DLuyindula%26aufirst%3DP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3DNonhydrolyzable%2520ATP%2520Analogues%2520as%2520Selective%2520Inhibitors%2520of%2520Human%2520NPP1%253A%2520a%2520Combined%2520Computational%252FExperimental%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8308%26epage%3D8320%26doi%3D10.1021%2Fjm400918s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nadel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilad, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-David, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenigsberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisman, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Highly Potent and Selective Ectonucleotide Pyrophosphatase/Phosphodiesterase I Inhibitors Based on an Adenosine 5′-(α or γ)-Thio-(α,β- or β,γ)-methylenetriphosphate Scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4677</span>– <span class="NLM_lpage">–4691</span>, <span class="refDoi"> DOI: 10.1021/jm500196c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500196c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFOhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4677-%E2%80%934691&author=Y.+Nadelauthor=J.+Leckaauthor=Y.+Giladauthor=G.+Ben-Davidauthor=D.+F%C3%B6rsterauthor=G.+Reiserauthor=S.+Kenigsbergauthor=J.+Camdenauthor=G.+A.+Weismanauthor=H.+Senderowitzauthor=J.+S%C3%A9vignyauthor=B.+Fischer&title=Highly+Potent+and+Selective+Ectonucleotide+Pyrophosphatase%2FPhosphodiesterase+I+Inhibitors+Based+on+an+Adenosine+5%E2%80%B2-%28%CE%B1+or+%CE%B3%29-Thio-%28%CE%B1%2C%CE%B2-+or+%CE%B2%2C%CE%B3%29-methylenetriphosphate+Scaffold&doi=10.1021%2Fjm500196c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Selective Ectonucleotide Pyrophosphatase/Phosphodiesterase I Inhibitors Based on an Adenosine 5'-(α or γ)-Thio-(α,β- or β,γ)-methylenetriphosphate Scaffold</span></div><div class="casAuthors">Nadel, Yael; Lecka, Joanna; Gilad, Yocheved; Ben-David, Gal; Forster, Daniel; Reiser, Georg; Kenigsberg, Sarah; Camden, Jean; Weisman, Gary A.; Senderowitz, Hanoch; Sevigny, Jean; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4677-4691</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) activity is assocd. with chondrocalcinosis, osteoarthritis, and type 2 diabetes.  The potential of NPP1 inhibitors as therapeutic agents, and the scarceness of their structure-activity relationship, encouraged the authors to develop new NPP1 inhibitors.  Specifically, the authors synthesized ATP-α-thio-β,γ-CH2 (1), ATP-α-thio-β,γ-CCl2 (2), ATP-α-CH2-γ-thio (3), and 8-SH-ATP (4) and established their resistance to hydrolysis by NPP1,3 and NTPDase1,2,3,8 (<5% hydrolysis) (NTPDase = ectonucleoside triphosphate diphosphohydrolase).  Analogs 1-3 at 100 μM inhibited thymidine 5'-monophosphate p-nitrophenyl ester hydrolysis by NPP1 and NPP3 by >90% and 23-43%, resp., and only slightly affected (0-40%) hydrolysis of ATP by NTPDase1,2,3,8.  Analog 3 is the most potent NPP1 inhibitor currently known, Ki = 20 nM and IC50 = 0.39 μM.  Analog adenosine 5'-Pα-Thio-β,γ-(dichloromethylene)triphosphate (2a) is a selective NPP1 inhibitor with Ki = 685 nM and IC50 = 0.57 μM.  Analogs 1-3 were found mostly to be non-agonists of P2Y1/P2Y2/P2Y11 receptors.  Docking analogs 1-3 into the NPP1 model suggested that activity correlates with the no. of H-bonds with binding site residues.  In conclusion, the authors propose analogs 2a and 3 as highly promising NPP1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWOOTCi6AzlLVg90H21EOLACvtfcHk0ljys1HA0Fvt1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFOhtb4%253D&md5=5a379536437d324b53aa7a059fce9c65</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm500196c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500196c%26sid%3Dliteratum%253Aachs%26aulast%3DNadel%26aufirst%3DY.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DGilad%26aufirst%3DY.%26aulast%3DBen-David%26aufirst%3DG.%26aulast%3DF%25C3%25B6rster%26aufirst%3DD.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DKenigsberg%26aufirst%3DS.%26aulast%3DCamden%26aufirst%3DJ.%26aulast%3DWeisman%26aufirst%3DG.%2BA.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DHighly%2520Potent%2520and%2520Selective%2520Ectonucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520I%2520Inhibitors%2520Based%2520on%2520an%2520Adenosine%25205%25E2%2580%25B2-%2528%25CE%25B1%2520or%2520%25CE%25B3%2529-Thio-%2528%25CE%25B1%252C%25CE%25B2-%2520or%2520%25CE%25B2%252C%25CE%25B3%2529-methylenetriphosphate%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4677%26epage%3D%25E2%2580%25934691%26doi%3D10.1021%2Fjm500196c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonczak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridine- and Purine-Thioacetamide Derivatives: Potent Inhibitors of Nucleotide Pyrophosphatase/Phosphodiesterase 1 (NPP1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10080</span>– <span class="NLM_lpage">10100</span>, <span class="refDoi"> DOI: 10.1021/jm501434y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501434y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKmsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10080-10100&author=L.+Changauthor=S.+Y.+Leeauthor=P.+Leonczakauthor=J.+Rozenskiauthor=S.+De+Jongheauthor=T.+Hanckauthor=C.+E.+M%C3%BCllerauthor=P.+Herdewijn&title=Imidazopyridine-+and+Purine-Thioacetamide+Derivatives%3A+Potent+Inhibitors+of+Nucleotide+Pyrophosphatase%2FPhosphodiesterase+1+%28NPP1%29&doi=10.1021%2Fjm501434y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazopyridine- and Purine-Thioacetamide Derivatives: Potent Inhibitors of Nucleotide Pyrophosphatase/Phosphodiesterase 1 (NPP1)</span></div><div class="casAuthors">Chang, Lei; Lee, Sang-Yong; Leonczak, Piotr; Rozenski, Jef; De Jonghe, Steven; Hanck, Theodor; Muller, Christa E.; Herdewijn, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10080-10100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) belongs to the family of ecto-nucleotidases, which control extracellular nucleotide, nucleoside, and (di)phosphate levels.  To study the (patho)physiol. roles of NPP1 potent and selective inhibitors with drug-like properties are required.  Therefore, a compd. library was screened for NPP1 inhibitors using a colorimetric assay with p-nitrophenyl 5'-thymidine monophosphate (p-Nph-5'-TMP) as an artificial substrate.  This led to the discovery of 2-(3H-imidazo[4,5-b]pyridin-2-ylthio)-N-(3,4-dimethoxyphenyl)acetamide (5a) as a hit compd. with a Ki value of 217 nM.  Subsequent structure-activity relationship studies led to the development of purine and imidazo[4,5-b]pyridine analogs with high inhibitory potency (Ki values of 5.00 nM and 29.6 nM, resp.) when assayed with p-Nph-5'-TMP as a substrate.  Surprisingly, the compds. were significantly less potent when tested vs. ATP as a substrate, with Ki values in the low micromolar range.  A prototypic inhibitor was investigated for its mechanism of inhibition and found to be competitive vs. both substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1oH5noS-80LVg90H21EOLACvtfcHk0lhg4DxOX8thDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmsb7O&md5=62c4add9c4e430b0c5a5d5efbbe54117</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501434y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501434y%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DLeonczak%26aufirst%3DP.%26aulast%3DRozenski%26aufirst%3DJ.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DHanck%26aufirst%3DT.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DHerdewijn%26aufirst%3DP.%26atitle%3DImidazopyridine-%2520and%2520Purine-Thioacetamide%2520Derivatives%253A%2520Potent%2520Inhibitors%2520of%2520Nucleotide%2520Pyrophosphatase%252FPhosphodiesterase%25201%2520%2528NPP1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10080%26epage%3D10100%26doi%3D10.1021%2Fjm501434y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Nucleotide Pyrophosphatase/Phosphodiesterase 1 (NPP1) and Its Inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1039/C7MD00015D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1039%2FC7MD00015D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30108800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=823-840&author=S.+Y.+Leeauthor=C.+E.+M%C3%BCller&title=Nucleotide+Pyrophosphatase%2FPhosphodiesterase+1+%28NPP1%29+and+Its+Inhibitors&doi=10.1039%2FC7MD00015D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors</span></div><div class="casAuthors">Lee, Sang-Yong; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-840</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1, EC 3.1.4.1) is a metalloenzyme that belongs to the NPP family, which comprises seven subtypes (NPP1-7).  NPP1 hydrolyzes a wide range of phosphodiester bonds, e.g. in nucleoside triphosphates, (cyclic) dinucleotides, and nucleotide sugars yielding nucleoside 5'-monophosphates as products.  Its main substrate is ATP which is cleaved to AMP and diphosphate.  The enzyme is involved in various biol. processes including bone mineralization, soft-tissue calcification, insulin receptor signalling, cancer cell proliferation and immune modulation.  Therefore, NPP1 inhibitors have potential as novel drugs, e.g. for (immuno)oncol.  In the last two decades several inhibitors of NPP1 derived from nucleotide- or non-nucleotide scaffolds have been developed.  The most potent and selective NPP1-inhibitory substrate analog is adenosine 5'-α,β-methylene-γ-thiotriphosphate (Ki = 20 nM vs. p-Nph-5'-TMP, human membrane-bound NPP1).  Non-nucleotide-derived NPP1 inhibitors comprise polysulfonates, polysaccharides, polyoxometalates and small heterocyclic compds.  The polyoxometalate [TiW11CoO40]8- (PSB-POM141) is the most potent and selective NPP1 inhibitor described to date (Ki = 1.46 nM vs. ATP, human sol. NPP1); it displays an allosteric mechanism of inhibition and represents a useful pharmacol. tool for evaluating the potential of NPP1 as a novel drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYX4x_-RuSKbVg90H21EOLACvtfcHk0lhg4DxOX8thDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D&md5=59169b98f5f53799ae43cde20df7c000</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC7MD00015D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00015D%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DNucleotide%2520Pyrophosphatase%252FPhosphodiesterase%25201%2520%2528NPP1%2529%2520and%2520Its%2520Inhibitors%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D823%26epage%3D840%26doi%3D10.1039%2FC7MD00015D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zelikman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simhaev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sela, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arguin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5′-P<sub>α,α</sub>-Dithiophosphate Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3939</span>– <span class="NLM_lpage">–3951</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVaht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3939-%E2%80%933951&author=V.+Zelikmanauthor=J.+Pelletierauthor=L.+Simhaevauthor=A.+Selaauthor=F.+P.+Gendronauthor=G.+Arguinauthor=H.+Senderowitzauthor=J.+S%C3%A9vignyauthor=B.+Fischer&title=Highly+Selective+and+Potent+Ectonucleotide+Pyrophosphatase-1+%28NPP1%29+Inhibitors+Based+on+Uridine+5%E2%80%B2-P%CE%B1%2C%CE%B1-Dithiophosphate+Analogues&doi=10.1021%2Facs.jmedchem.7b01906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-Pα,α-Dithiophosphate Analogues</span></div><div class="casAuthors">Zelikman, Vadim; Pelletier, Julie; Simhaev, Luba; Sela, Aviad; Gendron, Fernand-Pierre; Arguin, Guillaume; Senderowitz, Hanoch; Sevigny, Jean; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3939-3951</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) hydrolyzes phosphodiester bonds of nucleotides such as ATP, resulting mainly in the formation of AMP and pyrophosphate.  NPP1 activity plays a deleterious function in calcified aortic valve disease and calcium pyrophosphate deposition disease.  Thus, inhibitors of NPP1 represent a medical need.  We developed novel NPP1 inhibitors based on uridine 5'-Pα,α-dithiophosphate analogs, 9-12.  All these analogs potently inhibited hNPP1 (80-100% inhibition) at 100 μM, with no, or minimal, inhibition of NPP3 and other ectonucleotidases (NTPDase1,2,3,8).  These compds. showed nearly no activity at uracil-nucleotide sensitive P2Y2,4,6-receptors and thus represent highly selective NPP1 inhibitors.  The most promising inhibitor was diuridine 5'-Pα,α,5''-Pα,α-tetrathiotetraphosphate, 12, exhibiting Ki of 27 nM.  Analogs 9-12 proved to be highly stable to air oxidn. and to acidic and basic pH.  Docking simulations suggested that the enhanced NPP1 inhibitory activity and selectivity of analog 12 could be attributed to the simultaneous occupancy of two sites (the AMP site and an alternative site) of NPP1 by this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooyDIcZpImjLVg90H21EOLACvtfcHk0lhg4DxOX8thDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVaht74%253D&md5=1e25944172b3f431e854527d2360b4f6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01906%26sid%3Dliteratum%253Aachs%26aulast%3DZelikman%26aufirst%3DV.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSimhaev%26aufirst%3DL.%26aulast%3DSela%26aufirst%3DA.%26aulast%3DGendron%26aufirst%3DF.%2BP.%26aulast%3DArguin%26aufirst%3DG.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DHighly%2520Selective%2520and%2520Potent%2520Ectonucleotide%2520Pyrophosphatase-1%2520%2528NPP1%2529%2520Inhibitors%2520Based%2520on%2520Uridine%25205%25E2%2580%25B2-P%25CE%25B1%252C%25CE%25B1-Dithiophosphate%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3939%26epage%3D%25E2%2580%25933951%26doi%3D10.1021%2Facs.jmedchem.7b01906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Screening and X-ray Crystal Structure-Based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1713</span>– <span class="NLM_lpage">1721</span>, <span class="refDoi"> DOI: 10.1021/cb400150c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400150c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1713-1721&author=M.+Kawaguchiauthor=T.+Okabeauthor=S.+Okudairaauthor=H.+Nishimasuauthor=R.+Ishitaniauthor=H.+Kojimaauthor=O.+Nurekiauthor=J.+Aokiauthor=T.+Nagano&title=Screening+and+X-ray+Crystal+Structure-Based+Optimization+of+Autotaxin+%28ENPP2%29+Inhibitors%2C+Using+a+Newly+Developed+Fluorescence+Probe&doi=10.1021%2Fcb400150c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and X-ray Crystal Structure-based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Okabe, Takayoshi; Okudaira, Shinichi; Nishimasu, Hiroshi; Ishitani, Ryuichiro; Kojima, Hirotatsu; Nureki, Osamu; Aoki, Junken; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1713-1721</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), was originally identified as a tumor cell autocrine motility factor and is identical to plasma lysophospholipase D, which is the predominant contributor to lysophosphatidic acid (LPA) prodn. from lysophospholipids.  ATX is therefore considered to regulate the physiol. and pathol. roles of LPA, including angiogenesis, lymphocyte trafficking, tissue fibrosis, and cancer cell invasion and metastasis.  Thus, it is a potential therapeutic target.  Here, the authors first developed a sensitive and specific ATX fluorescence probe, TG-mTMP, and used it to screen ATX inhibitors in a large chem. library.  This probe, which is superior to previously available probes FS-3 and CPF4 in terms of sensitivity or specificity, enabled the authors to identify several novel ATX inhibitor scaffolds.  The authors solved the crystal structures of ATX complexes with the hit compds. at high resoln. (1.75-1.95 Å) and used this information to guide optimization of the structure of a selected inhibitor.  The optimized compds., 3BoA and its derivs., exhibited potent ATX-inhibitory activity both in vitro and in vivo.  These inhibitors are expected to be useful tools to understand the roles of ATX in vitro and in vivo and may also be candidate anti-ATX therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-DjhUd2uXULVg90H21EOLACvtfcHk0lgfalm5c4pi9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVKgsLY%253D&md5=fdd7e4fcad2cda139edb17673fc4c829</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcb400150c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400150c%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DNureki%26aufirst%3DO.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DScreening%2520and%2520X-ray%2520Crystal%2520Structure-Based%2520Optimization%2520of%2520Autotaxin%2520%2528ENPP2%2529%2520Inhibitors%252C%2520Using%2520a%2520Newly%2520Developed%2520Fluorescence%2520Probe%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1713%26epage%3D1721%26doi%3D10.1021%2Fcb400150c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Evolution of Fluorescein as a Platform for Finely Tunable Fluorescence Probes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">4888</span>– <span class="NLM_lpage">4894</span>, <span class="refDoi"> DOI: 10.1021/ja043919h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja043919h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVyntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=4888-4894&author=Y.+Uranoauthor=M.+Kamiyaauthor=K.+Kandaauthor=T.+Uenoauthor=K.+Hiroseauthor=T.+Nagano&title=Evolution+of+Fluorescein+as+a+Platform+for+Finely+Tunable+Fluorescence+Probes&doi=10.1021%2Fja043919h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of fluorescein as a platform for finely tunable fluorescence probes</span></div><div class="casAuthors">Urano, Yasuteru; Kamiya, Mako; Kanda, Kojiro; Ueno, Tasuku; Hirose, Kenzo; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4888-4894</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fluorescence imaging is the most powerful technique currently available for continuous observation of dynamic intracellular processes in living cells.  Suitable fluorescence probes are naturally of crit. importance for fluorescence imaging, but only a very limited range of biomols. can currently be visualized because of the lack of flexible design strategies for fluorescence probes.  At present, design is largely empirical.  Here we show that the carboxylic group of traditional fluorescein dyes, formerly considered indispensable, has been replaced with other substituents, affording various kinds of new fluoresceins.  Further, by breaking out of the traditional structure of fluorescein, we developed the first and totally rational design strategy for novel fluorescence probes based on a strict photochem. basis.  The value of this approach is exemplified by its application to develop a novel, highly sensitive, and membrane-permeable fluorescence probe for β-galactosidase, which is the most widely used reporter enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqopW9kkNKKgrVg90H21EOLACvtfcHk0lgfalm5c4pi9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVyntLc%253D&md5=a9e9ad6046baac2efa11b078786bb26c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja043919h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja043919h%26sid%3Dliteratum%253Aachs%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DKamiya%26aufirst%3DM.%26aulast%3DKanda%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DK.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DEvolution%2520of%2520Fluorescein%2520as%2520a%2520Platform%2520for%2520Finely%2520Tunable%2520Fluorescence%2520Probes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D4888%26epage%3D4894%26doi%3D10.1021%2Fja043919h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata-Ninomiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurashima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karasuyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span> <span> </span><span class="NLM_article-title">The Ectoenzyme E-NPP3 Negatively Regulates ATP-Dependent Chronic Allergic Responses by Basophils and Mast Cells</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2015.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.immuni.2015.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=25692702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=279-293&author=S.+H.+Tsaiauthor=M.+Kinoshitaauthor=T.+Kusuauthor=H.+Kayamaauthor=R.+Okumuraauthor=K.+Ikedaauthor=Y.+Shimadaauthor=A.+Takedaauthor=S.+Yoshikawaauthor=K.+Obata-Ninomiyaauthor=Y.+Kurashimaauthor=S.+Satoauthor=E.+Umemotoauthor=H.+Kiyonoauthor=H.+Karasuyamaauthor=K.+Takeda&title=The+Ectoenzyme+E-NPP3+Negatively+Regulates+ATP-Dependent+Chronic+Allergic+Responses+by+Basophils+and+Mast+Cells&doi=10.1016%2Fj.immuni.2015.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The Ectoenzyme E-NPP3 Negatively Regulates ATP-Dependent Chronic Allergic Responses by Basophils and Mast Cells</span></div><div class="casAuthors">Tsai, Shih Han; Kinoshita, Makoto; Kusu, Takashi; Kayama, Hisako; Okumura, Ryu; Ikeda, Kayo; Shimada, Yosuke; Takeda, Akira; Yoshikawa, Soichiro; Obata-Ninomiya, Kazushige; Kurashima, Yosuke; Sato, Shintaro; Umemoto, Eiji; Kiyono, Hiroshi; Karasuyama, Hajime; Takeda, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-293</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Crosslinking of the Ig receptor FcεRI activates basophils and mast cells to induce immediate and chronic allergic inflammation.  However, it remains unclear how the chronic allergic inflammation is regulated.  Here, we showed that ecto-nucleotide pyrophosphatase-phosphodiesterase 3 (E-NPP3), also known as CD203c, rapidly induced by FcεRI crosslinking, neg. regulated chronic allergic inflammation.  Basophil and mast cell nos. increased in Enpp3-/- mice with augmented serum ATP concns.  Enpp3-/- mice were highly sensitive to chronic allergic pathologies, which was reduced by ATP blockade.  FcεRI crosslinking induced ATP secretion from basophils and mast cells, and ATP activated both cells.  ATP clearance was impaired in Enpp3-/- cells.  Enpp3-/-P2rx7-/- mice showed decreased responses to FcεRI crosslinking.  Thus, ATP released by FcεRI crosslinking stimulates basophils and mast cells for further activation causing allergic inflammation.  E-NPP3 decreases ATP concn. and suppresses basophil and mast cell activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQtIKaELo5LVg90H21EOLACvtfcHk0lgfalm5c4pi9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSks7c%253D&md5=7339a66746243af611100875ee1ddfb1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2015.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2015.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DS.%2BH.%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DKusu%26aufirst%3DT.%26aulast%3DKayama%26aufirst%3DH.%26aulast%3DOkumura%26aufirst%3DR.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DObata-Ninomiya%26aufirst%3DK.%26aulast%3DKurashima%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DUmemoto%26aufirst%3DE.%26aulast%3DKiyono%26aufirst%3DH.%26aulast%3DKarasuyama%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26atitle%3DThe%2520Ectoenzyme%2520E-NPP3%2520Negatively%2520Regulates%2520ATP-Dependent%2520Chronic%2520Allergic%2520Responses%2520by%2520Basophils%2520and%2520Mast%2520Cells%26jtitle%3DImmunity%26date%3D2015%26volume%3D42%26spage%3D279%26epage%3D293%26doi%3D10.1016%2Fj.immuni.2015.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Enpp1, an Extracellular Glycoprotein Involved in Bone Mineralization and Insulin Signaling</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16876</span>– <span class="NLM_lpage">16881</span>, <span class="refDoi"> DOI: 10.1073/pnas.1208017109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1073%2Fpnas.1208017109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23027977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16876-16881&author=K.+Katoauthor=H.+Nishimasuauthor=S.+Okudairaauthor=E.+Miharaauthor=R.+Ishitaniauthor=J.+Takagiauthor=J.+Aokiauthor=O.+Nureki&title=Crystal+Structure+of+Enpp1%2C+an+Extracellular+Glycoprotein+Involved+in+Bone+Mineralization+and+Insulin+Signaling&doi=10.1073%2Fpnas.1208017109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling</span></div><div class="casAuthors">Kato, Kazuki; Nishimasu, Hiroshi; Okudaira, Shinichi; Mihara, Emiko; Ishitani, Ryuichiro; Takagi, Junichi; Aoki, Junken; Nureki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16876-16881, S16876/1-S16876/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Enpp1 is a membrane-bound glycoprotein that regulates bone mineralization by hydrolyzing extracellular nucleotide triphosphates to produce pyrophosphate.  Enpp1 dysfunction causes human diseases characterized by ectopic calcification.  Enpp1 also inhibits insulin signaling, and an Enpp1 polymorphism is assocd. with insulin resistance.  However, the precise mechanism by which Enpp1 functions in these cellular processes remains elusive.  Here, we report the crystal structures of the extracellular region of mouse Enpp1 in complex with four different nucleotide monophosphates, at resolns. of 2.7-3.2 Å.  The nucleotides are accommodated in a pocket formed by an insertion loop in the catalytic domain, explaining the preference of Enpp1 for an ATP substrate.  Structural mapping of disease-assocd. mutations indicated the functional importance of the interdomain interactions.  A structural comparison of Enpp1 with Enpp2, a lysophospholipase D, revealed marked differences in the domain arrangements and active-site architectures.  Notably, the Enppl mutant lacking the insertion loop lost the nucleotide-hydrolyzing activity but instead gained the lysophospholipid-hydrolyzing activity of Enpp2.  Our findings provide structural insights into how the Enpp family proteins evolved to exert their diverse cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox0R6ZUOJBc7Vg90H21EOLACvtfcHk0lj18twGMKbYGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WksL7F&md5=ae06fa446ff3041f42b35cc9d0cc1a94</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1208017109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1208017109%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DCrystal%2520Structure%2520of%2520Enpp1%252C%2520an%2520Extracellular%2520Glycoprotein%2520Involved%2520in%2520Bone%2520Mineralization%2520and%2520Insulin%2520Signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D16876%26epage%3D16881%26doi%3D10.1073%2Fpnas.1208017109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominsky, S. L.</span></span> <span> </span><span class="NLM_article-title">Enpp1: a Potential Facilitator of Breast Cancer Bone Metastasis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e66752</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0066752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1371%2Fjournal.pone.0066752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23861746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKktL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e66752&author=W.+M.+Lauauthor=M.+Doucetauthor=R.+Stadelauthor=D.+Huangauthor=K.+L.+Weberauthor=S.+L.+Kominsky&title=Enpp1%3A+a+Potential+Facilitator+of+Breast+Cancer+Bone+Metastasis&doi=10.1371%2Fjournal.pone.0066752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Enpp1: a potential facilitator of breast cancer bone metastasis</span></div><div class="casAuthors">Lau, Wen Min; Doucet, Michele; Stadel, Ryan; Huang, David; Weber, Kristy L.; Kominsky, Scott L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e66752</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Bone is the most common site of breast cancer metastasis and once established, it is frequently incurable.  Crit. to our ability to prevent and treat bone metastasis is the identification of the key factors mediating its establishment and understanding their biol. function.  To address this issue we previously carried out an in vivo selection process to isolate murine mammary tumor sublines possessing an enhanced ability to colonize the bone.  A comparison of gene expression between parental cells and sublines by genome-wide cDNA microarray anal. revealed several potential mediators of bone metastasis, including the pyrophosphate-generating ectoenzyme Enpp1.  By qRT-PCR and Western anal. we found that expression of Enpp1 was elevated in human breast cancer cell lines known to produce bone metastasis in animal models compared to non-metastatic and normal mammary epithelial cell lines.  Further, in clin. specimens, levels of Enpp1 were significantly elevated in human primary breast tumors relative to normal mammary epithelium, with highest levels obsd. in breast-bone metastasis as detd. by qRT-PCR and immunohistochem. anal.  To examine the potential role of Enpp1 in the development of bone metastasis, Enpp1 expression was stably increased in the breast cancer cell line MDA-MB-231 and the ability to colonize the bone following intracardiac and direct intratibial injection of athymic nude mice was detd.  By both routes of administration, increased expression of Enpp1 enhanced the ability of MDA-MB-231 cells to form tumors in the bone relative to cells expressing vector alone, as detd. by digital radiog. and histol. anal.  Taken together, these data suggest a potential role for Enpp1 in the development of breast cancer bone metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNHWinX3-OSrVg90H21EOLACvtfcHk0lj18twGMKbYGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKktL3F&md5=8c7822315a968b59ee44d97ec1b25da2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0066752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0066752%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DW.%2BM.%26aulast%3DDoucet%26aufirst%3DM.%26aulast%3DStadel%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DWeber%26aufirst%3DK.%2BL.%26aulast%3DKominsky%26aufirst%3DS.%2BL.%26atitle%3DEnpp1%253A%2520a%2520Potential%2520Facilitator%2520of%2520Breast%2520Cancer%2520Bone%2520Metastasis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De66752%26doi%3D10.1371%2Fjournal.pone.0066752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grobben, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slegers, H.</span></span> <span> </span><span class="NLM_article-title">Rat C6 Glioma as Experimental Model System for the Study of Glioblastoma Growth and Invasion</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1007/s00441-002-0651-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1007%2Fs00441-002-0651-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=12457224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2002&pages=257-270&author=B.+Grobbenauthor=P.+P.+De+Deynauthor=H.+Slegers&title=Rat+C6+Glioma+as+Experimental+Model+System+for+the+Study+of+Glioblastoma+Growth+and+Invasion&doi=10.1007%2Fs00441-002-0651-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion</span></div><div class="casAuthors">Grobben, Bert; De Deyn, Peter Paul; Slegers, Herman</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-270</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  Infiltration of the central nervous system by neoplastic cells in patients with glioblastoma multiforme (GBM) leads to neurol. dysfunction and eventually to death.  The elucidation of the mechanisms underlying the aggressive nature of GBM aims at improving radio-, chemo- and gene therapy.  This review is focused on the use of rat C6 glioma as an exptl. model system for GBM and provides an overview of the exptl. data published in the literature using this cell line in elucidating the mechanism of tumor growth, angiogenesis and invasion, and in the design and evaluation of anticancer therapies.  Understanding the stages of malignant brain tumor progression requires a series of exptl. approaches with a varying degree of complexity.  Implantation of malignant cells into animal brain tissue closely resembles in vivo tumor growth and has the advantage over simplified models that inflammatory and vascular mechanisms are activated.  However, the complexity of these models makes it difficult to identify the individual processes involved in sustained tumor growth, angiogenesis and invasion.  In cell culture models, the effect of growth factors, extracellular matrix components, proteases and adhesion mols. can be investigated.  The secretion of tumor-derived factors into the medium can also be analyzed when simplified models are used.  This review is a compilation of exptl. data focused on the characterization of tumor-related processes and on the evaluation of new therapies for the treatment of malignant glial neoplasms using rat C6 glioma as a model system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhBTbKj6JnbVg90H21EOLACvtfcHk0lj18twGMKbYGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cruw%253D%253D&md5=e3745b59b0a152ded9784a09647d47cb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs00441-002-0651-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-002-0651-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrobben%26aufirst%3DB.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26aulast%3DSlegers%26aufirst%3DH.%26atitle%3DRat%2520C6%2520Glioma%2520as%2520Experimental%2520Model%2520System%2520for%2520the%2520Study%2520of%2520Glioblastoma%2520Growth%2520and%2520Invasion%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2002%26volume%3D310%26spage%3D257%26epage%3D270%26doi%3D10.1007%2Fs00441-002-0651-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Development of a Highly Selective Fluorescence Probe for Alkaline Phosphatase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5088</span>– <span class="NLM_lpage">5091</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.bmcl.2011.03.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=21482108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaisLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5088-5091&author=M.+Kawaguchiauthor=K.+Hanaokaauthor=T.+Komatsuauthor=T.+Teraiauthor=T.+Nagano&title=Development+of+a+Highly+Selective+Fluorescence+Probe+for+Alkaline+Phosphatase&doi=10.1016%2Fj.bmcl.2011.03.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a highly selective fluorescence probe for alkaline phosphatase</span></div><div class="casAuthors">Kawaguchi, Mitsuyasu; Hanaoka, Kenjiro; Komatsu, Toru; Terai, Takuya; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5088-5091</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed the first highly selective fluorescence probe for alk. phosphatase (ALP), TG-mPhos.  This probe shows selectivity for ALP over protein tyrosine phosphatase and protein serine/threonine phosphatase.  Our previously developed TG-Phos, which has a phenolic phosphate linkage in place of the alc. phosphate linkage of TG-mPhos, lacks this selectivity.  TG-mPhos should enable precise fluorescence imaging of ALP activity in biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVyaOhwpX_LVg90H21EOLACvtfcHk0lj18twGMKbYGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaisLrJ&md5=8f795af8c6009bb3fd2382f9e058aa1c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DT.%26aulast%3DTerai%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520a%2520Highly%2520Selective%2520Fluorescence%2520Probe%2520for%2520Alkaline%2520Phosphatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5088%26epage%3D5091%26doi%3D10.1016%2Fj.bmcl.2011.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Acker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyten, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Structure of NPP1, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Involved in Tissue Calcification</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1016%2Fj.str.2012.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=23041369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKrtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1948-1959&author=S.+Jansenauthor=A.+Perrakisauthor=C.+Ulensauthor=C.+Winklerauthor=M.+Andriesauthor=R.+P.+Joostenauthor=M.+Van+Ackerauthor=F.+P.+Luytenauthor=W.+H.+Moolenaarauthor=M.+Bollen&title=Structure+of+NPP1%2C+an+Ectonucleotide+Pyrophosphatase%2FPhosphodiesterase+Involved+in+Tissue+Calcification&doi=10.1016%2Fj.str.2012.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of NPP1, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Involved in Tissue Calcification</span></div><div class="casAuthors">Jansen, Silvia; Perrakis, Anastassis; Ulens, Chris; Winkler, Claudia; Andries, Maria; Joosten, Robbie P.; Van Acker, Maarten; Luyten, Frank P.; Moolenaar, Wouter H.; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1959</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) converts extracellular nucleotides into inorg. pyrophosphate, whereas its close relative NPP2/autotaxin hydrolyzes lysophospholipids.  NPP1 regulates calcification in mineralization-competent tissues, and a lack of NPP1 function underlies calcification disorders.  Here, we show that NPP1 forms homodimers via intramembrane disulfide bonding, but is also processed intracellularly to a secreted monomer.  The structure of secreted NPP1 reveals a characteristic bimetallic active site and a nucleotide-binding groove, but it lacks the lipid-binding pocket and open tunnel present in NPP2.  A loop adjacent to the nucleotide-binding site, which is disordered in NPP2, is well ordered in NPP1 and might promote nucleotide binding.  Remarkably, the N-terminal somatomedin B-like domains of NPP1, unlike those in NPP2, are flexible and do not contact the catalytic domain.  Our results provide a structural basis for the nucleotide pyrophosphatase activity of NPP1 and help to understand how disease-causing mutations may affect NPP1 structure and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYawdR58GvWbVg90H21EOLACvtfcHk0lgQ9Qu18lXWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKrtbvM&md5=ea22feb6c6d2d047b6d8780fd2c54a17</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DS.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DUlens%26aufirst%3DC.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DAndries%26aufirst%3DM.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DVan%2BAcker%26aufirst%3DM.%26aulast%3DLuyten%26aufirst%3DF.%2BP.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DStructure%2520of%2520NPP1%252C%2520an%2520Ectonucleotide%2520Pyrophosphatase%252FPhosphodiesterase%2520Involved%2520in%2520Tissue%2520Calcification%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D1948%26epage%3D1959%26doi%3D10.1016%2Fj.str.2012.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oikawa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuya, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span> <span> </span><span class="NLM_article-title">Structural Insights into cGAMP Degradation by Ecto-Nucleotide Pyrophosphatase Phosphodiesterase 1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4424</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06922-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1038%2Fs41467-018-06922-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=30356045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADC%252BB3cvivVWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4424&author=K.+Katoauthor=H.+Nishimasuauthor=D.+Oikawaauthor=S.+Hiranoauthor=H.+Hiranoauthor=G.+Kasuyaauthor=R.+Ishitaniauthor=F.+Tokunagaauthor=O.+Nureki&title=Structural+Insights+into+cGAMP+Degradation+by+Ecto-Nucleotide+Pyrophosphatase+Phosphodiesterase+1&doi=10.1038%2Fs41467-018-06922-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1</span></div><div class="casAuthors">Kato Kazuki; Nishimasu Hiroshi; Hirano Seiichi; Hirano Hisato; Kasuya Go; Ishitani Ryuichiro; Nureki Osamu; Oikawa Daisuke; Tokunaga Fuminori</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">ENPP1 (Ecto-nucleotide pyrophosphatase phosphodiesterase 1), a type II transmembrane glycoprotein, hydrolyzes ATP to produce AMP and diphosphate, thereby inhibiting bone mineralization.  A recent study showed that ENPP1 also preferentially hydrolyzes 2'3'-cGAMP (cyclic GMP-AMP) but not its linkage isomer 3'3'-cGAMP, and negatively regulates the cGAS-STING pathway in the innate immune system.  Here, we present the high-resolution crystal structures of ENPP1 in complex with 3'3'-cGAMP and the reaction intermediate pA(3',5')pG.  The structures revealed that the adenine and guanine bases of the dinucleotides are recognized by nucleotide- and guanine-pockets, respectively.  Furthermore, the structures indicate that 2'3'-cGAMP, but not 3'3'-cGAMP, binds to the active site in a conformation suitable for catalysis, thereby explaining the specific degradation of 2'3'-cGAMP by ENPP1.  Our findings provide insights into how ENPP1 hydrolyzes both ATP and cGAMP to participate in the two distinct biological processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMhgmGs8bVbxKDYG3bNImrfW6udTcc2easzlP01WDLDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvivVWjsQ%253D%253D&md5=09b877db90b775fab733e5e301bb9fb1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06922-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06922-7%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNishimasu%26aufirst%3DH.%26aulast%3DOikawa%26aufirst%3DD.%26aulast%3DHirano%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DH.%26aulast%3DKasuya%26aufirst%3DG.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DTokunaga%26aufirst%3DF.%26aulast%3DNureki%26aufirst%3DO.%26atitle%3DStructural%2520Insights%2520into%2520cGAMP%2520Degradation%2520by%2520Ecto-Nucleotide%2520Pyrophosphatase%2520Phosphodiesterase%25201%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4424%26doi%3D10.1038%2Fs41467-018-06922-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allred, D. C.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Status by Immunohistochemistry is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1474</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1200/JCO.1999.17.5.1474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10.1200%2FJCO.1999.17.5.1474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=10334533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;key=1%3ACAS%3A280%3ADyaK1M3msFOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=1474-1481&author=J.+M.+Harveyauthor=G.+M.+Clarkauthor=C.+K.+Osborneauthor=D.+C.+Allred&title=Estrogen+Receptor+Status+by+Immunohistochemistry+is+Superior+to+the+Ligand-Binding+Assay+for+Predicting+Response+to+Adjuvant+Endocrine+Therapy+in+Breast+Cancer&doi=10.1200%2FJCO.1999.17.5.1474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer</span></div><div class="casAuthors">Harvey J M; Clark G M; Osborne C K; Allred D C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1474-81</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the traditional ligand-binding assay (LBA).  The purpose of this study was to evaluate the ability of ER status determination by IHC, compared with LBA, to predict clinical outcome-especially response to adjuvant endocrine therapy-in a large number of patients with long-term clinical follow-up.  PATIENTS AND METHODS:  ER status was evaluated in 1,982 primary breast cancers by IHC on formalin-fixed paraffin-embedded tissue sections, using antibody 6F11 and standard methodology.  Slides were scored on a scale representing the estimated proportion and intensity of positive-staining tumor cells (range, 0 to 8).  Results were compared with ER values obtained by the LBA in the same tumors and to clinical outcome.  RESULTS:  An IHC score of greater than 2 (corresponding to as few as 1% to 10% weakly positive cells) was used to define ER positivity on the basis of a univariate cut-point analysis of all possible scores and disease-free survival (DFS) in patients receiving any adjuvant endocrine therapy.  Using this definition, 71% of all tumors were determined to be ER-positive by IHC, and the level of agreement with the LBA was 86%.  In multivariate analyses of patients receiving adjuvant endocrine therapy alone, ER status determined by IHC was better than that determined by the LBA at predicting improved DFS (hazard ratios/P = 0.474/.0008 and 0.707/.3214, respectively) and equivalent at predicting overall survival (0.379/.0001 and 0.381/.0003, respectively).  CONCLUSION:  IHC is superior to the LBA for assessing ER status in primary breast cancer because it is easier, safer, and less expensive, and has an equivalent or better ability to predict response to adjuvant endocrine therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7IXUUuibgZ4USrryheKE6fW6udTcc2easzlP01WDLDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3msFOjsA%253D%253D&md5=3d682260f5876081bea69d26dabf43c8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1200%2FJCO.1999.17.5.1474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.1999.17.5.1474%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DG.%2BM.%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DAllred%26aufirst%3DD.%2BC.%26atitle%3DEstrogen%2520Receptor%2520Status%2520by%2520Immunohistochemistry%2520is%2520Superior%2520to%2520the%2520Ligand-Binding%2520Assay%2520for%2520Predicting%2520Response%2520to%2520Adjuvant%2520Endocrine%2520Therapy%2520in%2520Breast%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1999%26volume%3D17%26spage%3D1474%26epage%3D1481%26doi%3D10.1200%2FJCO.1999.17.5.1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i76"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01213">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55268"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01213">10.1021/acs.jmedchem.9b01213</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Reactivity of TG-AMP and TG-GMP with ENPPs, Michaelis–Menten plots of TG-mAMP, TG-mGMP, and <i>p</i>NP-TMP, optimization of screening condition, ENPP1 and ENPP3 inhibition curves of compounds <b>A</b>–<b>E</b>, competition analyses of compounds <b>A</b>–<b>C</b>, dose-dependent inhibition of compound <b>C</b> in MDA-MB-231 cells, normalized fluorescence intensity of each specimen by each weight, and purity data of four fluorescence probes (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and enzyme inhibition data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_001.pdf">jm9b01213_si_001.pdf (1.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01213/suppl_file/jm9b01213_si_002.csv">jm9b01213_si_002.csv (0.65 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01213&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01213%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-20%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01213" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991da7bd0c3bfe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
